AI 銘柄分析 · 10年

Smith & Nephew plc

SN. · GBP · 分析基準日 2026-11-06

{ "method": "旧株主の実日数別現金受取＋2037以降毎年固定株数のSBC交付・有償発行・申込金を同時評価する動的終価", "price_GBP": 11.61, "market_cap_oku": 97.20288656, "expected_PV_oku": 80.20475177, "expected_IRR": 0.0697092425, "expected_value_to_market": 0.82512726, "valuation_date": "2026-11-06", "calculation_status": "Verified actuals and explicit nonverified projections are distinguished.", "terminal_revision": "corrected_paid_issue_cash_and_nonconstant_dilution_per_year" }

10年期待年率6.97%

資本コスト9.50%

直近終値11.61 GBP2026-11-06

AIによるシナリオ分析です。基準日以降の出来事、株価や為替の変化は個別に確認が必要です。各数値は元の分析の単位と前提に従います。

分析の要約

{
"investment_thesis": "スポーツ医療の新製品回復と米国整形外科の再建が価値を左右。2026Q3の売上/利益見通し下方修正を起点に、SBCと資本配分を所有権台帳で別管理した。",
"principal_risks": "米国人工関節の売上構成下振れ、Bioactivesの米国償還による数量・価格減、股関節訴訟と製造品質、買収成果、FX、未確定の事業構成見直し。",
"cashflow_definition": "旧株主現金＝配当権利落ち日に確定した配当受取＋比例応募した買戻し代金。株式報酬交付・有償増資は旧株主の現金受領0。",
"terminal_definition": "2036-11-06時点の同一旧株主コホート価値。2037年以降の一定年株数を年次分母に反映。有償社員申込金は営業FCFEでなく調達資金として受け入れ、その年の発行前株主へ還元するという明示的な定常資本政策を適用。資本投入の受益を一度のみ計上し純負債を再控除しない。",
"status_and_limitation": "完全JSONは将来の定量モデルであり、日付と確率・為替・買戻し株価などは会社予想ではない。四半期末以降の正確な信託持分・株数・財務更新が必要。 2037以降の有償20万株/年・時価90%の想定は公表された制度確約ではない。将来の日付の再確認イベントはスケジュール上の目印で実際の監視や通知ではない。"
}

株数は2026年10月末の議決権株数から従業員信託20万株の未確認代理値を差し引く。予測はGBP/USD 1.3352固定。2037年以降の株式報酬と有償発行は仮定であり、毎年の希薄化と払込資金を反映する。予測の配当・買戻し・発行等の確認日を過ぎた場合、実績確認まで期待リターンを保留。2036年表示損益は暦年予測で、10年受取CFは終点まで。

事業

説明

関節置換・外傷/再建、スポーツ医療関節修復/関節鏡器具/耳鼻咽喉科、および高度創傷管理の医療機器・処置製品。病院の手術件数・保険償還・販売セット数に連動。

portfolio_2025_reported_usdm

orthopaedics: 2437
sports_medicine_ENT: 1934
advanced_wound: 1793

revenue_recognition

医療機器の大半は商品引渡しで売上認識。卸売向け創傷管理には流通在庫への曝露。

competitive_moat_and_risks

整形外科はZimmer Biomet、Stryker、DePuy Synthes等との技術・営業力競争が激しい。スポーツ分野ではREGENETEN、CARTIHEAL、TESSA、CORI等、創傷ではPICO、LEAF、ALLEVYN等が差別化要素。ただし製品承認と償還は販売保証ではない。

Orthopaedics_2026_Nov04_status

米国膝−7.3%、米国股関節−1.0%（2026Q3の基礎成長）、北米市場鈍化。LANDMARKセメントレス膝510(k)、CORI Hip 2027上市計画。DePuy Synthesとの協議は終了し事業売却/提携は未決定。

Sports_2026_Nov04_status

スポーツ関節修復2026Q3+11.2% underlying、REGENETEN/CARTIHEAL/TENDON SEAM。TESSAの追加FDA用途は申請段階。

Wound_2026_Nov04_status

2026Q3 Wound Bioactives−8.8% underlying。2026年米国皮膚代用物償還改定により数量・純価格がともに低下。PICO/LEAFデバイス+10.7%。

research_and_development

2026H1 R&D 150m USDはIFRS費用として営業利益に既に反映。予測も年次RD費用として営業利益に含め、無形資産への二重加算をしない。

manufacturing_litigation_legal_risks

金属対金属股関節訴訟、製造品質・供給制約、医療機器の回収、サイバー対策、薬機規制、訴訟賠償額超過。2025非IFRS調整にlegal and other 162m USDを含むため調整後利益を丸ごとIFRS基礎利益としない。

売上・利益の報告通貨はUSD。欧州・日本等の地域売上は為替で報告額と実質成長が乖離し得る。主計算はGBPUSD固定、FXの移動リスクは明記。

M_and_A

2026年1月Integrity Orthopaedics買収、H1現金買収支出221m USD。2025年末Bioventus持分の評価戻入109m USDは一過性のため永続化しない。

unverified_asp_volume_disclosure

処置件数×ネット単価を全製品全地域で会社が開示しているわけではない。実績数量・単価を捏造せず、2026=100指数・確定売上・仮定価格/数量成長率を完全台帳に分けた。

競争力・事業の質

score_10_assumed

strengths

内容を開く

1: スポーツ医療の二桁成長と新製品
2: 創傷管理の安定的な治療需要
3: 2025年実績FCF840m USD
4: 中期の営業効率改善余地

weaknesses

内容を開く

1: 米国Hip/Kneeのシェア・営業回復が遅延
2: 創傷Bioactives償還による数量・価格の同時圧迫
3: 金属対金属股関節訴訟
4: 買収ののれんと条件付対価
5: SBCと継続買戻しの資本配分リスク

NCI_treatment

FY2025・H1 2026のIFRS利益は親会社帰属利益、H1損益包括利益すべて親会社帰属。未公表将来NCI=0を仮定。

業界と環境

財務・資本配分

actual_reported_usdm

内容を開く

FY2025_parent_equity: 5289
H1_2026_parent_equity: 5180
FY2025_dividends_paid: 330
FY2025_own_share_purchases: 502
FY2025_equity_settled_SBC_expense: 43
H1_2026_equity_settled_SBC_expense: 34
H1_2026_own_share_purchase_equity_reduction: 250
H1_2026_own_share_purchase_cash_paid: 116
H1_2026_own_share_purchase_contingent_commitment: 113
H1_2026_lease_inclusive_gross_borrowings: 3785
H1_2026_cash: 754
H1_2026_reported_net_debt: 3019

2026_500m_USD_share_buyback_program

内容を開く

announcement_date: 2026-05-06
completed_USDm_end_Q3_2026: 250
programme_USDm_total: 500
not_yet_reported_as_completed_USDm: 250
full_completion_deadline_described: 2027-05頃、当初は発表から12か月内
注記: Remaining $250m is board programme not unconditional cash obligation; scenarios assume partial/full realization.

cohort_rule

基準日時点の外部実効株式の全てを旧株主コホートと置く。配当はex日の旧株主株数に確定した権利を支払日まで維持し、自己株取得には旧株主がその時点の外部保有比率で比例応札、受取現金と売却株数を同時記帳。非売却モデルに途中切替しない。

SBC_rule

売上原価・SG&A等に含まれるSBC費用控除後IFRS利益を採用。非現金SBCの資本繰入は利益計上の逆側であり株主の受取現金ではない。自己株/信託から従業員へ交付すると実効流通株が増え、旧コホート比率が減る。

buyback_rule

会社支払額は会社現金・資本を減らす。旧コホート応札受取は保有比率で按分。応札した旧株数は減るので、終価に全当初株数を掛け戻さない。

capital_ledger_identity

E_end=E_begin+IFRS_NI(after_SBC)+noncash_SBC_credit+issue_cash-issuer_cash_dividend-issuer_cash_buyback+OCI(assumed0); stock transfers within treasury/trust have no net total equity debit. Cash_end=Cash_begin+FCFE+issue_cash-company_payouts+borrowings-repayments. Debt_end=Debt_begin+borrowings-repayments.

fcfe_identity

FCFE_before_equity_payouts=IFRS_parent_NI+depreciation_amortization+noncash_SBC-charge-CAPEX-working_capital_investment-cash_acquisitions-lease_principal_paid. Interest/tax is already in NI. Avoid extra subtract of debt at terminal.

special_case_H1_buyback_commitment

At H1 2026 $250m is charged to total equity although only $116m has settled in cash; $113m future buyback obligation and $137m acquired consideration. Pre-basis cash proxy assumes $134m further settlement until Nov06, with zero duplicate equity debit.

unknown_and_sensitive

内容を開く

1: Nov06 precise trust shares not published: proxy 0.2m
2: Oct31-Nov06 precise treasury/issued movements not confirmed
3: Post-H1 2026 actual cash/balance/net debt unreported
4: All future buybacks/share issue/grants/ex-dates are assumptions

post_2036_employee_equity_financing_terminal_policy

内容を開く

full_year_old_holder_CFs_to_2036_are_unchanged: はい
paid_issuer_subscriptions_classification: employee cash -> company cash (equity financing, NOT trading FCFE or net income); same-year passes to pre-issuance stockholders in terminal policy; company does not retain or reinvest it
free_SBC_classification: no cash from new shares; IFRS SBC already expensed, FCFE noncash addback remains; extra effective economic shares dilute holders
repurchase_sensitivity: repurchase all employee shares at fair price and credit the same employee subscription proceeds against gross cost. No additional SBC accounting debit.
tranche_timing: annual aggregation at 2037-11-06 and each later anniversary, not actual forecast employee exercise dates
share_price_and_h_discount: future paid issue exercise price =90% x fair year-end stock price solved from continuation cash flows; hypothetical, not actual ShareSave plan exercise terms
source_key: company_fy2025_20f

評価の前提と確認

2025_revenue_usdm: 6164
2026_H1_revenue_usdm: 3097
2026_Q3_revenue_usdm: 1551
2026_FY_reported_revenue_proxy_usdm: 6411
計算式: Q4 estimated 1763 = FY reported growth target 6411 − H1 actual 3097 − Q3 actual 1551
2026_FY_revenue_growth_reported_proxy: 0.04007138
market_cap_oku_using_proxy: 97.20288656
2025_reported_EPS_USD: 0.721
FY2025_2026_H1_SBC_already_in_IFRS_profit: はい
FY2025_reporting_vs_normalization: 2025 IFRS親会社利益625mには金額・再現性の異なる一時要因があるため、調整後EPSAのみを終価へ延長しない。
market_PER_not_terminal_anchor: はい
market_PBR_not_terminal_anchor: はい
future_repayment_at_terminal_net_debt_not_subtracted: はい
initial_stock_price_not_used_for_perpetuity: 市場価格£11.61は旧株主投資額と2026-2036仮想買戻し価格曲線の起点のみ。2036終価は次期FCFE,k,g,希薄化で独立計算。
GBPUSD_fixed_conversion_is_scenario_assumption: はい
strict_calendar_ten_year_endpoint_note: 2026-11-06→2036-11-06は閏日3日を含み3653日、365.25除算の年数は10.001369。2026-11-06終値をt0、2036-11-06を指定終点として扱い、2036-11-07以降のキャッシュを期中CFに入れない。
post2036_market_multiple_not_used_to_set_issuer_subscription_price: はい
post2036_issuer_subscription_price_reference: Fair ex-issuance price solved from fundamental FCFE, 90% assumed discount. Market PER/PBR not used.

資本コストの前提

資本コスト

9.50%

applied_to

各旧株主コホートの時点別現金流入と同一集団の2036-11-06残存終価を現在価値に割り引く共通ハードル

currency

GBP

nominal

はい

component_based_reasoning

内容を開く

risk_free_nominal_assumed: 0.042
long_run_equity_risk_premium_assumed: 0.05
business_specific_risk_assumed: 0.003
sum: 0.095

注記

構成比率は分析上の仮定。英国債2026-11-06の実勢金利との厳密照合値ではない。各シナリオ終価のkは事業リスク別に別途設定。

事業別データ

事業別の内訳と、収録されている年度別データを確認できます。

事業別データを開く →

10年のシナリオ

シナリオごとの確率、期間内の株主還元・追加負担、終価です。金額は億GBP。株主の範囲や受取時点は各分析の前提を確認してください。

シナリオ	確率	株主還元・追加負担	終価
最良	8.0%	81.16	305.35
強気	22.0%	66.39	206.18
中立	40.0%	49.06	115.75
弱気	20.0%	26.02	42.30
最悪	10.0%	17.65	10.77

最良（確率 8.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.06
Sports_Medicine_ENT: 0.1
Advanced_Wound_Management: 0.07

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.011
Sports_Medicine_ENT: 0.011
Advanced_Wound_Management: 0.011

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.215

terminal_cost_of_equity

0.084

terminal_perpetual_total_FCFE_growth

0.03

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.57

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.24

annual_2027_plus_vested_awards_m_assumed

3.05

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.097

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

強気（確率 22.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.044
Sports_Medicine_ENT: 0.08
Advanced_Wound_Management: 0.053

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.006
Sports_Medicine_ENT: 0.009
Advanced_Wound_Management: 0.007

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.195

terminal_cost_of_equity

0.088

terminal_perpetual_total_FCFE_growth

0.024

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.5

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.2

annual_2027_plus_vested_awards_m_assumed

2.9

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.072

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

中立（確率 40.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.024
Sports_Medicine_ENT: 0.06
Advanced_Wound_Management: 0.035

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.002
Sports_Medicine_ENT: 0.006
Advanced_Wound_Management: 0.003

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.165

terminal_cost_of_equity

0.095

terminal_perpetual_total_FCFE_growth

0.018

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.43

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.2

annual_2027_plus_vested_awards_m_assumed

2.9

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.042

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

弱気（確率 20.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.004
Sports_Medicine_ENT: 0.025
Advanced_Wound_Management: 0.01

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: -0.006
Sports_Medicine_ENT: 0
Advanced_Wound_Management: -0.004

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.12

terminal_cost_of_equity

0.108

terminal_perpetual_total_FCFE_growth

0.008

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.12

2026_announced_500m_buyback_remaining_completion_fraction_assumed

0.8

annual_2027_plus_ESPP_new_shares_m_assumed

0.28

annual_2027_plus_vested_awards_m_assumed

3.15

buyback_execution_GBP_per_share_growth_from_11_61_assumed

-0.006

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

事業別の前提

内容を開く

id: consolidated
数量: 1
価格・単価: 52.94296745
営業利益: 6.35315609
注記: 2036年暦年の連結売上・SBC控除後のIFRS営業利益の予測。詳細内訳は年次台帳。

日付別キャッシュフロー

内容を開く

year: 0.106776180698
想定日: 2026-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.45
source_treasury_shares_m: 0.45
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9994628047

内容を開く

year: 0.112251882272
想定日: 2026-12-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.056
discounted_issuer_subscription_gbp: 10.441944
issuer_cash_proceeds_oku: 0.0058474885
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9993959941

内容を開く

year: 0.11498973306
想定日: 2026-12-18
金額: 0.8981989162
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.8987417615
assumed_execution_price_gbp: 11.601968
bought_total_shares_m: 7.74645927
tendered_old_cohort_shares_m: 7.74178036
old_holder_fraction_before: 0.9993959941
old_holder_fraction_after: 0.9993959941
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.323066392882
想定日: 2027-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2026
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2027-03-25

内容を開く

year: 0.35318275154
想定日: 2027-03-15
金額: 0.5987992775
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.5991611744
assumed_execution_price_gbp: 11.585349
bought_total_shares_m: 5.17171433
tendered_old_cohort_shares_m: 5.16859058
old_holder_fraction_before: 0.9993959941
old_holder_fraction_after: 0.9993959941
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.355920602327
想定日: 2027-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9983665468

内容を開く

year: 0.380561259411
想定日: 2027-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2026
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2027-03-26
payment_date: 2027-05-26
board_declaration_date_assumed: 2027-02-26
usd_per_share: 0.25
gbp_per_share: 0.18723787
entitled_old_cohort_shares_m: 824.3237941
issuer_economic_shares_m: 825.6724914
old_holder_entitlement_oku: 1.5434462891
issuer_dividend_liability_oku: 1.5459715612
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-03-04
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2027-03-25

内容を開く

year: 0.550308008214
想定日: 2027-05-26
金額: 1.5434462891
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.5459715612
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2026
dividend_kind: final

内容を開く

year: 0.607802874743
想定日: 2027-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9973012096

内容を開く

year: 0.777549623546
想定日: 2027-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.40022
issuer_cash_proceeds_oku: 0.0291206151
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9969634826

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2027-10-07

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9959390379

内容を開く

year: 0.917180013689
想定日: 2027-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2027-10-08
payment_date: 2027-11-05
board_declaration_date_assumed: 2027-08-04
usd_per_share: 0.1624
gbp_per_share: 0.12162972
entitled_old_cohort_shares_m: 824.3237941
issuer_economic_shares_m: 827.6849914
old_holder_entitlement_oku: 1.0026227094
issuer_dividend_liability_oku: 1.0067109242
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-09-16
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2027-10-07

内容を開く

year: 0.996577686516
想定日: 2027-11-05
金額: 1.0026227094
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.0067109242
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: interim

内容を開く

year: 1.108829568789
想定日: 2027-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9952572437

内容を開く

year: 1.338809034908
想定日: 2028-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2028-03-30

内容を開く

year: 1.357973990418
想定日: 2028-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9942363008

内容を開く

year: 1.368925393566
想定日: 2028-03-20
金額: 0.066946527
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.514746
bought_total_shares_m: 0.58476862
tendered_old_cohort_shares_m: 0.58139819
old_holder_fraction_before: 0.9942363008
old_holder_fraction_after: 0.9942363008
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.396303901437
想定日: 2028-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2028-03-31
payment_date: 2028-05-24
board_declaration_date_assumed: 2028-02-25
usd_per_share: 0.2078209
gbp_per_share: 0.15564777
entitled_old_cohort_shares_m: 823.7423959
issuer_economic_shares_m: 828.5177228
old_holder_entitlement_oku: 1.2821366306
issuer_dividend_liability_oku: 1.2895693202
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-03-09
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2028-03-30

内容を開く

year: 1.54688569473
想定日: 2028-05-24
金額: 1.2821366306
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.2895693202
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: final

内容を開く

year: 1.609856262834
想定日: 2028-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9931790104

内容を開く

year: 1.620807665982
想定日: 2028-06-20
金額: 0.0668753347
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.497305
bought_total_shares_m: 0.58565571
tendered_old_cohort_shares_m: 0.58166096
old_holder_fraction_before: 0.9931790104
old_holder_fraction_after: 0.9931790104
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.779603011636
想定日: 2028-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.337691
issuer_cash_proceeds_oku: 0.0289455338
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9928435959

内容を開く

year: 1.856262833676
想定日: 2028-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2028-10-05

内容を開く

year: 1.859000684463
想定日: 2028-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9918261623

内容を開く

year: 1.872689938398
想定日: 2028-09-20
金額: 0.0667842412
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.47989
bought_total_shares_m: 0.58654415
tendered_old_cohort_shares_m: 0.58174983
old_holder_fraction_before: 0.9918261623
old_holder_fraction_after: 0.9918261623
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.913757700205
想定日: 2028-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2028-10-06
payment_date: 2028-11-03
board_declaration_date_assumed: 2028-08-04
usd_per_share: 0.1480884
gbp_per_share: 0.11091099
entitled_old_cohort_shares_m: 822.5789851
issuer_economic_shares_m: 829.3580229
old_holder_entitlement_oku: 0.9123305243
issuer_dividend_liability_oku: 0.9198492226
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-09-14
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2028-10-05

内容を開く

year: 1.993155373032
想定日: 2028-11-03
金額: 0.9123305243
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.9198492226
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: interim

内容を開く

year: 2.108145106092
想定日: 2028-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9911485524

内容を開く

year: 2.121834360027
想定日: 2028-12-20
金額: 0.0667386146
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.46269
bought_total_shares_m: 0.58742426
tendered_old_cohort_shares_m: 0.5822247
old_holder_fraction_before: 0.9911485524
old_holder_fraction_after: 0.9911485524
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.335386721424
想定日: 2029-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2029-03-29

内容を開く

year: 2.357289527721
想定日: 2029-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9901331538

内容を開く

year: 2.368240930869
想定日: 2029-03-20
金額: 0.0678621168
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.445705
bought_total_shares_m: 0.59881304
tendered_old_cohort_shares_m: 0.59290465
old_holder_fraction_before: 0.9901331538
old_holder_fraction_after: 0.9901331538
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.392881587953
想定日: 2029-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2029-03-30
payment_date: 2029-05-23
board_declaration_date_assumed: 2029-02-26
usd_per_share: 0.2125797
gbp_per_share: 0.15921186
entitled_old_cohort_shares_m: 821.4038557
issuer_economic_shares_m: 829.5892856
old_holder_entitlement_oku: 1.3077723161
issuer_dividend_liability_oku: 1.3208044908
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-03-08
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2029-03-29

内容を開く

year: 2.543463381246
想定日: 2029-05-23
金額: 1.3077723161
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3208044908
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: final

内容を開く

year: 2.60643394935
想定日: 2029-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9890815853

内容を開く

year: 2.620123203285
想定日: 2029-06-20
金額: 0.067790044
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.428368
bought_total_shares_m: 0.59972144
tendered_old_cohort_shares_m: 0.59317343
old_holder_fraction_before: 0.9890815853
old_holder_fraction_after: 0.9890815853
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.778918548939
想定日: 2029-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.275707
issuer_cash_proceeds_oku: 0.0287719791
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9887479801

内容を開く

year: 2.852840520192
想定日: 2029-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2029-10-04

内容を開く

year: 2.855578370979
想定日: 2029-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.987736033

内容を開く

year: 2.872005475702
想定日: 2029-09-20
金額: 0.067697822
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.411058
bought_total_shares_m: 0.60063121
tendered_old_cohort_shares_m: 0.59326509
old_holder_fraction_before: 0.987736033
old_holder_fraction_after: 0.987736033
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.910335386721
想定日: 2029-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2029-10-05
payment_date: 2029-11-05
board_declaration_date_assumed: 2029-08-03
usd_per_share: 0.1442672
gbp_per_share: 0.10804914
entitled_old_cohort_shares_m: 820.2174172
issuer_economic_shares_m: 830.401433
old_holder_entitlement_oku: 0.8862378605
issuer_dividend_liability_oku: 0.8972416019
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-09-13
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2029-10-04

内容を開く

year: 2.99794661191
想定日: 2029-11-05
金額: 0.8862378605
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8972416019
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: interim

内容を開く

year: 3.104722792608
想定日: 2029-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9870620648

内容を開く

year: 3.121149897331
想定日: 2029-12-20
金額: 0.0676516293
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.393961
bought_total_shares_m: 0.60153246
tendered_old_cohort_shares_m: 0.59374987
old_holder_fraction_before: 0.9870620648
old_holder_fraction_after: 0.9870620648
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.33196440794
想定日: 2030-03-07
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2030-03-28

内容を開く

year: 3.353867214237
想定日: 2030-03-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9860521048

内容を開く

year: 3.367556468172
想定日: 2030-03-20
金額: 0.0688023463
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.377078
bought_total_shares_m: 0.61329957
tendered_old_cohort_shares_m: 0.60474534
old_holder_fraction_before: 0.9860521048
old_holder_fraction_after: 0.9860521048
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.38945927447
想定日: 2030-03-28
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2030-03-29
payment_date: 2030-05-22
board_declaration_date_assumed: 2030-02-26
usd_per_share: 0.2151309
gbp_per_share: 0.16112261
entitled_old_cohort_shares_m: 819.018922
issuer_economic_shares_m: 830.6041009
old_holder_entitlement_oku: 1.3196246617
issuer_dividend_liability_oku: 1.3382910043
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-03-07
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2030-03-28

内容を開く

year: 3.540041067762
想定日: 2030-05-22
金額: 1.3196246617
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3382910043
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: final

内容を開く

year: 3.603011635866
想定日: 2030-06-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9850061487

内容を開く

year: 3.619438740589
想定日: 2030-06-20
金額: 0.0687293641
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.359845
bought_total_shares_m: 0.61422995
tendered_old_cohort_shares_m: 0.60502027
old_holder_fraction_before: 0.9850061487
old_holder_fraction_after: 0.9850061487
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.775496235455
想定日: 2030-08-16
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.214263
issuer_cash_proceeds_oku: 0.0285999362
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.984674318

内容を開く

year: 3.849418206708
想定日: 2030-09-12
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2030-10-03

内容を開く

year: 3.860369609856
想定日: 2030-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9836677517

内容を開く

year: 3.871321013005
想定日: 2030-09-20
金額: 0.0686359767
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.342638
bought_total_shares_m: 0.61516173
tendered_old_cohort_shares_m: 0.60511476
old_holder_fraction_before: 0.9836677517
old_holder_fraction_after: 0.9836677517
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.906913073238
想定日: 2030-10-03
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2030-10-04
payment_date: 2030-11-05
board_declaration_date_assumed: 2030-08-02
usd_per_share: 0.1437592
gbp_per_share: 0.1076687
entitled_old_cohort_shares_m: 817.808787
issuer_economic_shares_m: 831.3872093
old_holder_entitlement_oku: 0.8805240867
issuer_dividend_liability_oku: 0.8951437974
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-09-12
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2030-10-03

内容を開く

year: 3.997262149213
想定日: 2030-11-05
金額: 0.8805240867
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8951437974
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: interim

内容を開く

year: 4.109514031485
想定日: 2030-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9829973547

内容を開く

year: 4.120465434634
想定日: 2030-12-20
金額: 0.0685891993
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.325644
bought_total_shares_m: 0.61608478
tendered_old_cohort_shares_m: 0.60560971
old_holder_fraction_before: 0.9829973547
old_holder_fraction_after: 0.9829973547
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.328542094456
想定日: 2031-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2031-03-27

内容を開く

year: 4.350444900753
想定日: 2031-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9819927276

内容を開く

year: 4.366872005476
想定日: 2031-03-20
金額: 0.0697611912
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.308862
bought_total_shares_m: 0.62818378
tendered_old_cohort_shares_m: 0.61687191
old_holder_fraction_before: 0.9819927276
old_holder_fraction_after: 0.9819927276
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.386036960986
想定日: 2031-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2031-03-28
payment_date: 2031-05-28
board_declaration_date_assumed: 2031-02-26
usd_per_share: 0.2144498
gbp_per_share: 0.16061246
entitled_old_cohort_shares_m: 816.5863054
issuer_economic_shares_m: 831.5604407
old_holder_entitlement_oku: 1.3115393474
issuer_dividend_liability_oku: 1.3355896745
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-03-06
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2031-03-27

内容を開く

year: 4.555783709788
想定日: 2031-05-28
金額: 1.3115393474
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3355896745
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: final

内容を開く

year: 4.607802874743
想定日: 2031-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9809522742

内容を開く

year: 4.618754277892
想定日: 2031-06-20
金額: 0.0696872769
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.291732
bought_total_shares_m: 0.62913674
tendered_old_cohort_shares_m: 0.61715311
old_holder_fraction_before: 0.9809522742
old_holder_fraction_after: 0.9809522742
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.772073921971
想定日: 2031-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.153186
issuer_cash_proceeds_oku: 0.0284289221
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9806221831

内容を開く

year: 4.845995893224
想定日: 2031-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2031-10-02

内容を開く

year: 4.859685147159
想定日: 2031-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.979620892

内容を開く

year: 4.867898699521
想定日: 2031-09-19
金額: 0.0695926949
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.274814
bought_total_shares_m: 0.63008075
tendered_old_cohort_shares_m: 0.61724027
old_holder_fraction_before: 0.979620892
old_holder_fraction_after: 0.979620892
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.903490759754
想定日: 2031-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2031-10-03
payment_date: 2031-11-05
board_declaration_date_assumed: 2031-08-04
usd_per_share: 0.1432836
gbp_per_share: 0.10731246
entitled_old_cohort_shares_m: 815.351912
issuer_economic_shares_m: 832.3137232
old_holder_entitlement_oku: 0.8749742237
issuer_dividend_liability_oku: 0.8931763612
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-09-11
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2031-10-02

内容を開く

year: 4.996577686516
想定日: 2031-11-05
金額: 0.8749742237
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8931763612
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: interim

内容を開く

year: 5.108829568789
想定日: 2031-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9789539957

内容を開く

year: 5.11704312115
想定日: 2031-12-19
金額: 0.0695453183
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.257922
bought_total_shares_m: 0.63102618
tendered_old_cohort_shares_m: 0.6177456
old_holder_fraction_before: 0.9789539957
old_holder_fraction_after: 0.9789539957
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.325119780972
想定日: 2032-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2032-03-25

内容を開く

year: 5.357973990418
想定日: 2032-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9779545957

内容を開く

year: 5.366187542779
想定日: 2032-03-19
金額: 0.0707579959
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.241055
bought_total_shares_m: 0.64364999
tendered_old_cohort_shares_m: 0.62946046
old_holder_fraction_before: 0.9779545957
old_holder_fraction_after: 0.9779545957
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.382614647502
想定日: 2032-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2032-03-26
payment_date: 2032-05-26
board_declaration_date_assumed: 2032-02-26
usd_per_share: 0.2138049
gbp_per_share: 0.16012949
entitled_old_cohort_shares_m: 814.1047059
issuer_economic_shares_m: 832.456547
old_holder_entitlement_oku: 1.3036217043
issuer_dividend_liability_oku: 1.3330084137
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-03-04
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2032-03-25

内容を開く

year: 5.552361396304
想定日: 2032-05-26
金額: 1.3036217043
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3330084137
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: final

内容を開く

year: 5.609856262834
想定日: 2032-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.976919535

内容を開く

year: 5.615331964408
想定日: 2032-06-18
金額: 0.0706831061
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.224213
bought_total_shares_m: 0.64461578
tendered_old_cohort_shares_m: 0.62973775
old_holder_fraction_before: 0.976919535
old_holder_fraction_after: 0.976919535
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.779603011636
想定日: 2032-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.09181
issuer_cash_proceeds_oku: 0.0282570682
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9765911484

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2032-10-07

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9755950266

内容を開く

year: 5.872689938398
想定日: 2032-09-20
金額: 0.0705872739
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.206842
bought_total_shares_m: 0.64561493
tendered_old_cohort_shares_m: 0.62985872
old_holder_fraction_before: 0.9755950266
old_holder_fraction_after: 0.9755950266
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.91923340178
想定日: 2032-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2032-10-08
payment_date: 2032-11-05
board_declaration_date_assumed: 2032-08-04
usd_per_share: 0.1428354
gbp_per_share: 0.10697678
entitled_old_cohort_shares_m: 812.8451094
issuer_economic_shares_m: 833.1788163
old_holder_entitlement_oku: 0.8695555324
issuer_dividend_liability_oku: 0.8913078775
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-09-16
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2032-10-07

内容を開く

year: 5.998631074606
想定日: 2032-11-05
金額: 0.8695555324
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8913078775
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: interim

内容を開く

year: 6.110882956879
想定日: 2032-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9749315601

内容を開く

year: 6.121834360027
想定日: 2032-12-20
金額: 0.0705392701
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.190052
bought_total_shares_m: 0.64658367
tendered_old_cohort_shares_m: 0.63037483
old_holder_fraction_before: 0.9749315601
old_holder_fraction_after: 0.9749315601
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.340862422998
想定日: 2033-03-10
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2033-03-31

内容を開く

year: 6.357289527721
想定日: 2033-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9739372804

内容を開く

year: 6.362765229295
想定日: 2033-03-18
金額: 0.0717931668
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.173839
bought_total_shares_m: 0.65970492
tendered_old_cohort_shares_m: 0.64251122
old_holder_fraction_before: 0.9739372804
old_holder_fraction_after: 0.9739372804
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.398357289528
想定日: 2033-03-31
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2033-04-01
payment_date: 2033-05-25
board_declaration_date_assumed: 2033-02-25
usd_per_share: 0.2132415
gbp_per_share: 0.15970754
entitled_old_cohort_shares_m: 811.5722234
issuer_economic_shares_m: 833.2900277
old_holder_entitlement_oku: 1.2961420304
issuer_dividend_liability_oku: 1.3308270014
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-03-10
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2033-03-31

内容を開く

year: 6.54893908282
想定日: 2033-05-25
金額: 1.2961420304
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3308270014
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: final

内容を開く

year: 6.609171800137
想定日: 2033-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9729075016

内容を開く

year: 6.620123203285
想定日: 2033-06-20
金額: 0.0717172573
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.156546
bought_total_shares_m: 0.66072746
tendered_old_cohort_shares_m: 0.6428267
old_holder_fraction_before: 0.9729075016
old_holder_fraction_after: 0.9729075016
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.778918548939
想定日: 2033-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.031301
issuer_cash_proceeds_oku: 0.0280876415
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9725807842

内容を開く

year: 6.858316221766
想定日: 2033-09-15
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2033-10-06

100

内容を開く

year: 6.861054072553
想定日: 2033-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9715897244

101

内容を開く

year: 6.872005475702
想定日: 2033-09-20
金額: 0.0716201182
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.139647
bought_total_shares_m: 0.66172978
tendered_old_cohort_shares_m: 0.64292986
old_holder_fraction_before: 0.9715897244
old_holder_fraction_after: 0.9715897244
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

102

内容を開く

year: 6.915811088296
想定日: 2033-10-06
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2033-10-07
payment_date: 2033-11-04
board_declaration_date_assumed: 2033-08-04
usd_per_share: 0.1424308
gbp_per_share: 0.10667373
entitled_old_cohort_shares_m: 810.2864668
issuer_economic_shares_m: 833.9800705
old_holder_entitlement_oku: 0.8643627837
issuer_dividend_liability_oku: 0.889637634
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-09-15
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2033-10-06

103

内容を開く

year: 6.995208761123
想定日: 2033-11-04
金額: 0.8643627837
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.889637634
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: interim

104

内容を開く

year: 7.110198494182
想定日: 2033-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9709296162

105

内容を開く

year: 7.121149897331
想定日: 2033-12-20
金額: 0.0715714588
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.122957
bought_total_shares_m: 0.6627227
tendered_old_cohort_shares_m: 0.6434571
old_holder_fraction_before: 0.9709296162
old_holder_fraction_after: 0.9709296162
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

106

内容を開く

year: 7.337440109514
想定日: 2034-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2034-03-30

107

内容を開く

year: 7.356605065024
想定日: 2034-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9699403492

108

内容を開く

year: 7.367556468172
想定日: 2034-03-20
金額: 0.0728667587
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.106475
bought_total_shares_m: 0.67640711
tendered_old_cohort_shares_m: 0.65607455
old_holder_fraction_before: 0.9699403492
old_holder_fraction_after: 0.9699403492
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

109

内容を開く

year: 7.394934976044
想定日: 2034-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2034-03-31
payment_date: 2034-05-24
board_declaration_date_assumed: 2034-02-24
usd_per_share: 0.2127452
gbp_per_share: 0.1593358
entitled_old_cohort_shares_m: 808.9869352
issuer_economic_shares_m: 834.0584407
old_holder_entitlement_oku: 1.2890058447
issuer_dividend_liability_oku: 1.3289537298
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-03-09
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2034-03-30

110

内容を開く

year: 7.545516769336
想定日: 2034-05-24
金額: 1.2890058447
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3289537298
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: final

111

内容を開く

year: 7.60848733744
想定日: 2034-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9689157403

112

内容を開く

year: 7.619438740589
想定日: 2034-06-20
金額: 0.072789785
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.089652
bought_total_shares_m: 0.67743322
tendered_old_cohort_shares_m: 0.65637571
old_holder_fraction_before: 0.9689157403
old_holder_fraction_after: 0.9689157403
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

113

内容を開く

year: 7.778234086242
想定日: 2034-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 9.971154
issuer_cash_proceeds_oku: 0.0279192306
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9685906565

114

内容を開く

year: 7.854893908282
想定日: 2034-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2034-10-05

115

内容を開く

year: 7.857631759069
想定日: 2034-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9676045507

116

内容を開く

year: 7.871321013005
想定日: 2034-09-20
金額: 0.0726912819
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.072855
bought_total_shares_m: 0.67846088
tendered_old_cohort_shares_m: 0.65648184
old_holder_fraction_before: 0.9676045507
old_holder_fraction_after: 0.9676045507
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

117

内容を開く

year: 7.912388774812
想定日: 2034-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2034-10-06
payment_date: 2034-11-03
board_declaration_date_assumed: 2034-08-04
usd_per_share: 0.1420704
gbp_per_share: 0.10640381
entitled_old_cohort_shares_m: 807.6740776
issuer_economic_shares_m: 834.7150466
old_holder_entitlement_oku: 0.8593960173
issuer_dividend_liability_oku: 0.8881686394
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-09-14
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2034-10-05

118

内容を開く

year: 7.991786447639
想定日: 2034-11-03
金額: 0.8593960173
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8881686394
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: interim

119

内容を開く

year: 8.106776180698
想定日: 2034-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9669477286

120

内容を開く

year: 8.120465434634
想定日: 2034-12-20
金額: 0.0726419381
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.056265
bought_total_shares_m: 0.67947891
tendered_old_cohort_shares_m: 0.65702059
old_holder_fraction_before: 0.9669477286
old_holder_fraction_after: 0.9669477286
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

121

内容を開く

year: 8.33401779603
想定日: 2035-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2035-03-29

122

内容を開く

year: 8.355920602327
想定日: 2035-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9659633656

123

内容を開く

year: 8.366872005476
想定日: 2035-03-20
金額: 0.0739789056
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 11.039882
bought_total_shares_m: 0.69371776
tendered_old_cohort_shares_m: 0.67010594
old_holder_fraction_before: 0.9659633656
old_holder_fraction_after: 0.9659633656
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

124

内容を開く

year: 8.39151266256
想定日: 2035-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2035-03-30
payment_date: 2035-05-23
board_declaration_date_assumed: 2035-02-26
usd_per_share: 0.2123162
gbp_per_share: 0.15901453
entitled_old_cohort_shares_m: 806.3469511
issuer_economic_shares_m: 834.7593499
old_holder_entitlement_oku: 1.2822087899
issuer_dividend_liability_oku: 1.3273886315
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-03-08
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2035-03-29

125

内容を開く

year: 8.542094455852
想定日: 2035-05-23
金額: 1.2822087899
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3273886315
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: final

126

内容を開く

year: 8.605065023956
想定日: 2035-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9649438138

127

内容を開く

year: 8.618754277892
想定日: 2035-06-20
金額: 0.0739008226
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 11.02316
bought_total_shares_m: 0.69477013
tendered_old_cohort_shares_m: 0.67041414
old_holder_fraction_before: 0.9649438138
old_holder_fraction_after: 0.9649438138
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

128

内容を開く

year: 8.777549623546
想定日: 2035-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 9.911368
issuer_cash_proceeds_oku: 0.0277518296
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9646203276

129

内容を開く

year: 8.851471594798
想定日: 2035-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2035-10-04

130

内容を開く

year: 8.854209445585
想定日: 2035-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9636390668

131

内容を開く

year: 8.870636550308
想定日: 2035-09-20
金額: 0.0738008978
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 11.006463
bought_total_shares_m: 0.69582409
tendered_old_cohort_shares_m: 0.67052328
old_holder_fraction_before: 0.9636390668
old_holder_fraction_after: 0.9636390668
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

132

内容を開く

year: 8.908966461328
想定日: 2035-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2035-10-05
payment_date: 2035-11-05
board_declaration_date_assumed: 2035-08-03
usd_per_share: 0.1417546
gbp_per_share: 0.10616734
entitled_old_cohort_shares_m: 805.0060137
issuer_economic_shares_m: 835.3812557
old_holder_entitlement_oku: 0.8546534401
issuer_dividend_liability_oku: 0.8869020253
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-09-13
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2035-10-04

133

内容を開く

year: 8.996577686516
想定日: 2035-11-05
金額: 0.8546534401
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8869020253
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: interim

134

内容を開く

year: 9.103353867214
想定日: 2035-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9629854578

135

内容を開く

year: 9.119780971937
想定日: 2035-12-20
金額: 0.0737508407
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 10.989973
bought_total_shares_m: 0.69686817
tendered_old_cohort_shares_m: 0.67107391
old_holder_fraction_before: 0.9629854578
old_holder_fraction_after: 0.9629854578
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

136

内容を開く

year: 9.330595482546
想定日: 2036-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2036-03-27

137

内容を開く

year: 9.352498288843
想定日: 2036-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9620058892

138

内容を開く

year: 9.368925393566
想定日: 2036-03-20
金額: 0.0682822598
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0709790455
assumed_execution_price_gbp: 10.973507
bought_total_shares_m: 0.64682188
tendered_old_cohort_shares_m: 0.62224646
old_holder_fraction_before: 0.9620058892
old_holder_fraction_after: 0.9620058892
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

139

内容を開く

year: 9.388090349076
想定日: 2036-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2036-03-28
payment_date: 2036-05-28
board_declaration_date_assumed: 2036-02-26
usd_per_share: 0.2119554
gbp_per_share: 0.15874434
entitled_old_cohort_shares_m: 803.7126933
issuer_economic_shares_m: 835.4550656
old_holder_entitlement_oku: 1.2758483902
issuer_dividend_liability_oku: 1.3262376089
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-03-06
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2036-03-27

140

内容を開く

year: 9.557837097878
想定日: 2036-05-28
金額: 1.2758483902
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3262376089
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: final

141

内容を開く

year: 9.609856262834
想定日: 2036-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.960991359

142

内容を開く

year: 9.620807665982
想定日: 2036-06-20
金額: 0.0682102494
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0709790455
assumed_execution_price_gbp: 10.956886
bought_total_shares_m: 0.64780311
tendered_old_cohort_shares_m: 0.62253319
old_holder_fraction_before: 0.960991359
old_holder_fraction_after: 0.960991359
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

143

内容を開く

year: 9.774127310062
想定日: 2036-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 9.852102
issuer_cash_proceeds_oku: 0.0275858867
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9606694841

144

内容を開く

year: 9.848049281314
想定日: 2036-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2036
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2036-10-02

145

内容を開く

year: 9.86173853525
想定日: 2036-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9596931097

146

内容を開く

year: 9.869952087611
想定日: 2036-09-19
金額: 0.0681181009
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0709790455
assumed_execution_price_gbp: 10.940469
bought_total_shares_m: 0.64877513
tendered_old_cohort_shares_m: 0.62262503
old_holder_fraction_before: 0.9596931097
old_holder_fraction_after: 0.9596931097
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

147

内容を開く

year: 9.905544147844
想定日: 2036-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2036
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2036-10-03
payment_date: 2036-11-05
board_declaration_date_assumed: 2036-08-04
usd_per_share: 0.141484
gbp_per_share: 0.10596467
entitled_old_cohort_shares_m: 802.4675351
issuer_economic_shares_m: 836.1709874
old_holder_entitlement_oku: 0.8503320708
issuer_dividend_liability_oku: 0.8860458226
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-09-11
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2036-10-02

148

内容を開く

year: 9.998631074606
想定日: 2036-11-05
金額: 0.8503320708
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8860458226
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2036
dividend_kind: interim

その他の数値・前提

label

弱気

scenario_status

analyst_assumption_not_company_guidance

drivers

内容を開く

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.004
Sports_Medicine_ENT: 0.025
Advanced_Wound_Management: 0.01

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: -0.006
Sports_Medicine_ENT: 0
Advanced_Wound_Management: -0.004

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.12

terminal_cost_of_equity

0.108

terminal_perpetual_total_FCFE_growth

0.008

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.12

2026_announced_500m_buyback_remaining_completion_fraction_assumed

0.8

annual_2027_plus_ESPP_new_shares_m_assumed

0.28

annual_2027_plus_vested_awards_m_assumed

3.15

buyback_execution_GBP_per_share_growth_from_11_61_assumed

-0.006

future_fixed_FX_USD_per_GBP

1.3352

annual_ledger

内容を開く

fiscal_year

2026

period_start_inclusive

2026-11-07

期間末

2026-12-31

days_booked

days_full_calendar_year

365

accrual_fraction_of_calendar_year

0.150684931507

is_partial_period

はい

period_status

発行会社実績からの部分期間推計

financials_oku_gbp

内容を開く

year

2026

revenue

7.50428151

revenue_usd_m

1001.97166667

cogs

2.1912502

sga_including_sbc

4.0088587

0.36395765

operating_profit

0.94021495

営業利益率

12.53%

finance_cost_net

0.0621808

associates_profit

0.00858174

pretax_profit

0.88661588

tax_expense

0.20392165

parent_profit_after_sbc

0.68269423

sbc_expense_within_sga

0.07674188

sbc_equity_credit

0.07674188

depreciation_amortization

0.6771342

capital_expenditure

0.49656508

net_working_capital_investment

-0.68986738

cash_acquisitions

lease_principal_paid

0.06997053

fcfe_before_equity_distributions

1.55990207

segment_revenue_usd_m

Orthopaedics: 390.445
Sports_Medicine_ENT: 330.77
Advanced_Wound_Management: 280.75666666667

geography_revenue_usd_m

未確認

volume_price_region_matrix

未確認

dividend_policy_normalization_usd_m

未確認

dividend_policy_adjusted_profit_proxy_usd_m

未確認

capital

内容を開く

begin_parent_equity_oku: 39.43229479
period_parent_profit_after_sbc_oku: 0.68269423
noncash_sbc_equity_credit_oku: 0.07674188
new_issue_cash_proceeds_oku: 0.00584749
issuer_paid_dividends_oku: 0
issuer_gross_buybacks_oku: 0.89874176
ending_parent_equity_oku: 39.29883662
begin_gross_financing_debt_oku: 28.34781306
begin_cash_oku: 6.05901738
operating_fcfe_before_distributions_oku: 1.55990207
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 2.22602518
ending_gross_financing_debt_oku: 26.12178788
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 21.62178788
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.750024
begin_treasury_m: 40.315859
begin_employee_trust_m: 0.2
begin_old_cohort_m: 837.234165
new_issuance_m: 0.056
treasury_or_trust_shares_delivered_to_employees_m: 0.45
issuer_buyback_shares_m: 7.7464593
old_cohort_proportionally_tendered_shares_m: 7.7417804
ending_issued_m: 877.806024
ending_treasury_m: 47.6123183
ending_employee_trust_m: 0.2
ending_economic_shares_m: 829.9937057
ending_old_cohort_shares_m: 829.4923846
ending_old_cohort_economic_fraction: 0.9993959941

old_holder_cash_oku

dividends_received_oku: 0
proportional_tender_proceeds_oku: 0.8981989162
total_received_oku: 0.8981989162

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

fy_2026_reported_guidance_sales_usd_m_proxy: 6411
fy_2026_full_year_IFRS_operating_profit_usd_m_estimate: 850
fy_2026_full_year_parent_profit_usd_m_estimate: 585
fy_2026_full_year_capex_usd_m_estimate: 440
fy_2026_full_year_sbc_usd_m_estimate: 68
fy_2026_full_year_fcf_usd_m_company_guidance: 750
h1_actual_sales_usd_m: 3097
q3_actual_sales_usd_m: 1551
q4_full_estimated_sales_usd_m: 1763
q4_post_basis_day_fraction: 0.57291666666667
full_year_is_forecast: はい

内容を開く

fiscal_year

2027

period_start_inclusive

2027-01-01

期間末

2027-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2027

segment_revenue_usd_m

Orthopaedics: 2484.82815
Sports_Medicine_ENT: 2158.55991
Advanced_Wound_Management: 1826.56168

geography_revenue_usd_m

US: 3368.98138
Other_Established: 1977.91594
Emerging: 1123.05241

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.1
net_realised_price_index_2026_100: 99.5
revenue_usd_m: 1364.01515
売上高: 10.21581151
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 100.6
net_realised_price_index_2026_100: 99.4
revenue_usd_m: 746.97311
売上高: 5.59446606
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 101
net_realised_price_index_2026_100: 99.1
revenue_usd_m: 373.83989
売上高: 2.79987931
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 102.2
net_realised_price_index_2026_100: 100.1
revenue_usd_m: 1184.96638
売上高: 8.87482312
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 102.7
net_realised_price_index_2026_100: 100
revenue_usd_m: 627.22998
売上高: 4.69764814
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 103.1
net_realised_price_index_2026_100: 99.7
revenue_usd_m: 346.36354
売上高: 2.59409484
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 100.7
net_realised_price_index_2026_100: 99.7
revenue_usd_m: 819.99985
売上高: 6.1414009
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 101.2
net_realised_price_index_2026_100: 99.6
revenue_usd_m: 603.71285
売上高: 4.52151626
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 101.6
net_realised_price_index_2026_100: 99.3
revenue_usd_m: 402.84898
売上高: 3.01714334
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

48.45678346

revenue_usd_m

6469.94972787

cogs

14.1881462

sga_including_sbc

25.54757154

2.35742252

operating_profit

6.36364321

営業利益率

13.13%

finance_cost_net

1.11048927

associates_profit

0.06740563

pretax_profit

5.32055957

tax_expense

1.2237287

parent_profit_after_sbc

4.09683087

sbc_expense_within_sga

0.52734617

sbc_equity_credit

0.52734617

depreciation_amortization

4.45802408

capital_expenditure

3.87654268

net_working_capital_investment

4.39692627

cash_acquisitions

0.43611105

lease_principal_paid

0.46033944

fcfe_before_equity_distributions

-0.08771832

dividend_policy_adjusted_profit_proxy_usd_m

808.63424618

dividend_policy_normalization_usd_m

261.62538816

capital

内容を開く

begin_parent_equity_oku: 39.29883662
period_parent_profit_after_sbc_oku: 4.09683087
noncash_sbc_equity_credit_oku: 0.52734617
new_issue_cash_proceeds_oku: 0.02912062
issuer_paid_dividends_oku: 2.55268249
issuer_gross_buybacks_oku: 0.59916117
ending_parent_equity_oku: 40.80029062
begin_gross_financing_debt_oku: 26.12178788
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: -0.08771832
additional_new_debt_borrowings_oku: 3.21044136
debt_principal_repayment_oku: 0
ending_gross_financing_debt_oku: 29.33222925
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 24.83222925
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.806024
begin_treasury_m: 47.6123183
begin_employee_trust_m: 0.2
begin_old_cohort_m: 829.4923846
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 5.1717143
old_cohort_proportionally_tendered_shares_m: 5.1685906
ending_issued_m: 878.086024
ending_treasury_m: 49.7340326
ending_employee_trust_m: 0.1
ending_economic_shares_m: 828.2519914
ending_old_cohort_shares_m: 824.3237941
ending_old_cohort_economic_fraction: 0.9952572437

old_holder_cash_oku

dividends_received_oku: 2.5460689984
proportional_tender_proceeds_oku: 0.5987992775
total_received_oku: 3.1448682759

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2028

period_start_inclusive

2028-01-01

期間末

2028-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2028

segment_revenue_usd_m

Orthopaedics: 2479.67857
Sports_Medicine_ENT: 2212.44138
Advanced_Wound_Management: 1838.2057

geography_revenue_usd_m

US: 3394.06158
Other_Established: 1999.62498
Emerging: 1136.63909

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.2001
net_realised_price_index_2026_100: 99.0025
revenue_usd_m: 1358.55227
売上高: 10.17489718
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 101.2036
net_realised_price_index_2026_100: 98.8036
revenue_usd_m: 746.94622
売上高: 5.59426466
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 102.01
net_realised_price_index_2026_100: 98.2081
revenue_usd_m: 374.18008
売上高: 2.8024272
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 104.4484
net_realised_price_index_2026_100: 100.2001
revenue_usd_m: 1212.24668
売上高: 9.07913929
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 105.4729
net_realised_price_index_2026_100: 100
revenue_usd_m: 644.16519
売上高: 4.82448464
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 106.2961
net_realised_price_index_2026_100: 99.4009
revenue_usd_m: 356.02951
売上高: 2.66648824
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 101.4049
net_realised_price_index_2026_100: 99.4009
revenue_usd_m: 823.26263
売上高: 6.16583753
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 102.4144
net_realised_price_index_2026_100: 99.2016
revenue_usd_m: 608.51357
売上高: 4.55747135
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 103.2256
net_realised_price_index_2026_100: 98.6049
revenue_usd_m: 406.4295
売上高: 3.04395971
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

48.90896981

revenue_usd_m

6530.32564906

cogs

14.35967354

sga_including_sbc

25.80106152

2.38675773

operating_profit

6.36147702

営業利益率

13.01%

finance_cost_net

1.2453278

associates_profit

0.06740563

pretax_profit

5.18355485

tax_expense

1.19221762

parent_profit_after_sbc

3.99133724

sbc_expense_within_sga

0.53049038

sbc_equity_credit

0.53049038

depreciation_amortization

4.49962522

capital_expenditure

3.91271758

net_working_capital_investment

0.14529751

cash_acquisitions

0.44018073

lease_principal_paid

0.46463521

fcfe_before_equity_distributions

4.05862181

dividend_policy_adjusted_profit_proxy_usd_m

786.11582068

dividend_policy_normalization_usd_m

253.19247296

capital

内容を開く

begin_parent_equity_oku: 40.80029062
period_parent_profit_after_sbc_oku: 3.99133724
noncash_sbc_equity_credit_oku: 0.53049038
new_issue_cash_proceeds_oku: 0.02894553
issuer_paid_dividends_oku: 2.20941854
issuer_gross_buybacks_oku: 0.26933849
ending_parent_equity_oku: 42.87230674
begin_gross_financing_debt_oku: 29.33222925
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.05862181
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.60881031
ending_gross_financing_debt_oku: 27.72341894
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 23.22341894
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.086024
begin_treasury_m: 49.7340326
begin_employee_trust_m: 0.1
begin_old_cohort_m: 824.3237941
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.3443927
old_cohort_proportionally_tendered_shares_m: 2.3270337
ending_issued_m: 878.366024
ending_treasury_m: 49.0284253
ending_employee_trust_m: 0
ending_economic_shares_m: 829.3375987
ending_old_cohort_shares_m: 821.9967604
ending_old_cohort_economic_fraction: 0.9911485524

old_holder_cash_oku

dividends_received_oku: 2.1944671549
proportional_tender_proceeds_oku: 0.2673447175
total_received_oku: 2.4618118725

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2029

period_start_inclusive

2029-01-01

期間末

2029-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2029

segment_revenue_usd_m

Orthopaedics: 2474.55118
Sports_Medicine_ENT: 2267.6779
Advanced_Wound_Management: 1849.93271

geography_revenue_usd_m

US: 3419.80468
Other_Established: 2021.82945
Emerging: 1150.52765

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.3003
net_realised_price_index_2026_100: 98.50749
revenue_usd_m: 1353.11127
売上高: 10.13414672
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 101.81082
net_realised_price_index_2026_100: 98.21078
revenue_usd_m: 746.91933
売上高: 5.59406326
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 103.0301
net_realised_price_index_2026_100: 97.32423
revenue_usd_m: 374.52058
売上高: 2.80497741
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 106.74626
net_realised_price_index_2026_100: 100.3003
revenue_usd_m: 1240.15502
売上高: 9.28815924
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 108.32067
net_realised_price_index_2026_100: 100
revenue_usd_m: 661.55765
売上高: 4.95474573
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 109.59128
net_realised_price_index_2026_100: 99.1027
revenue_usd_m: 365.96523
売上高: 2.74090193
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 102.11473
net_realised_price_index_2026_100: 99.1027
revenue_usd_m: 826.53839
売上高: 6.1903714
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 103.64337
net_realised_price_index_2026_100: 98.80479
revenue_usd_m: 613.35247
売上高: 4.59371236
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 104.87721
net_realised_price_index_2026_100: 97.91467
revenue_usd_m: 410.04185
売上高: 3.07101442
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

49.37209247

revenue_usd_m

6592.16178705

cogs

14.53514402

sga_including_sbc

26.0606031

2.41676393

operating_profit

6.35958142

営業利益率

12.88%

finance_cost_net

1.17775777

associates_profit

0.06740563

pretax_profit

5.24922928

tax_expense

1.20732273

parent_profit_after_sbc

4.04190655

sbc_expense_within_sga

0.53369981

sbc_equity_credit

0.53369981

depreciation_amortization

4.54223251

capital_expenditure

3.9497674

net_working_capital_investment

0.14737206

cash_acquisitions

0.44434883

lease_principal_paid

0.46903488

fcfe_before_equity_distributions

4.10731569

dividend_policy_adjusted_profit_proxy_usd_m

784.37466681

dividend_policy_normalization_usd_m

244.69930492

capital

内容を開く

begin_parent_equity_oku: 42.87230674
period_parent_profit_after_sbc_oku: 4.04190655
noncash_sbc_equity_credit_oku: 0.53369981
new_issue_cash_proceeds_oku: 0.02877198
issuer_paid_dividends_oku: 2.21804609
issuer_gross_buybacks_oku: 0.2741535
ending_parent_equity_oku: 44.98448548
begin_gross_financing_debt_oku: 27.72341894
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.10731569
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.64388808
ending_gross_financing_debt_oku: 26.07953086
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 21.57953086
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.366024
begin_treasury_m: 49.0284253
begin_employee_trust_m: 0
begin_old_cohort_m: 821.9967604
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.4006982
old_cohort_proportionally_tendered_shares_m: 2.373093
ending_issued_m: 878.646024
ending_treasury_m: 48.2791235
ending_employee_trust_m: 0
ending_economic_shares_m: 830.3669005
ending_old_cohort_shares_m: 819.6236673
ending_old_cohort_economic_fraction: 0.98706206476

old_holder_cash_oku

dividends_received_oku: 2.1940101765
proportional_tender_proceeds_oku: 0.2710016121
total_received_oku: 2.4650117887

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2030

period_start_inclusive

2030-01-01

期間末

2030-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2030

segment_revenue_usd_m

Orthopaedics: 2469.44589
Sports_Medicine_ENT: 2324.30379
Advanced_Wound_Management: 1861.74334

geography_revenue_usd_m

US: 3446.22512
Other_Established: 2044.542
Emerging: 1164.72591

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.4006
net_realised_price_index_2026_100: 98.01495
revenue_usd_m: 1347.69206
売上高: 10.09355946
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 102.42169
net_realised_price_index_2026_100: 97.62151
revenue_usd_m: 746.89244
売上高: 5.59386188
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 104.0604
net_realised_price_index_2026_100: 96.44831
revenue_usd_m: 374.8614
売上高: 2.80752993
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 109.09468
net_realised_price_index_2026_100: 100.4006
revenue_usd_m: 1268.70587
売上高: 9.50199124
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 111.24533
net_realised_price_index_2026_100: 100
revenue_usd_m: 679.41971
売上高: 5.08852386
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 112.98861
net_realised_price_index_2026_100: 98.80539
revenue_usd_m: 376.17822
売上高: 2.81739228
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 102.82954
net_realised_price_index_2026_100: 98.80539
revenue_usd_m: 829.82719
売上高: 6.21500289
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 104.88709
net_realised_price_index_2026_100: 98.40957
revenue_usd_m: 618.22985
売上高: 4.63024157
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 106.55524
net_realised_price_index_2026_100: 97.22926
revenue_usd_m: 413.6863
売上高: 3.0983096
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

49.84641271

revenue_usd_m

6655.4930251

cogs

14.71466103

sga_including_sbc

26.32634439

2.44745886

operating_profit

6.35794843

営業利益率

12.76%

finance_cost_net

1.10871447

associates_profit

0.06740563

pretax_profit

5.31663959

tax_expense

1.22282711

parent_profit_after_sbc

4.09381248

sbc_expense_within_sga

0.53697562

sbc_equity_credit

0.53697562

depreciation_amortization

4.58586997

capital_expenditure

3.98771302

net_working_capital_investment

0.14949645

cash_acquisitions

0.44861771

lease_principal_paid

0.47354092

fcfe_before_equity_distributions

4.15728997

dividend_policy_adjusted_profit_proxy_usd_m

782.7497367

dividend_policy_normalization_usd_m

236.14389402

capital

内容を開く

begin_parent_equity_oku: 44.98448548
period_parent_profit_after_sbc_oku: 4.09381248
noncash_sbc_equity_credit_oku: 0.53697562
new_issue_cash_proceeds_oku: 0.02859994
issuer_paid_dividends_oku: 2.2334348
issuer_gross_buybacks_oku: 0.27910227
ending_parent_equity_oku: 47.13133644
begin_gross_financing_debt_oku: 26.07953086
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.15728997
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.67335283
ending_gross_financing_debt_oku: 24.40617803
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 19.90617803
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.646024
begin_treasury_m: 48.2791235
begin_employee_trust_m: 0
begin_old_cohort_m: 819.6236673
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.458776
old_cohort_proportionally_tendered_shares_m: 2.4204901
ending_issued_m: 878.926024
ending_treasury_m: 47.5878995
ending_employee_trust_m: 0
ending_economic_shares_m: 831.3381245
ending_old_cohort_shares_m: 817.2031773
ending_old_cohort_economic_fraction: 0.98299735474

old_holder_cash_oku

dividends_received_oku: 2.2001487484
proportional_tender_proceeds_oku: 0.2747568864
total_received_oku: 2.4749056348

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2031

period_start_inclusive

2031-01-01

期間末

2031-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2031

segment_revenue_usd_m

Orthopaedics: 2464.36262
Sports_Medicine_ENT: 2382.35428
Advanced_Wound_Management: 1873.63823

geography_revenue_usd_m

US: 3473.33764
Other_Established: 2067.77561
Emerging: 1179.24188

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.501
net_realised_price_index_2026_100: 97.52488
revenue_usd_m: 1342.29455
売上高: 10.05313476
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 103.03622
net_realised_price_index_2026_100: 97.03578
revenue_usd_m: 746.86555
売上高: 5.5936605
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 105.10101
net_realised_price_index_2026_100: 95.58027
revenue_usd_m: 375.20252
売上高: 2.81008479
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 111.49477
net_realised_price_index_2026_100: 100.501
revenue_usd_m: 1297.91402
売上高: 9.72074608
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 114.24895
net_realised_price_index_2026_100: 100
revenue_usd_m: 697.76404
売上高: 5.22591401
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 116.49126
net_realised_price_index_2026_100: 98.50897
revenue_usd_m: 386.67622
売上高: 2.89601725
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 103.54934
net_realised_price_index_2026_100: 98.50897
revenue_usd_m: 833.12907
売上高: 6.23973239
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 106.14574
net_realised_price_index_2026_100: 98.01594
revenue_usd_m: 623.14602
売上高: 4.66706125
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 108.26013
net_realised_price_index_2026_100: 96.54866
revenue_usd_m: 417.36314
売上高: 3.12584737
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

50.33219838

revenue_usd_m

6720.35512826

cogs

14.89833072

sga_including_sbc

26.59843729

2.47886077

operating_profit

6.35656961

営業利益率

12.63%

finance_cost_net

1.03843365

associates_profit

0.06740563

pretax_profit

5.38554158

tax_expense

1.23867456

parent_profit_after_sbc

4.14686702

sbc_expense_within_sga

0.540319

sbc_equity_credit

0.540319

depreciation_amortization

4.63056225

capital_expenditure

4.02657587

net_working_capital_investment

0.15167189

cash_acquisitions

0.45298979

lease_principal_paid

0.47815588

fcfe_before_equity_distributions

4.20835484

dividend_policy_adjusted_profit_proxy_usd_m

781.21389375

dividend_policy_normalization_usd_m

227.52420923

capital

内容を開く

begin_parent_equity_oku: 47.13133644
period_parent_profit_after_sbc_oku: 4.14686702
noncash_sbc_equity_credit_oku: 0.540319
new_issue_cash_proceeds_oku: 0.02842892
issuer_paid_dividends_oku: 2.22876604
issuer_gross_buybacks_oku: 0.28416174
ending_parent_equity_oku: 49.33402361
begin_gross_financing_debt_oku: 24.40617803
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.20835484
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.72385599
ending_gross_financing_debt_oku: 22.68232205
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 18.18232205
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.926024
begin_treasury_m: 47.5878995
begin_employee_trust_m: 0
begin_old_cohort_m: 817.2031773
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.5184275
old_cohort_proportionally_tendered_shares_m: 2.4690109
ending_issued_m: 879.206024
ending_treasury_m: 46.956327
ending_employee_trust_m: 0
ending_economic_shares_m: 832.249697
ending_old_cohort_shares_m: 814.7341664
ending_old_cohort_economic_fraction: 0.97895399575

old_holder_cash_oku

dividends_received_oku: 2.1865135711
proportional_tender_proceeds_oku: 0.2785864813
total_received_oku: 2.4651000524

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2032

period_start_inclusive

2032-01-01

期間末

2032-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2032

segment_revenue_usd_m

Orthopaedics: 2459.30128
Sports_Medicine_ENT: 2441.86546
Advanced_Wound_Management: 1885.61803

geography_revenue_usd_m

US: 3501.15735
Other_Established: 2091.5436
Emerging: 1194.08382

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.6015
net_realised_price_index_2026_100: 97.03725
revenue_usd_m: 1336.91866
売上高: 10.01287195
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 103.65443
net_realised_price_index_2026_100: 96.45357
revenue_usd_m: 746.83866
売上高: 5.59345913
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 106.15202
net_realised_price_index_2026_100: 94.72005
revenue_usd_m: 375.54396
売上高: 2.81264196
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 113.94765
net_realised_price_index_2026_100: 100.6015
revenue_usd_m: 1327.79459
売上高: 9.9445371
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 117.33367
net_realised_price_index_2026_100: 100
revenue_usd_m: 716.60367
売上高: 5.36701368
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 120.10248
net_realised_price_index_2026_100: 98.21345
revenue_usd_m: 397.4672
売上高: 2.9768364
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 104.27419
net_realised_price_index_2026_100: 98.21345
revenue_usd_m: 836.44409
売上高: 6.26456028
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 107.41949
net_realised_price_index_2026_100: 97.62387
revenue_usd_m: 628.10127
売上高: 4.70417372
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 109.99229
net_realised_price_index_2026_100: 95.87282
revenue_usd_m: 421.07266
売上高: 3.1536299
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

50.82972413

revenue_usd_m

6786.78476588

cogs

15.08626212

sga_including_sbc

26.87703763

2.51098837

operating_profit

6.355436

営業利益率

12.50%

finance_cost_net

0.9660317

associates_profit

0.06740563

pretax_profit

5.45680993

tax_expense

1.25506628

parent_profit_after_sbc

4.20174365

sbc_expense_within_sga

0.54373117

sbc_equity_credit

0.54373117

depreciation_amortization

4.67633462

capital_expenditure

4.06637793

net_working_capital_investment

0.15389965

cash_acquisitions

0.45746752

lease_principal_paid

0.48288238

fcfe_before_equity_distributions

4.26118196

dividend_policy_adjusted_profit_proxy_usd_m

779.85499004

dividend_policy_normalization_usd_m

218.83817796

capital

内容を開く

begin_parent_equity_oku: 49.33402361
period_parent_profit_after_sbc_oku: 4.20174365
noncash_sbc_equity_credit_oku: 0.54373117
new_issue_cash_proceeds_oku: 0.02825707
issuer_paid_dividends_oku: 2.22431629
issuer_gross_buybacks_oku: 0.28941219
ending_parent_equity_oku: 51.59402701
begin_gross_financing_debt_oku: 22.68232205
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.26118196
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.77571054
ending_gross_financing_debt_oku: 20.90661151
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 16.40661151
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.206024
begin_treasury_m: 46.956327
begin_employee_trust_m: 0
begin_old_cohort_m: 814.7341664
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.5804644
old_cohort_proportionally_tendered_shares_m: 2.5194318
ending_issued_m: 879.486024
ending_treasury_m: 46.3867913
ending_employee_trust_m: 0
ending_economic_shares_m: 833.0992327
ending_old_cohort_shares_m: 812.2147346
ending_old_cohort_economic_fraction: 0.9749315601

old_holder_cash_oku

dividends_received_oku: 2.1731772367
proportional_tender_proceeds_oku: 0.2825676459
total_received_oku: 2.4557448826

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2033

period_start_inclusive

2033-01-01

期間末

2033-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2033

segment_revenue_usd_m

Orthopaedics: 2454.26178
Sports_Medicine_ENT: 2502.87436
Advanced_Wound_Management: 1897.68339

geography_revenue_usd_m

US: 3529.69968
Other_Established: 2115.85968
Emerging: 1209.26017

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.7021
net_realised_price_index_2026_100: 96.55206
revenue_usd_m: 1331.5643
売上高: 9.9727704
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 104.27636
net_realised_price_index_2026_100: 95.87485
revenue_usd_m: 746.81178
売上高: 5.59325776
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 107.21354
net_realised_price_index_2026_100: 93.86757
revenue_usd_m: 375.8857
売上高: 2.81520147
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 116.4545
net_realised_price_index_2026_100: 100.7021
revenue_usd_m: 1358.36308
売上高: 10.17348023
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 120.50168
net_realised_price_index_2026_100: 100
revenue_usd_m: 735.95197
売上高: 5.51192305
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 123.82566
net_realised_price_index_2026_100: 97.91881
revenue_usd_m: 408.55931
売上高: 3.05991097
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 105.00411
net_realised_price_index_2026_100: 97.91881
revenue_usd_m: 839.7723
売上高: 6.28948697
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 108.70852
net_realised_price_index_2026_100: 97.23338
revenue_usd_m: 633.09594
売上高: 4.74158131
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 111.75217
net_realised_price_index_2026_100: 95.20171
revenue_usd_m: 424.81516
売上高: 3.18165937
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

51.33927153

revenue_usd_m

6854.81953485

cogs

15.27856721

sga_including_sbc

27.16230527

2.5438609

operating_profit

6.35453815

営業利益率

12.38%

finance_cost_net

0.89145186

associates_profit

0.06740563

pretax_profit

5.53049193

tax_expense

1.27201314

parent_profit_after_sbc

4.25847878

sbc_expense_within_sga

0.54721334

sbc_equity_credit

0.54721334

depreciation_amortization

4.72321298

capital_expenditure

4.10714172

net_working_capital_investment

0.15618102

cash_acquisitions

0.46205344

lease_principal_paid

0.48772308

fcfe_before_equity_distributions

4.31580584

dividend_policy_adjusted_profit_proxy_usd_m

778.67577269

dividend_policy_normalization_usd_m

210.08368556

capital

内容を開く

begin_parent_equity_oku: 51.59402701
period_parent_profit_after_sbc_oku: 4.25847878
noncash_sbc_equity_credit_oku: 0.54721334
new_issue_cash_proceeds_oku: 0.02808764
issuer_paid_dividends_oku: 2.22046464
issuer_gross_buybacks_oku: 0.29485745
ending_parent_equity_oku: 53.91248469
begin_gross_financing_debt_oku: 20.90661151
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.31580584
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.82857139
ending_gross_financing_debt_oku: 19.07804012
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 14.57804012
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.486024
begin_treasury_m: 46.3867913
begin_employee_trust_m: 0
begin_old_cohort_m: 812.2147346
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.6448849
old_cohort_proportionally_tendered_shares_m: 2.5717249
ending_issued_m: 879.766024
ending_treasury_m: 45.8816762
ending_employee_trust_m: 0
ending_economic_shares_m: 833.8843478
ending_old_cohort_shares_m: 809.6430097
ending_old_cohort_economic_fraction: 0.97092961618

old_holder_cash_oku

dividends_received_oku: 2.1605048141
proportional_tender_proceeds_oku: 0.2867020011
total_received_oku: 2.4472068152

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2034

period_start_inclusive

2034-01-01

期間末

2034-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2034

segment_revenue_usd_m

Orthopaedics: 2449.24404
Sports_Medicine_ENT: 2565.41896
Advanced_Wound_Management: 1909.83498

geography_revenue_usd_m

US: 3558.98046
Other_Established: 2140.73788
Emerging: 1224.77965

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.80281
net_realised_price_index_2026_100: 96.0693
revenue_usd_m: 1326.23139
売上高: 9.93282945
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 104.90202
net_realised_price_index_2026_100: 95.2996
revenue_usd_m: 746.78489
売上高: 5.5930564
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 108.28567
net_realised_price_index_2026_100: 93.02276
revenue_usd_m: 376.22776
売上高: 2.8177633
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 119.0165
net_realised_price_index_2026_100: 100.80281
revenue_usd_m: 1389.63532
売上高: 10.4076941
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 123.75523
net_realised_price_index_2026_100: 100
revenue_usd_m: 755.82267
売上高: 5.66074498
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 127.66426
net_realised_price_index_2026_100: 97.62505
revenue_usd_m: 419.96098
売上高: 3.14530391
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 105.73914
net_realised_price_index_2026_100: 97.62505
revenue_usd_m: 843.11375
売上高: 6.31451284
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 110.01302
net_realised_price_index_2026_100: 96.84444
revenue_usd_m: 638.13031
売上高: 4.77928636
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 113.5402
net_realised_price_index_2026_100: 94.5353
revenue_usd_m: 428.59092
売上高: 3.20993796
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

51.86112929

revenue_usd_m

6924.49798325

cogs

15.47536098

sga_including_sbc

27.45440415

2.57749813

operating_profit

6.35386604

営業利益率

12.25%

finance_cost_net

0.81465186

associates_profit

0.06740563

pretax_profit

5.60661981

tax_expense

1.28952256

parent_profit_after_sbc

4.31709725

sbc_expense_within_sga

0.55076677

sbc_equity_credit

0.55076677

depreciation_amortization

4.77122389

capital_expenditure

4.14889034

net_working_capital_investment

0.15851732

cash_acquisitions

0.46675016

lease_principal_paid

0.49268073

fcfe_before_equity_distributions

4.37224936

dividend_policy_adjusted_profit_proxy_usd_m

777.67740001

dividend_policy_normalization_usd_m

201.25857478

capital

内容を開く

begin_parent_equity_oku: 53.91248469
period_parent_profit_after_sbc_oku: 4.31709725
noncash_sbc_equity_credit_oku: 0.55076677
new_issue_cash_proceeds_oku: 0.02791923
issuer_paid_dividends_oku: 2.21712237
issuer_gross_buybacks_oku: 0.30049996
ending_parent_equity_oku: 56.29064561
begin_gross_financing_debt_oku: 19.07804012
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.37224936
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.88254626
ending_gross_financing_debt_oku: 17.19549386
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 12.69549386
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.766024
begin_treasury_m: 45.8816762
begin_employee_trust_m: 0
begin_old_cohort_m: 809.6430097
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.7117801
old_cohort_proportionally_tendered_shares_m: 2.6259527
ending_issued_m: 880.046024
ending_treasury_m: 45.4434563
ending_employee_trust_m: 0
ending_economic_shares_m: 834.6025677
ending_old_cohort_shares_m: 807.0170571
ending_old_cohort_economic_fraction: 0.96694772855

old_holder_cash_oku

dividends_received_oku: 2.148401862
proportional_tender_proceeds_oku: 0.2909897636
total_received_oku: 2.4393916256

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2035

period_start_inclusive

2035-01-01

期間末

2035-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2035

segment_revenue_usd_m

Orthopaedics: 2444.24796
Sports_Medicine_ENT: 2629.53821
Advanced_Wound_Management: 1922.07346

geography_revenue_usd_m

US: 3589.01584
Other_Established: 2166.19262
Emerging: 1240.65118

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.90361
net_realised_price_index_2026_100: 95.58896
revenue_usd_m: 1320.91983
売上高: 9.89304847
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 105.53143
net_realised_price_index_2026_100: 94.7278
revenue_usd_m: 746.75801
売上高: 5.59285505
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 109.36853
net_realised_price_index_2026_100: 92.18556
revenue_usd_m: 376.57012
売上高: 2.82032747
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 121.63486
net_realised_price_index_2026_100: 100.90361
revenue_usd_m: 1421.6275
売上高: 10.64730003
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 127.09662
net_realised_price_index_2026_100: 100
revenue_usd_m: 776.22988
売上高: 5.81358509
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 131.62185
net_realised_price_index_2026_100: 97.33217
revenue_usd_m: 431.68083
売上高: 3.2330799
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 106.47931
net_realised_price_index_2026_100: 97.33217
revenue_usd_m: 846.4685
売上高: 6.33963828
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 111.33318
net_realised_price_index_2026_100: 96.45707
revenue_usd_m: 643.20473
売上高: 4.81729125
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 115.35685
net_realised_price_index_2026_100: 93.87355
revenue_usd_m: 432.40023
売上高: 3.23846788
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.39559343

revenue_usd_m

6995.85963481

cogs

15.67676155

sga_including_sbc

27.75350247

2.61192033

operating_profit

6.35340908

営業利益率

12.13%

finance_cost_net

0.73558492

associates_profit

0.06740563

pretax_profit

5.68522979

tax_expense

1.30760285

parent_profit_after_sbc

4.37762694

sbc_expense_within_sga

0.55439272

sbc_equity_credit

0.55439272

depreciation_amortization

4.8203946

capital_expenditure

4.19164747

net_working_capital_investment

0.16090992

cash_acquisitions

0.47156034

lease_principal_paid

0.49775814

fcfe_before_equity_distributions

4.43053837

dividend_policy_adjusted_profit_proxy_usd_m

776.86139408

dividend_policy_normalization_usd_m

192.36064529

capital

内容を開く

begin_parent_equity_oku: 56.29064561
period_parent_profit_after_sbc_oku: 4.37762694
noncash_sbc_equity_credit_oku: 0.55439272
new_issue_cash_proceeds_oku: 0.02775183
issuer_paid_dividends_oku: 2.21429066
issuer_gross_buybacks_oku: 0.30634249
ending_parent_equity_oku: 58.72978394
begin_gross_financing_debt_oku: 17.19549386
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.43053837
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.93765706
ending_gross_financing_debt_oku: 15.2578368
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 10.7578368
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 880.046024
begin_treasury_m: 45.4434563
begin_employee_trust_m: 0
begin_old_cohort_m: 807.0170571
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.7811802
old_cohort_proportionally_tendered_shares_m: 2.6821173
ending_issued_m: 880.326024
ending_treasury_m: 45.0746365
ending_employee_trust_m: 0
ending_economic_shares_m: 835.2513875
ending_old_cohort_shares_m: 804.3349398
ending_old_cohort_economic_fraction: 0.96298545779

old_holder_cash_oku

dividends_received_oku: 2.13686223
proportional_tender_proceeds_oku: 0.2954314668
total_received_oku: 2.4322936968

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2036

period_start_inclusive

2036-01-01

期間末

2036-11-06

days_booked

311

days_full_calendar_year

366

accrual_fraction_of_calendar_year

0.849726775956

is_partial_period

はい

period_status

暦年将来予測・最終期途中打切り

financials_oku_gbp

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 2072.7159813388
Sports_Medicine_ENT: 2290.2448208743
Advanced_Wound_Management: 1643.7110505464

geography_revenue_usd_m

US: 3075.8599834973
Other_Established: 1862.8039226776
Emerging: 1068.0079465847

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 101.00451
net_realised_price_index_2026_100: 95.11101
revenue_usd_m: 1117.92566
売上高: 8.3727206
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.16462
net_realised_price_index_2026_100: 94.15944
revenue_usd_m: 634.51743
売上高: 4.75222761
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 110.46221
net_realised_price_index_2026_100: 91.35589
revenue_usd_m: 320.2729
売上高: 2.39868858
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 124.31083
net_realised_price_index_2026_100: 101.00451
revenue_usd_m: 1235.80541
売上高: 9.25558277
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 130.52823
net_realised_price_index_2026_100: 100
revenue_usd_m: 677.39207
売上高: 5.07333781
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.70213
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 377.04735
売上高: 2.82390164
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 107.22467
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 722.12891
売上高: 5.40839511
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 112.66918
net_realised_price_index_2026_100: 96.07124
revenue_usd_m: 550.89443
売上高: 4.12593193
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 117.20256
net_realised_price_index_2026_100: 93.21643
revenue_usd_m: 370.68771
売上高: 2.77627099
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

44.98705704

revenue_usd_m

6006.67185601

cogs

13.49611711

sga_including_sbc

23.84314023

2.24935285

operating_profit

5.39844684

営業利益率

12.00%

finance_cost_net

0.55589408

associates_profit

0.05727637

pretax_profit

4.89982914

tax_expense

1.1269607

parent_profit_after_sbc

3.77286843

sbc_expense_within_sga

0.47422612

sbc_equity_credit

0.47422612

depreciation_amortization

4.13880925

capital_expenditure

3.59896456

net_working_capital_investment

0.13881154

cash_acquisitions

0.40488351

lease_principal_paid

0.42737704

fcfe_before_equity_distributions

3.81586714

dividend_policy_adjusted_profit_proxy_usd_m

776.22926723

dividend_policy_normalization_usd_m

183.38765314

capital

内容を開く

begin_parent_equity_oku: 58.72978394
period_parent_profit_after_sbc_oku: 3.77286843
noncash_sbc_equity_credit_oku: 0.47422612
new_issue_cash_proceeds_oku: 0.02758589
issuer_paid_dividends_oku: 2.21228343
issuer_gross_buybacks_oku: 0.21293714
ending_parent_equity_oku: 60.57924382
begin_gross_financing_debt_oku: 15.2578368
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 3.81586714
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.41823246
ending_gross_financing_debt_oku: 13.83960434
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 9.33960434
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 880.326024
begin_treasury_m: 45.0746365
begin_employee_trust_m: 0
begin_old_cohort_m: 804.3349398
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 2.583
issuer_buyback_shares_m: 1.9434001
old_cohort_proportionally_tendered_shares_m: 1.8674047
ending_issued_m: 880.606024
ending_treasury_m: 44.4350366
ending_employee_trust_m: 0
ending_economic_shares_m: 836.1709874
ending_old_cohort_shares_m: 802.4675351
ending_old_cohort_economic_fraction: 0.95969310967

old_holder_cash_oku

dividends_received_oku: 2.1261804611
proportional_tender_proceeds_oku: 0.2046106101
total_received_oku: 2.3307910712

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 2439.27347
Sports_Medicine_ENT: 2695.27204
Advanced_Wound_Management: 1934.3995

geography_revenue_usd_m

US: 3619.82236
Other_Established: 2192.2387
Emerging: 1256.88395

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 101.00451
net_realised_price_index_2026_100: 95.11101
revenue_usd_m: 1315.62955
売上高: 9.85342681
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.16462
net_realised_price_index_2026_100: 94.15944
revenue_usd_m: 746.73112
売上高: 5.59265371
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 110.46221
net_realised_price_index_2026_100: 91.35589
revenue_usd_m: 376.9128
売上高: 2.82289396
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 124.31083
net_realised_price_index_2026_100: 101.00451
revenue_usd_m: 1454.35621
売上高: 10.89242217
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 130.52823
net_realised_price_index_2026_100: 100
revenue_usd_m: 797.18809
売上高: 5.97055189
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.70213
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 443.72775
売上高: 3.32330547
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 107.22467
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 849.8366
売上高: 6.3648637
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 112.66918
net_realised_price_index_2026_100: 96.07124
revenue_usd_m: 648.31949
売上高: 4.85559835
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 117.20256
net_realised_price_index_2026_100: 93.21643
revenue_usd_m: 436.24341
売上高: 3.26725139
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.94296745

revenue_usd_m

7068.94501382

cogs

15.88289023

sga_including_sbc

28.05977275

2.64714837

operating_profit

6.35315609

営業利益率

12.00%

finance_cost_net

0.65420332

associates_profit

0.06740563

pretax_profit

5.7663584

tax_expense

1.32626243

parent_profit_after_sbc

4.44009597

sbc_expense_within_sga

0.55809247

sbc_equity_credit

0.55809247

depreciation_amortization

4.87075301

capital_expenditure

4.2354374

net_working_capital_investment

0.16336021

cash_acquisitions

0.47648671

lease_principal_paid

0.50295819

fcfe_before_equity_distributions

4.49069895

dividend_policy_adjusted_profit_proxy_usd_m

776.22926723

dividend_policy_normalization_usd_m

183.38765314

注記

2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。

financials_2026_to_2036_including_partial_periods

内容を開く

fiscal_year

2026

period_start_inclusive

2026-11-07

期間末

2026-12-31

days_booked

days_full_calendar_year

365

accrual_fraction_of_calendar_year

0.150684931507

is_partial_period

はい

period_status

発行会社実績からの部分期間推計

financials_oku_gbp

内容を開く

year

2026

revenue

7.50428151

revenue_usd_m

1001.97166667

cogs

2.1912502

sga_including_sbc

4.0088587

0.36395765

operating_profit

0.94021495

営業利益率

12.53%

finance_cost_net

0.0621808

associates_profit

0.00858174

pretax_profit

0.88661588

tax_expense

0.20392165

parent_profit_after_sbc

0.68269423

sbc_expense_within_sga

0.07674188

sbc_equity_credit

0.07674188

depreciation_amortization

0.6771342

capital_expenditure

0.49656508

net_working_capital_investment

-0.68986738

cash_acquisitions

lease_principal_paid

0.06997053

fcfe_before_equity_distributions

1.55990207

segment_revenue_usd_m

Orthopaedics: 390.445
Sports_Medicine_ENT: 330.77
Advanced_Wound_Management: 280.75666666667

geography_revenue_usd_m

未確認

volume_price_region_matrix

未確認

dividend_policy_normalization_usd_m

未確認

dividend_policy_adjusted_profit_proxy_usd_m

未確認

capital

内容を開く

begin_parent_equity_oku: 39.43229479
period_parent_profit_after_sbc_oku: 0.68269423
noncash_sbc_equity_credit_oku: 0.07674188
new_issue_cash_proceeds_oku: 0.00584749
issuer_paid_dividends_oku: 0
issuer_gross_buybacks_oku: 0.89874176
ending_parent_equity_oku: 39.29883662
begin_gross_financing_debt_oku: 28.34781306
begin_cash_oku: 6.05901738
operating_fcfe_before_distributions_oku: 1.55990207
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 2.22602518
ending_gross_financing_debt_oku: 26.12178788
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 21.62178788
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.750024
begin_treasury_m: 40.315859
begin_employee_trust_m: 0.2
begin_old_cohort_m: 837.234165
new_issuance_m: 0.056
treasury_or_trust_shares_delivered_to_employees_m: 0.45
issuer_buyback_shares_m: 7.7464593
old_cohort_proportionally_tendered_shares_m: 7.7417804
ending_issued_m: 877.806024
ending_treasury_m: 47.6123183
ending_employee_trust_m: 0.2
ending_economic_shares_m: 829.9937057
ending_old_cohort_shares_m: 829.4923846
ending_old_cohort_economic_fraction: 0.9993959941

old_holder_cash_oku

dividends_received_oku: 0
proportional_tender_proceeds_oku: 0.8981989162
total_received_oku: 0.8981989162

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

fy_2026_reported_guidance_sales_usd_m_proxy: 6411
fy_2026_full_year_IFRS_operating_profit_usd_m_estimate: 850
fy_2026_full_year_parent_profit_usd_m_estimate: 585
fy_2026_full_year_capex_usd_m_estimate: 440
fy_2026_full_year_sbc_usd_m_estimate: 68
fy_2026_full_year_fcf_usd_m_company_guidance: 750
h1_actual_sales_usd_m: 3097
q3_actual_sales_usd_m: 1551
q4_full_estimated_sales_usd_m: 1763
q4_post_basis_day_fraction: 0.57291666666667
full_year_is_forecast: はい

内容を開く

fiscal_year

2027

period_start_inclusive

2027-01-01

期間末

2027-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2027

segment_revenue_usd_m

Orthopaedics: 2484.82815
Sports_Medicine_ENT: 2158.55991
Advanced_Wound_Management: 1826.56168

geography_revenue_usd_m

US: 3368.98138
Other_Established: 1977.91594
Emerging: 1123.05241

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.1
net_realised_price_index_2026_100: 99.5
revenue_usd_m: 1364.01515
売上高: 10.21581151
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 100.6
net_realised_price_index_2026_100: 99.4
revenue_usd_m: 746.97311
売上高: 5.59446606
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 101
net_realised_price_index_2026_100: 99.1
revenue_usd_m: 373.83989
売上高: 2.79987931
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 102.2
net_realised_price_index_2026_100: 100.1
revenue_usd_m: 1184.96638
売上高: 8.87482312
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 102.7
net_realised_price_index_2026_100: 100
revenue_usd_m: 627.22998
売上高: 4.69764814
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 103.1
net_realised_price_index_2026_100: 99.7
revenue_usd_m: 346.36354
売上高: 2.59409484
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 100.7
net_realised_price_index_2026_100: 99.7
revenue_usd_m: 819.99985
売上高: 6.1414009
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 101.2
net_realised_price_index_2026_100: 99.6
revenue_usd_m: 603.71285
売上高: 4.52151626
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 101.6
net_realised_price_index_2026_100: 99.3
revenue_usd_m: 402.84898
売上高: 3.01714334
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

48.45678346

revenue_usd_m

6469.94972787

cogs

14.1881462

sga_including_sbc

25.54757154

2.35742252

operating_profit

6.36364321

営業利益率

13.13%

finance_cost_net

1.11048927

associates_profit

0.06740563

pretax_profit

5.32055957

tax_expense

1.2237287

parent_profit_after_sbc

4.09683087

sbc_expense_within_sga

0.52734617

sbc_equity_credit

0.52734617

depreciation_amortization

4.45802408

capital_expenditure

3.87654268

net_working_capital_investment

4.39692627

cash_acquisitions

0.43611105

lease_principal_paid

0.46033944

fcfe_before_equity_distributions

-0.08771832

dividend_policy_adjusted_profit_proxy_usd_m

808.63424618

dividend_policy_normalization_usd_m

261.62538816

capital

内容を開く

begin_parent_equity_oku: 39.29883662
period_parent_profit_after_sbc_oku: 4.09683087
noncash_sbc_equity_credit_oku: 0.52734617
new_issue_cash_proceeds_oku: 0.02912062
issuer_paid_dividends_oku: 2.55268249
issuer_gross_buybacks_oku: 0.59916117
ending_parent_equity_oku: 40.80029062
begin_gross_financing_debt_oku: 26.12178788
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: -0.08771832
additional_new_debt_borrowings_oku: 3.21044136
debt_principal_repayment_oku: 0
ending_gross_financing_debt_oku: 29.33222925
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 24.83222925
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.806024
begin_treasury_m: 47.6123183
begin_employee_trust_m: 0.2
begin_old_cohort_m: 829.4923846
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 5.1717143
old_cohort_proportionally_tendered_shares_m: 5.1685906
ending_issued_m: 878.086024
ending_treasury_m: 49.7340326
ending_employee_trust_m: 0.1
ending_economic_shares_m: 828.2519914
ending_old_cohort_shares_m: 824.3237941
ending_old_cohort_economic_fraction: 0.9952572437

old_holder_cash_oku

dividends_received_oku: 2.5460689984
proportional_tender_proceeds_oku: 0.5987992775
total_received_oku: 3.1448682759

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2028

period_start_inclusive

2028-01-01

期間末

2028-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2028

segment_revenue_usd_m

Orthopaedics: 2479.67857
Sports_Medicine_ENT: 2212.44138
Advanced_Wound_Management: 1838.2057

geography_revenue_usd_m

US: 3394.06158
Other_Established: 1999.62498
Emerging: 1136.63909

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.2001
net_realised_price_index_2026_100: 99.0025
revenue_usd_m: 1358.55227
売上高: 10.17489718
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 101.2036
net_realised_price_index_2026_100: 98.8036
revenue_usd_m: 746.94622
売上高: 5.59426466
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 102.01
net_realised_price_index_2026_100: 98.2081
revenue_usd_m: 374.18008
売上高: 2.8024272
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 104.4484
net_realised_price_index_2026_100: 100.2001
revenue_usd_m: 1212.24668
売上高: 9.07913929
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 105.4729
net_realised_price_index_2026_100: 100
revenue_usd_m: 644.16519
売上高: 4.82448464
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 106.2961
net_realised_price_index_2026_100: 99.4009
revenue_usd_m: 356.02951
売上高: 2.66648824
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 101.4049
net_realised_price_index_2026_100: 99.4009
revenue_usd_m: 823.26263
売上高: 6.16583753
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 102.4144
net_realised_price_index_2026_100: 99.2016
revenue_usd_m: 608.51357
売上高: 4.55747135
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 103.2256
net_realised_price_index_2026_100: 98.6049
revenue_usd_m: 406.4295
売上高: 3.04395971
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

48.90896981

revenue_usd_m

6530.32564906

cogs

14.35967354

sga_including_sbc

25.80106152

2.38675773

operating_profit

6.36147702

営業利益率

13.01%

finance_cost_net

1.2453278

associates_profit

0.06740563

pretax_profit

5.18355485

tax_expense

1.19221762

parent_profit_after_sbc

3.99133724

sbc_expense_within_sga

0.53049038

sbc_equity_credit

0.53049038

depreciation_amortization

4.49962522

capital_expenditure

3.91271758

net_working_capital_investment

0.14529751

cash_acquisitions

0.44018073

lease_principal_paid

0.46463521

fcfe_before_equity_distributions

4.05862181

dividend_policy_adjusted_profit_proxy_usd_m

786.11582068

dividend_policy_normalization_usd_m

253.19247296

capital

内容を開く

begin_parent_equity_oku: 40.80029062
period_parent_profit_after_sbc_oku: 3.99133724
noncash_sbc_equity_credit_oku: 0.53049038
new_issue_cash_proceeds_oku: 0.02894553
issuer_paid_dividends_oku: 2.20941854
issuer_gross_buybacks_oku: 0.26933849
ending_parent_equity_oku: 42.87230674
begin_gross_financing_debt_oku: 29.33222925
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.05862181
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.60881031
ending_gross_financing_debt_oku: 27.72341894
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 23.22341894
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.086024
begin_treasury_m: 49.7340326
begin_employee_trust_m: 0.1
begin_old_cohort_m: 824.3237941
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.3443927
old_cohort_proportionally_tendered_shares_m: 2.3270337
ending_issued_m: 878.366024
ending_treasury_m: 49.0284253
ending_employee_trust_m: 0
ending_economic_shares_m: 829.3375987
ending_old_cohort_shares_m: 821.9967604
ending_old_cohort_economic_fraction: 0.9911485524

old_holder_cash_oku

dividends_received_oku: 2.1944671549
proportional_tender_proceeds_oku: 0.2673447175
total_received_oku: 2.4618118725

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2029

period_start_inclusive

2029-01-01

期間末

2029-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2029

segment_revenue_usd_m

Orthopaedics: 2474.55118
Sports_Medicine_ENT: 2267.6779
Advanced_Wound_Management: 1849.93271

geography_revenue_usd_m

US: 3419.80468
Other_Established: 2021.82945
Emerging: 1150.52765

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.3003
net_realised_price_index_2026_100: 98.50749
revenue_usd_m: 1353.11127
売上高: 10.13414672
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 101.81082
net_realised_price_index_2026_100: 98.21078
revenue_usd_m: 746.91933
売上高: 5.59406326
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 103.0301
net_realised_price_index_2026_100: 97.32423
revenue_usd_m: 374.52058
売上高: 2.80497741
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 106.74626
net_realised_price_index_2026_100: 100.3003
revenue_usd_m: 1240.15502
売上高: 9.28815924
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 108.32067
net_realised_price_index_2026_100: 100
revenue_usd_m: 661.55765
売上高: 4.95474573
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 109.59128
net_realised_price_index_2026_100: 99.1027
revenue_usd_m: 365.96523
売上高: 2.74090193
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 102.11473
net_realised_price_index_2026_100: 99.1027
revenue_usd_m: 826.53839
売上高: 6.1903714
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 103.64337
net_realised_price_index_2026_100: 98.80479
revenue_usd_m: 613.35247
売上高: 4.59371236
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 104.87721
net_realised_price_index_2026_100: 97.91467
revenue_usd_m: 410.04185
売上高: 3.07101442
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

49.37209247

revenue_usd_m

6592.16178705

cogs

14.53514402

sga_including_sbc

26.0606031

2.41676393

operating_profit

6.35958142

営業利益率

12.88%

finance_cost_net

1.17775777

associates_profit

0.06740563

pretax_profit

5.24922928

tax_expense

1.20732273

parent_profit_after_sbc

4.04190655

sbc_expense_within_sga

0.53369981

sbc_equity_credit

0.53369981

depreciation_amortization

4.54223251

capital_expenditure

3.9497674

net_working_capital_investment

0.14737206

cash_acquisitions

0.44434883

lease_principal_paid

0.46903488

fcfe_before_equity_distributions

4.10731569

dividend_policy_adjusted_profit_proxy_usd_m

784.37466681

dividend_policy_normalization_usd_m

244.69930492

capital

内容を開く

begin_parent_equity_oku: 42.87230674
period_parent_profit_after_sbc_oku: 4.04190655
noncash_sbc_equity_credit_oku: 0.53369981
new_issue_cash_proceeds_oku: 0.02877198
issuer_paid_dividends_oku: 2.21804609
issuer_gross_buybacks_oku: 0.2741535
ending_parent_equity_oku: 44.98448548
begin_gross_financing_debt_oku: 27.72341894
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.10731569
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.64388808
ending_gross_financing_debt_oku: 26.07953086
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 21.57953086
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.366024
begin_treasury_m: 49.0284253
begin_employee_trust_m: 0
begin_old_cohort_m: 821.9967604
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.4006982
old_cohort_proportionally_tendered_shares_m: 2.373093
ending_issued_m: 878.646024
ending_treasury_m: 48.2791235
ending_employee_trust_m: 0
ending_economic_shares_m: 830.3669005
ending_old_cohort_shares_m: 819.6236673
ending_old_cohort_economic_fraction: 0.98706206476

old_holder_cash_oku

dividends_received_oku: 2.1940101765
proportional_tender_proceeds_oku: 0.2710016121
total_received_oku: 2.4650117887

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2030

period_start_inclusive

2030-01-01

期間末

2030-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2030

segment_revenue_usd_m

Orthopaedics: 2469.44589
Sports_Medicine_ENT: 2324.30379
Advanced_Wound_Management: 1861.74334

geography_revenue_usd_m

US: 3446.22512
Other_Established: 2044.542
Emerging: 1164.72591

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.4006
net_realised_price_index_2026_100: 98.01495
revenue_usd_m: 1347.69206
売上高: 10.09355946
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 102.42169
net_realised_price_index_2026_100: 97.62151
revenue_usd_m: 746.89244
売上高: 5.59386188
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 104.0604
net_realised_price_index_2026_100: 96.44831
revenue_usd_m: 374.8614
売上高: 2.80752993
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 109.09468
net_realised_price_index_2026_100: 100.4006
revenue_usd_m: 1268.70587
売上高: 9.50199124
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 111.24533
net_realised_price_index_2026_100: 100
revenue_usd_m: 679.41971
売上高: 5.08852386
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 112.98861
net_realised_price_index_2026_100: 98.80539
revenue_usd_m: 376.17822
売上高: 2.81739228
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 102.82954
net_realised_price_index_2026_100: 98.80539
revenue_usd_m: 829.82719
売上高: 6.21500289
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 104.88709
net_realised_price_index_2026_100: 98.40957
revenue_usd_m: 618.22985
売上高: 4.63024157
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 106.55524
net_realised_price_index_2026_100: 97.22926
revenue_usd_m: 413.6863
売上高: 3.0983096
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

49.84641271

revenue_usd_m

6655.4930251

cogs

14.71466103

sga_including_sbc

26.32634439

2.44745886

operating_profit

6.35794843

営業利益率

12.76%

finance_cost_net

1.10871447

associates_profit

0.06740563

pretax_profit

5.31663959

tax_expense

1.22282711

parent_profit_after_sbc

4.09381248

sbc_expense_within_sga

0.53697562

sbc_equity_credit

0.53697562

depreciation_amortization

4.58586997

capital_expenditure

3.98771302

net_working_capital_investment

0.14949645

cash_acquisitions

0.44861771

lease_principal_paid

0.47354092

fcfe_before_equity_distributions

4.15728997

dividend_policy_adjusted_profit_proxy_usd_m

782.7497367

dividend_policy_normalization_usd_m

236.14389402

capital

内容を開く

begin_parent_equity_oku: 44.98448548
period_parent_profit_after_sbc_oku: 4.09381248
noncash_sbc_equity_credit_oku: 0.53697562
new_issue_cash_proceeds_oku: 0.02859994
issuer_paid_dividends_oku: 2.2334348
issuer_gross_buybacks_oku: 0.27910227
ending_parent_equity_oku: 47.13133644
begin_gross_financing_debt_oku: 26.07953086
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.15728997
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.67335283
ending_gross_financing_debt_oku: 24.40617803
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 19.90617803
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.646024
begin_treasury_m: 48.2791235
begin_employee_trust_m: 0
begin_old_cohort_m: 819.6236673
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.458776
old_cohort_proportionally_tendered_shares_m: 2.4204901
ending_issued_m: 878.926024
ending_treasury_m: 47.5878995
ending_employee_trust_m: 0
ending_economic_shares_m: 831.3381245
ending_old_cohort_shares_m: 817.2031773
ending_old_cohort_economic_fraction: 0.98299735474

old_holder_cash_oku

dividends_received_oku: 2.2001487484
proportional_tender_proceeds_oku: 0.2747568864
total_received_oku: 2.4749056348

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2031

period_start_inclusive

2031-01-01

期間末

2031-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2031

segment_revenue_usd_m

Orthopaedics: 2464.36262
Sports_Medicine_ENT: 2382.35428
Advanced_Wound_Management: 1873.63823

geography_revenue_usd_m

US: 3473.33764
Other_Established: 2067.77561
Emerging: 1179.24188

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.501
net_realised_price_index_2026_100: 97.52488
revenue_usd_m: 1342.29455
売上高: 10.05313476
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 103.03622
net_realised_price_index_2026_100: 97.03578
revenue_usd_m: 746.86555
売上高: 5.5936605
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 105.10101
net_realised_price_index_2026_100: 95.58027
revenue_usd_m: 375.20252
売上高: 2.81008479
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 111.49477
net_realised_price_index_2026_100: 100.501
revenue_usd_m: 1297.91402
売上高: 9.72074608
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 114.24895
net_realised_price_index_2026_100: 100
revenue_usd_m: 697.76404
売上高: 5.22591401
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 116.49126
net_realised_price_index_2026_100: 98.50897
revenue_usd_m: 386.67622
売上高: 2.89601725
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 103.54934
net_realised_price_index_2026_100: 98.50897
revenue_usd_m: 833.12907
売上高: 6.23973239
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 106.14574
net_realised_price_index_2026_100: 98.01594
revenue_usd_m: 623.14602
売上高: 4.66706125
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 108.26013
net_realised_price_index_2026_100: 96.54866
revenue_usd_m: 417.36314
売上高: 3.12584737
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

50.33219838

revenue_usd_m

6720.35512826

cogs

14.89833072

sga_including_sbc

26.59843729

2.47886077

operating_profit

6.35656961

営業利益率

12.63%

finance_cost_net

1.03843365

associates_profit

0.06740563

pretax_profit

5.38554158

tax_expense

1.23867456

parent_profit_after_sbc

4.14686702

sbc_expense_within_sga

0.540319

sbc_equity_credit

0.540319

depreciation_amortization

4.63056225

capital_expenditure

4.02657587

net_working_capital_investment

0.15167189

cash_acquisitions

0.45298979

lease_principal_paid

0.47815588

fcfe_before_equity_distributions

4.20835484

dividend_policy_adjusted_profit_proxy_usd_m

781.21389375

dividend_policy_normalization_usd_m

227.52420923

capital

内容を開く

begin_parent_equity_oku: 47.13133644
period_parent_profit_after_sbc_oku: 4.14686702
noncash_sbc_equity_credit_oku: 0.540319
new_issue_cash_proceeds_oku: 0.02842892
issuer_paid_dividends_oku: 2.22876604
issuer_gross_buybacks_oku: 0.28416174
ending_parent_equity_oku: 49.33402361
begin_gross_financing_debt_oku: 24.40617803
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.20835484
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.72385599
ending_gross_financing_debt_oku: 22.68232205
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 18.18232205
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.926024
begin_treasury_m: 47.5878995
begin_employee_trust_m: 0
begin_old_cohort_m: 817.2031773
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.5184275
old_cohort_proportionally_tendered_shares_m: 2.4690109
ending_issued_m: 879.206024
ending_treasury_m: 46.956327
ending_employee_trust_m: 0
ending_economic_shares_m: 832.249697
ending_old_cohort_shares_m: 814.7341664
ending_old_cohort_economic_fraction: 0.97895399575

old_holder_cash_oku

dividends_received_oku: 2.1865135711
proportional_tender_proceeds_oku: 0.2785864813
total_received_oku: 2.4651000524

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2032

period_start_inclusive

2032-01-01

期間末

2032-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2032

segment_revenue_usd_m

Orthopaedics: 2459.30128
Sports_Medicine_ENT: 2441.86546
Advanced_Wound_Management: 1885.61803

geography_revenue_usd_m

US: 3501.15735
Other_Established: 2091.5436
Emerging: 1194.08382

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.6015
net_realised_price_index_2026_100: 97.03725
revenue_usd_m: 1336.91866
売上高: 10.01287195
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 103.65443
net_realised_price_index_2026_100: 96.45357
revenue_usd_m: 746.83866
売上高: 5.59345913
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 106.15202
net_realised_price_index_2026_100: 94.72005
revenue_usd_m: 375.54396
売上高: 2.81264196
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 113.94765
net_realised_price_index_2026_100: 100.6015
revenue_usd_m: 1327.79459
売上高: 9.9445371
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 117.33367
net_realised_price_index_2026_100: 100
revenue_usd_m: 716.60367
売上高: 5.36701368
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 120.10248
net_realised_price_index_2026_100: 98.21345
revenue_usd_m: 397.4672
売上高: 2.9768364
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 104.27419
net_realised_price_index_2026_100: 98.21345
revenue_usd_m: 836.44409
売上高: 6.26456028
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 107.41949
net_realised_price_index_2026_100: 97.62387
revenue_usd_m: 628.10127
売上高: 4.70417372
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 109.99229
net_realised_price_index_2026_100: 95.87282
revenue_usd_m: 421.07266
売上高: 3.1536299
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

50.82972413

revenue_usd_m

6786.78476588

cogs

15.08626212

sga_including_sbc

26.87703763

2.51098837

operating_profit

6.355436

営業利益率

12.50%

finance_cost_net

0.9660317

associates_profit

0.06740563

pretax_profit

5.45680993

tax_expense

1.25506628

parent_profit_after_sbc

4.20174365

sbc_expense_within_sga

0.54373117

sbc_equity_credit

0.54373117

depreciation_amortization

4.67633462

capital_expenditure

4.06637793

net_working_capital_investment

0.15389965

cash_acquisitions

0.45746752

lease_principal_paid

0.48288238

fcfe_before_equity_distributions

4.26118196

dividend_policy_adjusted_profit_proxy_usd_m

779.85499004

dividend_policy_normalization_usd_m

218.83817796

capital

内容を開く

begin_parent_equity_oku: 49.33402361
period_parent_profit_after_sbc_oku: 4.20174365
noncash_sbc_equity_credit_oku: 0.54373117
new_issue_cash_proceeds_oku: 0.02825707
issuer_paid_dividends_oku: 2.22431629
issuer_gross_buybacks_oku: 0.28941219
ending_parent_equity_oku: 51.59402701
begin_gross_financing_debt_oku: 22.68232205
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.26118196
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.77571054
ending_gross_financing_debt_oku: 20.90661151
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 16.40661151
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.206024
begin_treasury_m: 46.956327
begin_employee_trust_m: 0
begin_old_cohort_m: 814.7341664
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.5804644
old_cohort_proportionally_tendered_shares_m: 2.5194318
ending_issued_m: 879.486024
ending_treasury_m: 46.3867913
ending_employee_trust_m: 0
ending_economic_shares_m: 833.0992327
ending_old_cohort_shares_m: 812.2147346
ending_old_cohort_economic_fraction: 0.9749315601

old_holder_cash_oku

dividends_received_oku: 2.1731772367
proportional_tender_proceeds_oku: 0.2825676459
total_received_oku: 2.4557448826

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2033

period_start_inclusive

2033-01-01

期間末

2033-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2033

segment_revenue_usd_m

Orthopaedics: 2454.26178
Sports_Medicine_ENT: 2502.87436
Advanced_Wound_Management: 1897.68339

geography_revenue_usd_m

US: 3529.69968
Other_Established: 2115.85968
Emerging: 1209.26017

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.7021
net_realised_price_index_2026_100: 96.55206
revenue_usd_m: 1331.5643
売上高: 9.9727704
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 104.27636
net_realised_price_index_2026_100: 95.87485
revenue_usd_m: 746.81178
売上高: 5.59325776
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 107.21354
net_realised_price_index_2026_100: 93.86757
revenue_usd_m: 375.8857
売上高: 2.81520147
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 116.4545
net_realised_price_index_2026_100: 100.7021
revenue_usd_m: 1358.36308
売上高: 10.17348023
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 120.50168
net_realised_price_index_2026_100: 100
revenue_usd_m: 735.95197
売上高: 5.51192305
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 123.82566
net_realised_price_index_2026_100: 97.91881
revenue_usd_m: 408.55931
売上高: 3.05991097
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 105.00411
net_realised_price_index_2026_100: 97.91881
revenue_usd_m: 839.7723
売上高: 6.28948697
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 108.70852
net_realised_price_index_2026_100: 97.23338
revenue_usd_m: 633.09594
売上高: 4.74158131
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 111.75217
net_realised_price_index_2026_100: 95.20171
revenue_usd_m: 424.81516
売上高: 3.18165937
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

51.33927153

revenue_usd_m

6854.81953485

cogs

15.27856721

sga_including_sbc

27.16230527

2.5438609

operating_profit

6.35453815

営業利益率

12.38%

finance_cost_net

0.89145186

associates_profit

0.06740563

pretax_profit

5.53049193

tax_expense

1.27201314

parent_profit_after_sbc

4.25847878

sbc_expense_within_sga

0.54721334

sbc_equity_credit

0.54721334

depreciation_amortization

4.72321298

capital_expenditure

4.10714172

net_working_capital_investment

0.15618102

cash_acquisitions

0.46205344

lease_principal_paid

0.48772308

fcfe_before_equity_distributions

4.31580584

dividend_policy_adjusted_profit_proxy_usd_m

778.67577269

dividend_policy_normalization_usd_m

210.08368556

capital

内容を開く

begin_parent_equity_oku: 51.59402701
period_parent_profit_after_sbc_oku: 4.25847878
noncash_sbc_equity_credit_oku: 0.54721334
new_issue_cash_proceeds_oku: 0.02808764
issuer_paid_dividends_oku: 2.22046464
issuer_gross_buybacks_oku: 0.29485745
ending_parent_equity_oku: 53.91248469
begin_gross_financing_debt_oku: 20.90661151
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.31580584
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.82857139
ending_gross_financing_debt_oku: 19.07804012
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 14.57804012
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.486024
begin_treasury_m: 46.3867913
begin_employee_trust_m: 0
begin_old_cohort_m: 812.2147346
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.6448849
old_cohort_proportionally_tendered_shares_m: 2.5717249
ending_issued_m: 879.766024
ending_treasury_m: 45.8816762
ending_employee_trust_m: 0
ending_economic_shares_m: 833.8843478
ending_old_cohort_shares_m: 809.6430097
ending_old_cohort_economic_fraction: 0.97092961618

old_holder_cash_oku

dividends_received_oku: 2.1605048141
proportional_tender_proceeds_oku: 0.2867020011
total_received_oku: 2.4472068152

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2034

period_start_inclusive

2034-01-01

期間末

2034-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2034

segment_revenue_usd_m

Orthopaedics: 2449.24404
Sports_Medicine_ENT: 2565.41896
Advanced_Wound_Management: 1909.83498

geography_revenue_usd_m

US: 3558.98046
Other_Established: 2140.73788
Emerging: 1224.77965

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.80281
net_realised_price_index_2026_100: 96.0693
revenue_usd_m: 1326.23139
売上高: 9.93282945
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 104.90202
net_realised_price_index_2026_100: 95.2996
revenue_usd_m: 746.78489
売上高: 5.5930564
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 108.28567
net_realised_price_index_2026_100: 93.02276
revenue_usd_m: 376.22776
売上高: 2.8177633
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 119.0165
net_realised_price_index_2026_100: 100.80281
revenue_usd_m: 1389.63532
売上高: 10.4076941
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 123.75523
net_realised_price_index_2026_100: 100
revenue_usd_m: 755.82267
売上高: 5.66074498
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 127.66426
net_realised_price_index_2026_100: 97.62505
revenue_usd_m: 419.96098
売上高: 3.14530391
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 105.73914
net_realised_price_index_2026_100: 97.62505
revenue_usd_m: 843.11375
売上高: 6.31451284
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 110.01302
net_realised_price_index_2026_100: 96.84444
revenue_usd_m: 638.13031
売上高: 4.77928636
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 113.5402
net_realised_price_index_2026_100: 94.5353
revenue_usd_m: 428.59092
売上高: 3.20993796
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

51.86112929

revenue_usd_m

6924.49798325

cogs

15.47536098

sga_including_sbc

27.45440415

2.57749813

operating_profit

6.35386604

営業利益率

12.25%

finance_cost_net

0.81465186

associates_profit

0.06740563

pretax_profit

5.60661981

tax_expense

1.28952256

parent_profit_after_sbc

4.31709725

sbc_expense_within_sga

0.55076677

sbc_equity_credit

0.55076677

depreciation_amortization

4.77122389

capital_expenditure

4.14889034

net_working_capital_investment

0.15851732

cash_acquisitions

0.46675016

lease_principal_paid

0.49268073

fcfe_before_equity_distributions

4.37224936

dividend_policy_adjusted_profit_proxy_usd_m

777.67740001

dividend_policy_normalization_usd_m

201.25857478

capital

内容を開く

begin_parent_equity_oku: 53.91248469
period_parent_profit_after_sbc_oku: 4.31709725
noncash_sbc_equity_credit_oku: 0.55076677
new_issue_cash_proceeds_oku: 0.02791923
issuer_paid_dividends_oku: 2.21712237
issuer_gross_buybacks_oku: 0.30049996
ending_parent_equity_oku: 56.29064561
begin_gross_financing_debt_oku: 19.07804012
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.37224936
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.88254626
ending_gross_financing_debt_oku: 17.19549386
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 12.69549386
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.766024
begin_treasury_m: 45.8816762
begin_employee_trust_m: 0
begin_old_cohort_m: 809.6430097
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.7117801
old_cohort_proportionally_tendered_shares_m: 2.6259527
ending_issued_m: 880.046024
ending_treasury_m: 45.4434563
ending_employee_trust_m: 0
ending_economic_shares_m: 834.6025677
ending_old_cohort_shares_m: 807.0170571
ending_old_cohort_economic_fraction: 0.96694772855

old_holder_cash_oku

dividends_received_oku: 2.148401862
proportional_tender_proceeds_oku: 0.2909897636
total_received_oku: 2.4393916256

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2035

period_start_inclusive

2035-01-01

期間末

2035-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2035

segment_revenue_usd_m

Orthopaedics: 2444.24796
Sports_Medicine_ENT: 2629.53821
Advanced_Wound_Management: 1922.07346

geography_revenue_usd_m

US: 3589.01584
Other_Established: 2166.19262
Emerging: 1240.65118

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 100.90361
net_realised_price_index_2026_100: 95.58896
revenue_usd_m: 1320.91983
売上高: 9.89304847
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 105.53143
net_realised_price_index_2026_100: 94.7278
revenue_usd_m: 746.75801
売上高: 5.59285505
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 109.36853
net_realised_price_index_2026_100: 92.18556
revenue_usd_m: 376.57012
売上高: 2.82032747
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 121.63486
net_realised_price_index_2026_100: 100.90361
revenue_usd_m: 1421.6275
売上高: 10.64730003
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 127.09662
net_realised_price_index_2026_100: 100
revenue_usd_m: 776.22988
売上高: 5.81358509
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 131.62185
net_realised_price_index_2026_100: 97.33217
revenue_usd_m: 431.68083
売上高: 3.2330799
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 106.47931
net_realised_price_index_2026_100: 97.33217
revenue_usd_m: 846.4685
売上高: 6.33963828
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 111.33318
net_realised_price_index_2026_100: 96.45707
revenue_usd_m: 643.20473
売上高: 4.81729125
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 115.35685
net_realised_price_index_2026_100: 93.87355
revenue_usd_m: 432.40023
売上高: 3.23846788
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.39559343

revenue_usd_m

6995.85963481

cogs

15.67676155

sga_including_sbc

27.75350247

2.61192033

operating_profit

6.35340908

営業利益率

12.13%

finance_cost_net

0.73558492

associates_profit

0.06740563

pretax_profit

5.68522979

tax_expense

1.30760285

parent_profit_after_sbc

4.37762694

sbc_expense_within_sga

0.55439272

sbc_equity_credit

0.55439272

depreciation_amortization

4.8203946

capital_expenditure

4.19164747

net_working_capital_investment

0.16090992

cash_acquisitions

0.47156034

lease_principal_paid

0.49775814

fcfe_before_equity_distributions

4.43053837

dividend_policy_adjusted_profit_proxy_usd_m

776.86139408

dividend_policy_normalization_usd_m

192.36064529

capital

内容を開く

begin_parent_equity_oku: 56.29064561
period_parent_profit_after_sbc_oku: 4.37762694
noncash_sbc_equity_credit_oku: 0.55439272
new_issue_cash_proceeds_oku: 0.02775183
issuer_paid_dividends_oku: 2.21429066
issuer_gross_buybacks_oku: 0.30634249
ending_parent_equity_oku: 58.72978394
begin_gross_financing_debt_oku: 17.19549386
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 4.43053837
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.93765706
ending_gross_financing_debt_oku: 15.2578368
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 10.7578368
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 880.046024
begin_treasury_m: 45.4434563
begin_employee_trust_m: 0
begin_old_cohort_m: 807.0170571
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 3.15
issuer_buyback_shares_m: 2.7811802
old_cohort_proportionally_tendered_shares_m: 2.6821173
ending_issued_m: 880.326024
ending_treasury_m: 45.0746365
ending_employee_trust_m: 0
ending_economic_shares_m: 835.2513875
ending_old_cohort_shares_m: 804.3349398
ending_old_cohort_economic_fraction: 0.96298545779

old_holder_cash_oku

dividends_received_oku: 2.13686223
proportional_tender_proceeds_oku: 0.2954314668
total_received_oku: 2.4322936968

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2036

period_start_inclusive

2036-01-01

期間末

2036-11-06

days_booked

311

days_full_calendar_year

366

accrual_fraction_of_calendar_year

0.849726775956

is_partial_period

はい

period_status

暦年将来予測・最終期途中打切り

financials_oku_gbp

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 2072.7159813388
Sports_Medicine_ENT: 2290.2448208743
Advanced_Wound_Management: 1643.7110505464

geography_revenue_usd_m

US: 3075.8599834973
Other_Established: 1862.8039226776
Emerging: 1068.0079465847

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 101.00451
net_realised_price_index_2026_100: 95.11101
revenue_usd_m: 1117.92566
売上高: 8.3727206
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.16462
net_realised_price_index_2026_100: 94.15944
revenue_usd_m: 634.51743
売上高: 4.75222761
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 110.46221
net_realised_price_index_2026_100: 91.35589
revenue_usd_m: 320.2729
売上高: 2.39868858
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 124.31083
net_realised_price_index_2026_100: 101.00451
revenue_usd_m: 1235.80541
売上高: 9.25558277
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 130.52823
net_realised_price_index_2026_100: 100
revenue_usd_m: 677.39207
売上高: 5.07333781
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.70213
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 377.04735
売上高: 2.82390164
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 107.22467
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 722.12891
売上高: 5.40839511
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 112.66918
net_realised_price_index_2026_100: 96.07124
revenue_usd_m: 550.89443
売上高: 4.12593193
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 117.20256
net_realised_price_index_2026_100: 93.21643
revenue_usd_m: 370.68771
売上高: 2.77627099
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

44.98705704

revenue_usd_m

6006.67185601

cogs

13.49611711

sga_including_sbc

23.84314023

2.24935285

operating_profit

5.39844684

営業利益率

12.00%

finance_cost_net

0.55589408

associates_profit

0.05727637

pretax_profit

4.89982914

tax_expense

1.1269607

parent_profit_after_sbc

3.77286843

sbc_expense_within_sga

0.47422612

sbc_equity_credit

0.47422612

depreciation_amortization

4.13880925

capital_expenditure

3.59896456

net_working_capital_investment

0.13881154

cash_acquisitions

0.40488351

lease_principal_paid

0.42737704

fcfe_before_equity_distributions

3.81586714

dividend_policy_adjusted_profit_proxy_usd_m

776.22926723

dividend_policy_normalization_usd_m

183.38765314

capital

内容を開く

begin_parent_equity_oku: 58.72978394
period_parent_profit_after_sbc_oku: 3.77286843
noncash_sbc_equity_credit_oku: 0.47422612
new_issue_cash_proceeds_oku: 0.02758589
issuer_paid_dividends_oku: 2.21228343
issuer_gross_buybacks_oku: 0.21293714
ending_parent_equity_oku: 60.57924382
begin_gross_financing_debt_oku: 15.2578368
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 3.81586714
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.41823246
ending_gross_financing_debt_oku: 13.83960434
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 9.33960434
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 880.326024
begin_treasury_m: 45.0746365
begin_employee_trust_m: 0
begin_old_cohort_m: 804.3349398
new_issuance_m: 0.28
treasury_or_trust_shares_delivered_to_employees_m: 2.583
issuer_buyback_shares_m: 1.9434001
old_cohort_proportionally_tendered_shares_m: 1.8674047
ending_issued_m: 880.606024
ending_treasury_m: 44.4350366
ending_employee_trust_m: 0
ending_economic_shares_m: 836.1709874
ending_old_cohort_shares_m: 802.4675351
ending_old_cohort_economic_fraction: 0.95969310967

old_holder_cash_oku

dividends_received_oku: 2.1261804611
proportional_tender_proceeds_oku: 0.2046106101
total_received_oku: 2.3307910712

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 2439.27347
Sports_Medicine_ENT: 2695.27204
Advanced_Wound_Management: 1934.3995

geography_revenue_usd_m

US: 3619.82236
Other_Established: 2192.2387
Emerging: 1256.88395

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 101.00451
net_realised_price_index_2026_100: 95.11101
revenue_usd_m: 1315.62955
売上高: 9.85342681
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.16462
net_realised_price_index_2026_100: 94.15944
revenue_usd_m: 746.73112
売上高: 5.59265371
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 110.46221
net_realised_price_index_2026_100: 91.35589
revenue_usd_m: 376.9128
売上高: 2.82289396
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 124.31083
net_realised_price_index_2026_100: 101.00451
revenue_usd_m: 1454.35621
売上高: 10.89242217
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 130.52823
net_realised_price_index_2026_100: 100
revenue_usd_m: 797.18809
売上高: 5.97055189
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.70213
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 443.72775
売上高: 3.32330547
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 107.22467
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 849.8366
売上高: 6.3648637
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 112.66918
net_realised_price_index_2026_100: 96.07124
revenue_usd_m: 648.31949
売上高: 4.85559835
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 117.20256
net_realised_price_index_2026_100: 93.21643
revenue_usd_m: 436.24341
売上高: 3.26725139
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.94296745

revenue_usd_m

7068.94501382

cogs

15.88289023

sga_including_sbc

28.05977275

2.64714837

operating_profit

6.35315609

営業利益率

12.00%

finance_cost_net

0.65420332

associates_profit

0.06740563

pretax_profit

5.7663584

tax_expense

1.32626243

parent_profit_after_sbc

4.44009597

sbc_expense_within_sga

0.55809247

sbc_equity_credit

0.55809247

depreciation_amortization

4.87075301

capital_expenditure

4.2354374

net_working_capital_investment

0.16336021

cash_acquisitions

0.47648671

lease_principal_paid

0.50295819

fcfe_before_equity_distributions

4.49069895

dividend_policy_adjusted_profit_proxy_usd_m

776.22926723

dividend_policy_normalization_usd_m

183.38765314

注記

2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。

dividend_timetable_ex_dates

内容を開く

fiscal_year: 2026
kind: final
declaration_date_assumed: 2027-02-26
ex_date: 2027-03-25
record_date: 2027-03-26
payment_date: 2027-05-26
状態: all_future_dates_assumed
usd_per_share: 0.25
gbp_per_share_fixed_fx: 0.1872379
recheck_date_assumed: 2027-03-04
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2027
kind: interim
declaration_date_assumed: 2027-08-04
ex_date: 2027-10-07
record_date: 2027-10-08
payment_date: 2027-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1624
gbp_per_share_fixed_fx: 0.1216297
recheck_date_assumed: 2027-09-16
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2027
kind: final
declaration_date_assumed: 2028-02-25
ex_date: 2028-03-30
record_date: 2028-03-31
payment_date: 2028-05-24
状態: all_future_dates_assumed
usd_per_share: 0.2078209
gbp_per_share_fixed_fx: 0.1556478
recheck_date_assumed: 2028-03-09
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2028
kind: interim
declaration_date_assumed: 2028-08-04
ex_date: 2028-10-05
record_date: 2028-10-06
payment_date: 2028-11-03
状態: all_future_dates_assumed
usd_per_share: 0.1480884
gbp_per_share_fixed_fx: 0.110911
recheck_date_assumed: 2028-09-14
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2028
kind: final
declaration_date_assumed: 2029-02-26
ex_date: 2029-03-29
record_date: 2029-03-30
payment_date: 2029-05-23
状態: all_future_dates_assumed
usd_per_share: 0.2125797
gbp_per_share_fixed_fx: 0.1592119
recheck_date_assumed: 2029-03-08
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2029
kind: interim
declaration_date_assumed: 2029-08-03
ex_date: 2029-10-04
record_date: 2029-10-05
payment_date: 2029-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1442672
gbp_per_share_fixed_fx: 0.1080491
recheck_date_assumed: 2029-09-13
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2029
kind: final
declaration_date_assumed: 2030-02-26
ex_date: 2030-03-28
record_date: 2030-03-29
payment_date: 2030-05-22
状態: all_future_dates_assumed
usd_per_share: 0.2151309
gbp_per_share_fixed_fx: 0.1611226
recheck_date_assumed: 2030-03-07
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2030
kind: interim
declaration_date_assumed: 2030-08-02
ex_date: 2030-10-03
record_date: 2030-10-04
payment_date: 2030-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1437592
gbp_per_share_fixed_fx: 0.1076687
recheck_date_assumed: 2030-09-12
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2030
kind: final
declaration_date_assumed: 2031-02-26
ex_date: 2031-03-27
record_date: 2031-03-28
payment_date: 2031-05-28
状態: all_future_dates_assumed
usd_per_share: 0.2144498
gbp_per_share_fixed_fx: 0.1606125
recheck_date_assumed: 2031-03-06
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2031
kind: interim
declaration_date_assumed: 2031-08-04
ex_date: 2031-10-02
record_date: 2031-10-03
payment_date: 2031-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1432836
gbp_per_share_fixed_fx: 0.1073125
recheck_date_assumed: 2031-09-11
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2031
kind: final
declaration_date_assumed: 2032-02-26
ex_date: 2032-03-25
record_date: 2032-03-26
payment_date: 2032-05-26
状態: all_future_dates_assumed
usd_per_share: 0.2138049
gbp_per_share_fixed_fx: 0.1601295
recheck_date_assumed: 2032-03-04
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2032
kind: interim
declaration_date_assumed: 2032-08-04
ex_date: 2032-10-07
record_date: 2032-10-08
payment_date: 2032-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1428354
gbp_per_share_fixed_fx: 0.1069768
recheck_date_assumed: 2032-09-16
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2032
kind: final
declaration_date_assumed: 2033-02-25
ex_date: 2033-03-31
record_date: 2033-04-01
payment_date: 2033-05-25
状態: all_future_dates_assumed
usd_per_share: 0.2132415
gbp_per_share_fixed_fx: 0.1597075
recheck_date_assumed: 2033-03-10
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2033
kind: interim
declaration_date_assumed: 2033-08-04
ex_date: 2033-10-06
record_date: 2033-10-07
payment_date: 2033-11-04
状態: all_future_dates_assumed
usd_per_share: 0.1424308
gbp_per_share_fixed_fx: 0.1066737
recheck_date_assumed: 2033-09-15
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2033
kind: final
declaration_date_assumed: 2034-02-24
ex_date: 2034-03-30
record_date: 2034-03-31
payment_date: 2034-05-24
状態: all_future_dates_assumed
usd_per_share: 0.2127452
gbp_per_share_fixed_fx: 0.1593358
recheck_date_assumed: 2034-03-09
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2034
kind: interim
declaration_date_assumed: 2034-08-04
ex_date: 2034-10-05
record_date: 2034-10-06
payment_date: 2034-11-03
状態: all_future_dates_assumed
usd_per_share: 0.1420704
gbp_per_share_fixed_fx: 0.1064038
recheck_date_assumed: 2034-09-14
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2034
kind: final
declaration_date_assumed: 2035-02-26
ex_date: 2035-03-29
record_date: 2035-03-30
payment_date: 2035-05-23
状態: all_future_dates_assumed
usd_per_share: 0.2123162
gbp_per_share_fixed_fx: 0.1590145
recheck_date_assumed: 2035-03-08
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2035
kind: interim
declaration_date_assumed: 2035-08-03
ex_date: 2035-10-04
record_date: 2035-10-05
payment_date: 2035-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1417546
gbp_per_share_fixed_fx: 0.1061673
recheck_date_assumed: 2035-09-13
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2035
kind: final
declaration_date_assumed: 2036-02-26
ex_date: 2036-03-27
record_date: 2036-03-28
payment_date: 2036-05-28
状態: all_future_dates_assumed
usd_per_share: 0.2119554
gbp_per_share_fixed_fx: 0.1587443
recheck_date_assumed: 2036-03-06
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2036
kind: interim
declaration_date_assumed: 2036-08-04
ex_date: 2036-10-02
record_date: 2036-10-03
payment_date: 2036-11-05
状態: all_future_dates_assumed
usd_per_share: 0.141484
gbp_per_share_fixed_fx: 0.1059647
recheck_date_assumed: 2036-09-11
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

終価

42.301083593

期間内株主受取

26.015324632

terminal_2036_11_06

内容を開く

終了日

2036-11-06

date_status

forecast_not_announced

terminal_year_actual_days_over_365_25

10.001368925394

company_issued_shares_m

880.606024

treasury_shares_m

44.4350366

employee_trust_shares_m

company_economic_shares_m

836.1709874

old_cohort_remaining_shares_m

802.4675351

old_cohort_fraction

0.9596931097

company_parent_equity_book_oku

60.57924382

company_gross_debt_oku

13.83960434

company_cash_oku

4.5

company_simple_net_debt_oku

9.33960434

forward_12_months_2036_11_07_to_2037_11_06_company_fcfe_oku

4.56977812

forward_fcfe_blend

2036_year_end_55_days_over_leap_366: 0.150273224
2037_to_Nov06_310_days_over_365: 0.8493150685

long_run_total_company_fcfe_growth

0.008

next_12m_vested_and_new_shares_m

3.43

post_horizon_annual_share_dilution_fraction

0.004102031823

post_horizon_cohort_fcfe_growth_after_dilution

未確認

cashflow_to_old_cohort_forward_year_after_dilution_oku

4.39838428

terminal_k

0.108

terminal_denominator_k_minus_effective_old_growth

未確認

terminal_company_equivalent_value_without_extra_cash_oku

44.07771939

old_cohort_operating_terminal_oku

42.30108359

nonoperating_excess_cash_company_oku

nonoperating_excess_cash_old_cohort_oku

terminal_old_cohort_total_oku

42.30108359

terminal_remaining_cohort_implied_price_per_share_gbp

5.27137632

IFRS_2036_full_calendar_year_reference_not_booked_in_full

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 2439.27347
Sports_Medicine_ENT: 2695.27204
Advanced_Wound_Management: 1934.3995

geography_revenue_usd_m

US: 3619.82236
Other_Established: 2192.2387
Emerging: 1256.88395

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 101.00451
net_realised_price_index_2026_100: 95.11101
revenue_usd_m: 1315.62955
売上高: 9.85342681
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.16462
net_realised_price_index_2026_100: 94.15944
revenue_usd_m: 746.73112
売上高: 5.59265371
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 110.46221
net_realised_price_index_2026_100: 91.35589
revenue_usd_m: 376.9128
売上高: 2.82289396
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 124.31083
net_realised_price_index_2026_100: 101.00451
revenue_usd_m: 1454.35621
売上高: 10.89242217
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 130.52823
net_realised_price_index_2026_100: 100
revenue_usd_m: 797.18809
売上高: 5.97055189
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.70213
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 443.72775
売上高: 3.32330547
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 107.22467
net_realised_price_index_2026_100: 97.04018
revenue_usd_m: 849.8366
売上高: 6.3648637
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 112.66918
net_realised_price_index_2026_100: 96.07124
revenue_usd_m: 648.31949
売上高: 4.85559835
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 117.20256
net_realised_price_index_2026_100: 93.21643
revenue_usd_m: 436.24341
売上高: 3.26725139
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.94296745

revenue_usd_m

7068.94501382

cogs

15.88289023

sga_including_sbc

28.05977275

2.64714837

operating_profit

6.35315609

営業利益率

12.00%

finance_cost_net

0.65420332

associates_profit

0.06740563

pretax_profit

5.7663584

tax_expense

1.32626243

parent_profit_after_sbc

4.44009597

sbc_expense_within_sga

0.55809247

sbc_equity_credit

0.55809247

depreciation_amortization

4.87075301

capital_expenditure

4.2354374

net_working_capital_investment

0.16336021

cash_acquisitions

0.47648671

lease_principal_paid

0.50295819

fcfe_before_equity_distributions

4.49069895

dividend_policy_adjusted_profit_proxy_usd_m

776.22926723

dividend_policy_normalization_usd_m

183.38765314

注記

2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。

IFRS_2037_full_calendar_year_forward_reference

内容を開く

year

2037

segment_revenue_usd_m

Orthopaedics: 2434.32049
Sports_Medicine_ENT: 2762.66142
Advanced_Wound_Management: 1946.81377

geography_revenue_usd_m

US: 3651.41695
Other_Established: 2218.89134
Emerging: 1273.48739

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 101.10552
net_realised_price_index_2026_100: 94.63546
revenue_usd_m: 1310.36045
売上高: 9.81396384
volume_growth_assumed: 0.001
net_price_growth_assumed: -0.005
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.80161
net_realised_price_index_2026_100: 93.59448
revenue_usd_m: 746.70424
売上高: 5.59245238
volume_growth_assumed: 0.006
net_price_growth_assumed: -0.006
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 111.56683
net_realised_price_index_2026_100: 90.53369
revenue_usd_m: 377.25579
売上高: 2.8254628
volume_growth_assumed: 0.01
net_price_growth_assumed: -0.009
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 127.04567
net_realised_price_index_2026_100: 101.10552
revenue_usd_m: 1487.8384
売上高: 11.14318751
volume_growth_assumed: 0.022
net_price_growth_assumed: 0.001
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 134.05249
net_realised_price_index_2026_100: 100
revenue_usd_m: 818.71217
売上高: 6.13175679
volume_growth_assumed: 0.027
net_price_growth_assumed: 0
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 139.90889
net_realised_price_index_2026_100: 96.74906
revenue_usd_m: 456.11086
売上高: 3.41604895
volume_growth_assumed: 0.031
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 107.97524
net_realised_price_index_2026_100: 96.74906
revenue_usd_m: 853.2181
売上高: 6.3901895
volume_growth_assumed: 0.007
net_price_growth_assumed: -0.003
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 114.02121
net_realised_price_index_2026_100: 95.68695
revenue_usd_m: 653.47493
売上高: 4.89421006
volume_growth_assumed: 0.012
net_price_growth_assumed: -0.004
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 119.0778
net_realised_price_index_2026_100: 92.56392
revenue_usd_m: 440.12074
売上高: 3.29629072
volume_growth_assumed: 0.016
net_price_growth_assumed: -0.007
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

53.50356254

revenue_usd_m

7143.79567084

cogs

16.05106876

sga_including_sbc

28.35688815

2.67517813

operating_profit

6.42042751

営業利益率

12.00%

finance_cost_net

0.59463756

associates_profit

0.06740563

pretax_profit

5.89319558

tax_expense

1.35543498

parent_profit_after_sbc

4.5377606

sbc_expense_within_sga

0.56186735

sbc_equity_credit

0.56186735

depreciation_amortization

4.92232775

capital_expenditure

4.280285

net_working_capital_investment

0.16586961

cash_acquisitions

0.48153206

lease_principal_paid

0.50828384

fcfe_before_equity_distributions

4.58598518

dividend_policy_adjusted_profit_proxy_usd_m

780.21910499

dividend_policy_normalization_usd_m

174.33731026

perpetuity_continuation_mode

zero_further_discretionary_buybacks;constant_absolute_annual_free_SBC_and_paid_employee_shares;paid_issue_subscriptions_immediately_pass_through_to_preissue_equity_holders;post_issue_share_count_increases;no_double_debt_deduction

neutral_repurchase_cost_sensitivity

内容を開く

方法: at_year_end_repurchase_exactly_free_awards_plus_paid_issued_shares_at_endogenous_policy_fair_price;paid_subscription_funds_offset_gross_repurchase_spending
policy: alternative_only_do_not_combine_with_dilution_terminal
old_cohort_tender_rule: For comparison assume shares repurchased from each year's newly delivered employee cohort, so old cohort has no repurchase proceeds and maintains same original share count; not a forecast of actual corporate repurchase allocation.
new_shares_per_year_m: 3.43
free_award_shares_per_year_m: 3.15
paid_employee_shares_per_year_m: 0.28
price_for_replacement_gbp_per_share_endogenous: 5.30558467
replacement_policy_2036_terminal_equilibrium_price_GBP: 5.26347686
replacement_policy_2037_year_end_price_GBP: 5.30558467
employee_paid_subscription_price_GBP: 4.7750262
required_cash_oku_per_year: 0.181981554
gross_market_repurchase_oku_2037: 0.181981554
employee_subscription_proceeds_oku_2037: 0.013370073
incremental_net_cash_needed_oku_2037: 0.168611481
market_neutral_share_equivalent_dilution_m: 3.178
SBC_expense_recognised_in_IFRS_profit_next_year_oku: 0.56106876
SBC_expense_reference_period: 2036-11-07 to 2037-11-06 blend: 55/366 FY2036 SBC plus 310/365 FY2037 SBC, matching FCFE forward year
SBC_non_cash_addback_to_company_FCFE_next_year_oku: 0.56106876
additional_cash_required_minus_SBC_accounting_expense_oku: -0.392457281
company_forward_FCFE_after_cash_replacement_oku: 4.401166639
neutral_company_terminal_oku_excess_cash_excluded: 44.01166639
neutral_old_cohort_terminal_value_oku_including_separate_excess_cash: 42.237692981
cashflow_and_shares_reconcile: はい
計算式: P0 = 100*FCFE1 / [S0*(k-g)+(1+g)*(q_free+(1-h)*q_paid)]; P1=P0*(1+g); gross buyback=(q_free+q_paid)*P1/100; employee cash=q_paid*h*P1/100; net cash=(q_free+(1-h)*q_paid)*P1/100.
注記: 会社は全付与・発行株を時価買戻し、申込金は支払額から一度だけ控除する。SBC会計費用は既にIFRS費用に計上されFCFEで非現金戻入済みなので、追加費用として重複控除しない。

post_horizon_model_revision

v2_constant_absolute_shares_paid_issuance_cash_included

next_12m_free_SBC_deliveries_m

3.15

next_12m_employee_paid_issuance_m

0.28

post_horizon_annual_share_dilution_fraction_description

FIRST YEAR ONLY: q/S0; every future year uses q/(S0+(t-1)q).

post_horizon_cohort_fcfe_growth_after_dilution_reason

S_t=S_0+t*q, constant absolute q implies year-varying percentage dilution; single Gordon-growth rate is mathematically invalid.

cashflow_to_old_cohort_forward_year_after_dilution_note

先に旧株主へ配分されるFCFE及び有償申込金。交付後希薄化は次年度以降の分母に反映。

terminal_denominator_k_minus_effective_old_growth_reason

旧式の一定d永久成長分母を廃止。未来1100期間を年次株数で逆算。

post_horizon_year2_share_increase_fraction

0.0040852739

continuation_financing_dilution_audit

内容を開く

方法

constant_number_annual_issue_dynamic_share_denominator_1100_step_backward_recursion

future_issuer_cash_policy

All annual paid employee share plan capital proceeds assumed distributed to shareholders who held shares just before that year's new deliveries, as a separate capital distribution. No capital proceeds kept in cash or reinvested; this prevents double recognition. Future gross FCFE remains operating FCFE only.

first_continuation_year_2036_11_07_to_2037_11_06

はい

timing_convention

All employee deliveries/subscriptions and their pass-through are aggregated at the END of each 12-month continuation year. This is a valuation modeling convention, not an exercise or ex-date prediction.

from_company_2025_20f

内容を開く

2025_12_31_share_options_outstanding_m

3.259

2025_share_option_range_gbp_per_share

1: 8.43
2: 12.35

2025_maximum_long_term_awards_m

7.542

2037_options_terms_known

いいえ

source_key

company_fy2025_20f

pre2036_calendar_year_subscription_proceeds_recorded_in_equity_cash_ledger

はい

post2036_start_economic_shares_m

836.1709874

post2036_start_old_remaining_shares_m

802.4675351

annual_free_SBC_shares_m

3.15

annual_paid_employee_new_shares_m

0.28

annual_total_new_economic_shares_m

3.43

annual_paid_issuance_discount_factor_of_endogenous_market_price

0.9

discount_and_issue_volume_are_analyst_assumptions_not_issuer_confirmations

はい

2037_post_issue_fair_GBP_per_share_endogenous

5.292577516

2037_employee_subscription_price_GBP

4.763319764

2037_company_subscription_cash_oku

0.0133372953

2037_forward_12m_SBC_expense_oku_55days_2036_plus_310days_2037

0.561068762

FY2036_full_SBC_oku_reference

0.55809247

FY2037_full_SBC_oku_reference

0.56186735

2037_company_operating_FCFE_excluding_paid_subscription_oku

4.56977812

2037_company_cash_to_equity_preissue_oku

4.583115415

2037_old_operating_cash_oku

4.385584574

2037_old_subscription_cash_oku

0.01279971

2037_old_total_cash_oku

4.398384285

2037_end_economic_shares_m

839.6009874

2037_end_old_fraction

0.955772500441

2038_year2_dilution_fraction

0.0040852739

annual_issue_cash_not_recorded_as_IFRS_profit_or_operating_FCFE

はい

SBC_non_cash_addback_in_FCFE_and_dilution_recognized_once_each

はい

if_subscription_funds_were_reinvested_or_retained_policy_would_need_new_explicit_cash_asset_valuation

はい

first_20_continuation_years_annual_ledger

内容を開く

continuation_year: 1
period_start: 2036-11-07
期間末: 2037-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 836.1709874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 839.6009874
old_cohort_m: 802.4675351
old_fraction_open: 0.959693109654
old_fraction_close: 0.955772500441
share_count_increase_fraction_of_opening: 0.004102031823
future_operating_FCFE_before_subscriptions_oku: 4.56977812
market_price_post_annual_issue_GBP_endogenous: 5.29257752
paid_issue_price_GBP_per_share_assumed: 4.76331976
issuer_paid_subscription_cash_oku: 0.013337295
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013337295
issuer_payout_from_operations_oku: 4.56977812
issuer_total_cash_to_preissue_shares_oku: 4.583115415
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.385584574
old_cohort_subscription_proceeds_cash_oku: 0.01279971
old_cohort_total_cash_oku: 4.398384285
old_cohort_cash_PV_at_terminal_oku: 3.969660907
old_cohort_residual_shares_value_oku: 42.471216336
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 2
period_start: 2037-11-07
期間末: 2038-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 839.6009874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 843.0309874
old_cohort_m: 802.4675351
old_fraction_open: 0.955772500441
old_fraction_close: 0.95188379442
share_count_increase_fraction_of_opening: 0.0040852739
future_operating_FCFE_before_subscriptions_oku: 4.606336345
market_price_post_annual_issue_GBP_endogenous: 5.31394696
paid_issue_price_GBP_per_share_assumed: 4.78255227
issuer_paid_subscription_cash_oku: 0.013391146
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013391146
issuer_payout_from_operations_oku: 4.606336345
issuer_total_cash_to_preissue_shares_oku: 4.619727491
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.402609606
old_cohort_subscription_proceeds_cash_oku: 0.012798889
old_cohort_total_cash_oku: 4.415408496
old_cohort_cash_PV_at_terminal_oku: 3.596593608
old_cohort_residual_shares_value_oku: 42.642699204
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 3
period_start: 2038-11-07
期間末: 2039-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 843.0309874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 846.4609874
old_cohort_m: 802.4675351
old_fraction_open: 0.95188379442
old_fraction_close: 0.94802660376
share_count_increase_fraction_of_opening: 0.004068652341
future_operating_FCFE_before_subscriptions_oku: 4.643187036
market_price_post_annual_issue_GBP_endogenous: 5.33548535
paid_issue_price_GBP_per_share_assumed: 4.80193681
issuer_paid_subscription_cash_oku: 0.013445423
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013445423
issuer_payout_from_operations_oku: 4.643187036
issuer_total_cash_to_preissue_shares_oku: 4.656632459
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.419774494
old_cohort_subscription_proceeds_cash_oku: 0.01279848
old_cohort_total_cash_oku: 4.432572974
old_cohort_cash_PV_at_terminal_oku: 3.258641717
old_cohort_residual_shares_value_oku: 42.815537744
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 4
period_start: 2039-11-07
期間末: 2040-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 846.4609874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 849.8909874
old_cohort_m: 802.4675351
old_fraction_open: 0.94802660376
old_fraction_close: 0.94420054689
share_count_increase_fraction_of_opening: 0.004052165488
future_operating_FCFE_before_subscriptions_oku: 4.680332532
market_price_post_annual_issue_GBP_endogenous: 5.35719337
paid_issue_price_GBP_per_share_assumed: 4.82147403
issuer_paid_subscription_cash_oku: 0.013500127
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013500127
issuer_payout_from_operations_oku: 4.680332532
issuer_total_cash_to_preissue_shares_oku: 4.693832659
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.437079755
old_cohort_subscription_proceeds_cash_oku: 0.01279848
old_cohort_total_cash_oku: 4.449878235
old_cohort_cash_PV_at_terminal_oku: 2.952494421
old_cohort_residual_shares_value_oku: 42.989737586
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 5
period_start: 2040-11-07
期間末: 2041-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 849.8909874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 853.3209874
old_cohort_m: 802.4675351
old_fraction_open: 0.94420054689
old_fraction_close: 0.940405248376
share_count_increase_fraction_of_opening: 0.004035811711
future_operating_FCFE_before_subscriptions_oku: 4.717775192
market_price_post_annual_issue_GBP_endogenous: 5.37907175
paid_issue_price_GBP_per_share_assumed: 4.84116457
issuer_paid_subscription_cash_oku: 0.013555261
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013555261
issuer_payout_from_operations_oku: 4.717775192
issuer_total_cash_to_preissue_shares_oku: 4.731330453
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.454525917
old_cohort_subscription_proceeds_cash_oku: 0.012798885
old_cohort_total_cash_oku: 4.467324801
old_cohort_cash_PV_at_terminal_oku: 2.675153627
old_cohort_residual_shares_value_oku: 43.165304444
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 6
period_start: 2041-11-07
期間末: 2042-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 853.3209874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 856.7509874
old_cohort_m: 802.4675351
old_fraction_open: 0.940405248376
old_fraction_close: 0.936640338793
share_count_increase_fraction_of_opening: 0.004019589405
future_operating_FCFE_before_subscriptions_oku: 4.755517394
market_price_post_annual_issue_GBP_endogenous: 5.40112119
paid_issue_price_GBP_per_share_assumed: 4.86100907
issuer_paid_subscription_cash_oku: 0.013610825
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013610825
issuer_payout_from_operations_oku: 4.755517394
issuer_total_cash_to_preissue_shares_oku: 4.769128219
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.472113516
old_cohort_subscription_proceeds_cash_oku: 0.012799692
old_cohort_total_cash_oku: 4.484913208
old_cohort_cash_PV_at_terminal_oku: 2.423904364
old_cohort_residual_shares_value_oku: 43.342244116
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 7
period_start: 2042-11-07
期間末: 2043-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 856.7509874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 860.1809874
old_cohort_m: 802.4675351
old_fraction_open: 0.936640338793
old_fraction_close: 0.932905454613
share_count_increase_fraction_of_opening: 0.004003496991
future_operating_FCFE_before_subscriptions_oku: 4.793561533
market_price_post_annual_issue_GBP_endogenous: 5.42334245
paid_issue_price_GBP_per_share_assumed: 4.88100821
issuer_paid_subscription_cash_oku: 0.013666823
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013666823
issuer_payout_from_operations_oku: 4.793561533
issuer_total_cash_to_preissue_shares_oku: 4.807228356
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.489843098
old_cohort_subscription_proceeds_cash_oku: 0.012800898
old_cohort_total_cash_oku: 4.502643996
old_cohort_cash_PV_at_terminal_oku: 2.196287996
old_cohort_residual_shares_value_oku: 43.520562485
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 8
period_start: 2043-11-07
期間末: 2044-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 860.1809874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 863.6109874
old_cohort_m: 802.4675351
old_fraction_open: 0.932905454613
old_fraction_close: 0.929200238079
share_count_increase_fraction_of_opening: 0.003987532915
future_operating_FCFE_before_subscriptions_oku: 4.831910025
market_price_post_annual_issue_GBP_endogenous: 5.44573626
paid_issue_price_GBP_per_share_assumed: 4.90116263
issuer_paid_subscription_cash_oku: 0.013723255
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013723255
issuer_payout_from_operations_oku: 4.831910025
issuer_total_cash_to_preissue_shares_oku: 4.845633281
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.507715219
old_cohort_subscription_proceeds_cash_oku: 0.0128025
old_cohort_total_cash_oku: 4.520517719
old_cohort_cash_PV_at_terminal_oku: 1.990077973
old_cohort_residual_shares_value_oku: 43.700265515
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 9
period_start: 2044-11-07
期間末: 2045-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 863.6109874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 867.0409874
old_cohort_m: 802.4675351
old_fraction_open: 0.929200238079
old_fraction_close: 0.925524337098
share_count_increase_fraction_of_opening: 0.003971695648
future_operating_FCFE_before_subscriptions_oku: 4.870565305
market_price_post_annual_issue_GBP_endogenous: 5.46830337
paid_issue_price_GBP_per_share_assumed: 4.92147303
issuer_paid_subscription_cash_oku: 0.013780124
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013780124
issuer_payout_from_operations_oku: 4.870565305
issuer_total_cash_to_preissue_shares_oku: 4.88434543
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.525730441
old_cohort_subscription_proceeds_cash_oku: 0.012804495
old_cohort_total_cash_oku: 4.538534936
old_cohort_cash_PV_at_terminal_oku: 1.803257883
old_cohort_residual_shares_value_oku: 43.881359254
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 10
period_start: 2045-11-07
期間末: 2046-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 867.0409874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 870.4709874
old_cohort_m: 802.4675351
old_fraction_open: 0.925524337098
old_fraction_close: 0.921877405124
share_count_increase_fraction_of_opening: 0.003955983685
future_operating_FCFE_before_subscriptions_oku: 4.909529828
market_price_post_annual_issue_GBP_endogenous: 5.49104455
paid_issue_price_GBP_per_share_assumed: 4.94194009
issuer_paid_subscription_cash_oku: 0.013837432
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013837432
issuer_payout_from_operations_oku: 4.909529828
issuer_total_cash_to_preissue_shares_oku: 4.92336726
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.543889339
old_cohort_subscription_proceeds_cash_oku: 0.01280688
old_cohort_total_cash_oku: 4.55669622
old_cohort_cash_PV_at_terminal_oku: 1.634001582
old_cohort_residual_shares_value_oku: 44.063849834
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 11
period_start: 2046-11-07
期間末: 2047-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 870.4709874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 873.9009874
old_cohort_m: 802.4675351
old_fraction_open: 0.921877405124
old_fraction_close: 0.918259101054
share_count_increase_fraction_of_opening: 0.003940395544
future_operating_FCFE_before_subscriptions_oku: 4.948806066
market_price_post_annual_issue_GBP_endogenous: 5.51396057
paid_issue_price_GBP_per_share_assumed: 4.96256451
issuer_paid_subscription_cash_oku: 0.013895181
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013895181
issuer_payout_from_operations_oku: 4.948806066
issuer_total_cash_to_preissue_shares_oku: 4.962701247
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.562192495
old_cohort_subscription_proceeds_cash_oku: 0.012809653
old_cohort_total_cash_oku: 4.575002148
old_cohort_cash_PV_at_terminal_oku: 1.480655206
old_cohort_residual_shares_value_oku: 44.247743468
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 12
period_start: 2047-11-07
期間末: 2048-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 873.9009874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 877.3309874
old_cohort_m: 802.4675351
old_fraction_open: 0.918259101054
old_fraction_close: 0.914669089118
share_count_increase_fraction_of_opening: 0.003924929768
future_operating_FCFE_before_subscriptions_oku: 4.988396515
market_price_post_annual_issue_GBP_endogenous: 5.53705222
paid_issue_price_GBP_per_share_assumed: 4.983347
issuer_paid_subscription_cash_oku: 0.013953372
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.013953372
issuer_payout_from_operations_oku: 4.988396515
issuer_total_cash_to_preissue_shares_oku: 5.002349887
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.5806405
old_cohort_subscription_proceeds_cash_oku: 0.01281281
old_cohort_total_cash_oku: 4.59345331
old_cohort_cash_PV_at_terminal_oku: 1.34172089
old_cohort_residual_shares_value_oku: 44.433046452
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 13
period_start: 2048-11-07
期間末: 2049-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 877.3309874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 880.7609874
old_cohort_m: 802.4675351
old_fraction_open: 0.914669089118
old_fraction_close: 0.911107038777
share_count_increase_fraction_of_opening: 0.003909584922
future_operating_FCFE_before_subscriptions_oku: 5.028303687
market_price_post_annual_issue_GBP_endogenous: 5.56032029
paid_issue_price_GBP_per_share_assumed: 5.00428826
issuer_paid_subscription_cash_oku: 0.014012007
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014012007
issuer_payout_from_operations_oku: 5.028303687
issuer_total_cash_to_preissue_shares_oku: 5.042315694
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.599233953
old_cohort_subscription_proceeds_cash_oku: 0.01281635
old_cohort_total_cash_oku: 4.612050303
old_cohort_cash_PV_at_terminal_oku: 1.215842025
old_cohort_residual_shares_value_oku: 44.619765166
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 14
period_start: 2049-11-07
期間末: 2050-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 880.7609874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 884.1909874
old_cohort_m: 802.4675351
old_fraction_open: 0.911107038777
old_fraction_close: 0.90757262462
share_count_increase_fraction_of_opening: 0.003894359593
future_operating_FCFE_before_subscriptions_oku: 5.068530117
market_price_post_annual_issue_GBP_endogenous: 5.58376559
paid_issue_price_GBP_per_share_assumed: 5.02538903
issuer_paid_subscription_cash_oku: 0.014071089
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014071089
issuer_payout_from_operations_oku: 5.068530117
issuer_total_cash_to_preissue_shares_oku: 5.082601206
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.617973466
old_cohort_subscription_proceeds_cash_oku: 0.012820268
old_cohort_total_cash_oku: 4.630793734
old_cohort_cash_PV_at_terminal_oku: 1.101789912
old_cohort_residual_shares_value_oku: 44.80790607
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 15
period_start: 2050-11-07
期間末: 2051-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 884.1909874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 887.6209874
old_cohort_m: 802.4675351
old_fraction_open: 0.90757262462
old_fraction_close: 0.904065526268
share_count_increase_fraction_of_opening: 0.003879252389
future_operating_FCFE_before_subscriptions_oku: 5.109078358
market_price_post_annual_issue_GBP_endogenous: 5.60738893
paid_issue_price_GBP_per_share_assumed: 5.04665003
issuer_paid_subscription_cash_oku: 0.01413062
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.01413062
issuer_payout_from_operations_oku: 5.109078358
issuer_total_cash_to_preissue_shares_oku: 5.123208978
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.636859654
old_cohort_subscription_proceeds_cash_oku: 0.012824564
old_cohort_total_cash_oku: 4.649684218
old_cohort_cash_PV_at_terminal_oku: 0.998451682
old_cohort_residual_shares_value_oku: 44.997475707
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 16
period_start: 2051-11-07
期間末: 2052-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 887.6209874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 891.0509874
old_cohort_m: 802.4675351
old_fraction_open: 0.904065526268
old_fraction_close: 0.900585428272
share_count_increase_fraction_of_opening: 0.003864261941
future_operating_FCFE_before_subscriptions_oku: 5.149950984
market_price_post_annual_issue_GBP_endogenous: 5.63119114
paid_issue_price_GBP_per_share_assumed: 5.06807202
issuer_paid_subscription_cash_oku: 0.014190602
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014190602
issuer_payout_from_operations_oku: 5.149950984
issuer_total_cash_to_preissue_shares_oku: 5.164141586
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.655893147
old_cohort_subscription_proceeds_cash_oku: 0.012829234
old_cohort_total_cash_oku: 4.668722381
old_cohort_cash_PV_at_terminal_oku: 0.904819358
old_cohort_residual_shares_value_oku: 45.188480703
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 17
period_start: 2052-11-07
期間末: 2053-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 891.0509874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 894.4809874
old_cohort_m: 802.4675351
old_fraction_open: 0.900585428272
old_fraction_close: 0.897132020025
share_count_increase_fraction_of_opening: 0.003849386902
future_operating_FCFE_before_subscriptions_oku: 5.191150592
market_price_post_annual_issue_GBP_endogenous: 5.65517305
paid_issue_price_GBP_per_share_assumed: 5.08965574
issuer_paid_subscription_cash_oku: 0.014251036
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014251036
issuer_payout_from_operations_oku: 5.191150592
issuer_total_cash_to_preissue_shares_oku: 5.205401628
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.675074579
old_cohort_subscription_proceeds_cash_oku: 0.012834275
old_cohort_total_cash_oku: 4.687908855
old_cohort_cash_PV_at_terminal_oku: 0.819979949
old_cohort_residual_shares_value_oku: 45.380927764
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 18
period_start: 2053-11-07
期間末: 2054-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 894.4809874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 897.9109874
old_cohort_m: 802.4675351
old_fraction_open: 0.897132020025
old_fraction_close: 0.893704995663
share_count_increase_fraction_of_opening: 0.003834625943
future_operating_FCFE_before_subscriptions_oku: 5.232679797
market_price_post_annual_issue_GBP_endogenous: 5.67933551
paid_issue_price_GBP_per_share_assumed: 5.11140196
issuer_paid_subscription_cash_oku: 0.014311925
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014311925
issuer_payout_from_operations_oku: 5.232679797
issuer_total_cash_to_preissue_shares_oku: 5.246991723
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.694404596
old_cohort_subscription_proceeds_cash_oku: 0.012839687
old_cohort_total_cash_oku: 4.707244283
old_cohort_cash_PV_at_terminal_oku: 0.743106482
old_cohort_residual_shares_value_oku: 45.574823679
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 19
period_start: 2054-11-07
期間末: 2055-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 897.9109874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 901.3409874
old_cohort_m: 802.4675351
old_fraction_open: 0.893704995663
old_fraction_close: 0.890304053979
share_count_increase_fraction_of_opening: 0.003819977757
future_operating_FCFE_before_subscriptions_oku: 5.274541235
market_price_post_annual_issue_GBP_endogenous: 5.70367938
paid_issue_price_GBP_per_share_assumed: 5.13331144
issuer_paid_subscription_cash_oku: 0.014373272
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014373272
issuer_payout_from_operations_oku: 5.274541235
issuer_total_cash_to_preissue_shares_oku: 5.288914507
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.713883852
old_cohort_subscription_proceeds_cash_oku: 0.012845465
old_cohort_total_cash_oku: 4.726729317
old_cohort_cash_PV_at_terminal_oku: 0.673449888
old_cohort_residual_shares_value_oku: 45.77017532
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 20
period_start: 2055-11-07
期間末: 2056-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 901.3409874
free_SBC_shares_delivered_m: 3.15
paid_employee_subscribed_shares_m: 0.28
issued_total_m: 3.43
shares_close_economic_m: 904.7709874
old_cohort_m: 802.4675351
old_fraction_open: 0.890304053979
old_fraction_close: 0.886928898335
share_count_increase_fraction_of_opening: 0.003805441057
future_operating_FCFE_before_subscriptions_oku: 5.316737565
market_price_post_annual_issue_GBP_endogenous: 5.72820552
paid_issue_price_GBP_per_share_assumed: 5.15538497
issuer_paid_subscription_cash_oku: 0.014435078
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.014435078
issuer_payout_from_operations_oku: 5.316737565
issuer_total_cash_to_preissue_shares_oku: 5.331172643
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 4.733513008
old_cohort_subscription_proceeds_cash_oku: 0.012851608
old_cohort_total_cash_oku: 4.746364617
old_cohort_cash_PV_at_terminal_oku: 0.610331647
old_cohort_residual_shares_value_oku: 45.966989637
discount_rate: 0.108
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

first_20_years_PV_old_cash_oku

36.390221117

end_20yr_residual_PV_old_oku

5.910862476

reconstructed_old_operating_terminal_PV_oku

42.301083593

reconstruction_abs_error_oku

8.18E-10

tail_years_used

1100

approximation_years_900_vs_1100_price_difference_GBP

per_share_recursive_equation

P[t-1] = (100 * FCFE[t] / S[t-1] + (1 + paid_discount * paid_shares / S[t-1]) * P[t]) / (1 + k); S[t] = S[t-1] + free_shares + paid_shares; F[t]=F[1]*(1+g)^(t-1).

per_share_gbp_price_at_terminal_ex_excess_cash

5.271376316

discounting_coc_is_scenario_specific

0.108

counterfactual_paid_issue_cash_ignored_but_same_share_dilution_terminal_old_oku

42.182331118

value_added_by_paid_subscriptions_vs_omission_oku

0.118752474

counterfactual_paid_issue_at_full_fair_market_terminal_old_oku

42.31431808

counterfactual_no_2037plus_share_issuance_terminal_old_oku

43.855845744

counterfactual_no_paid_employee_shares_but_free_awards_remain_old_oku

42.309510745

verified_fully_paid_fair_market_invariance_vs_no_issuance_GBP_price_abs_error

comparison_original_v1_terminal_old_oku

41.949231702

terminal_old_value_change_vs_v1_oku

0.351851891

y10

内容を開く

キャッシュフローの算出方法

timed_holder_cashflows_v1

開始日

2026-11-06

終了日

2036-11-06

期間内株主受取

26.015324632

終価

42.301083593

日付別キャッシュフロー

内容を開く

year: 0.106776180698
想定日: 2026-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.45
source_treasury_shares_m: 0.45
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9994628047

内容を開く

year: 0.112251882272
想定日: 2026-12-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.056
discounted_issuer_subscription_gbp: 10.441944
issuer_cash_proceeds_oku: 0.0058474885
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9993959941

内容を開く

year: 0.11498973306
想定日: 2026-12-18
金額: 0.8981989162
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.8987417615
assumed_execution_price_gbp: 11.601968
bought_total_shares_m: 7.74645927
tendered_old_cohort_shares_m: 7.74178036
old_holder_fraction_before: 0.9993959941
old_holder_fraction_after: 0.9993959941
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.323066392882
想定日: 2027-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2027-03-25
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2026
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 0.35318275154
想定日: 2027-03-15
金額: 0.5987992775
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.5991611744
assumed_execution_price_gbp: 11.585349
bought_total_shares_m: 5.17171433
tendered_old_cohort_shares_m: 5.16859058
old_holder_fraction_before: 0.9993959941
old_holder_fraction_after: 0.9993959941
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.355920602327
想定日: 2027-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9983665468

内容を開く

year: 0.380561259411
想定日: 2027-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2026
dividend_kind: final
date_confirmed: いいえ
ex_date: 2027-03-25
record_date: 2027-03-26
payment_date: 2027-05-26
board_declaration_date_assumed: 2027-02-26
usd_per_share: 0.25
gbp_per_share: 0.18723787
entitled_old_cohort_shares_m: 824.3237941
issuer_economic_shares_m: 825.6724914
old_holder_entitlement_oku: 1.5434462891
issuer_dividend_liability_oku: 1.5459715612
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-03-04
needs_issuer_confirmation_before_date: はい

内容を開く

year: 0.550308008214
想定日: 2027-05-26
金額: 1.5434462891
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.5459715612
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2026
dividend_kind: final

内容を開く

year: 0.607802874743
想定日: 2027-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9973012096

内容を開く

year: 0.777549623546
想定日: 2027-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.40022
issuer_cash_proceeds_oku: 0.0291206151
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9969634826

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2027-10-07
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9959390379

内容を開く

year: 0.917180013689
想定日: 2027-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2027-10-07
record_date: 2027-10-08
payment_date: 2027-11-05
board_declaration_date_assumed: 2027-08-04
usd_per_share: 0.1624
gbp_per_share: 0.12162972
entitled_old_cohort_shares_m: 824.3237941
issuer_economic_shares_m: 827.6849914
old_holder_entitlement_oku: 1.0026227094
issuer_dividend_liability_oku: 1.0067109242
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-09-16
needs_issuer_confirmation_before_date: はい

内容を開く

year: 0.996577686516
想定日: 2027-11-05
金額: 1.0026227094
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.0067109242
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: interim

内容を開く

year: 1.108829568789
想定日: 2027-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9952572437

内容を開く

year: 1.338809034908
想定日: 2028-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2028-03-30
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 1.357973990418
想定日: 2028-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9942363008

内容を開く

year: 1.368925393566
想定日: 2028-03-20
金額: 0.066946527
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.514746
bought_total_shares_m: 0.58476862
tendered_old_cohort_shares_m: 0.58139819
old_holder_fraction_before: 0.9942363008
old_holder_fraction_after: 0.9942363008
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.396303901437
想定日: 2028-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: final
date_confirmed: いいえ
ex_date: 2028-03-30
record_date: 2028-03-31
payment_date: 2028-05-24
board_declaration_date_assumed: 2028-02-25
usd_per_share: 0.2078209
gbp_per_share: 0.15564777
entitled_old_cohort_shares_m: 823.7423959
issuer_economic_shares_m: 828.5177228
old_holder_entitlement_oku: 1.2821366306
issuer_dividend_liability_oku: 1.2895693202
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-03-09
needs_issuer_confirmation_before_date: はい

内容を開く

year: 1.54688569473
想定日: 2028-05-24
金額: 1.2821366306
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.2895693202
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: final

内容を開く

year: 1.609856262834
想定日: 2028-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9931790104

内容を開く

year: 1.620807665982
想定日: 2028-06-20
金額: 0.0668753347
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.497305
bought_total_shares_m: 0.58565571
tendered_old_cohort_shares_m: 0.58166096
old_holder_fraction_before: 0.9931790104
old_holder_fraction_after: 0.9931790104
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.779603011636
想定日: 2028-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.337691
issuer_cash_proceeds_oku: 0.0289455338
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9928435959

内容を開く

year: 1.856262833676
想定日: 2028-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2028-10-05
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 1.859000684463
想定日: 2028-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9918261623

内容を開く

year: 1.872689938398
想定日: 2028-09-20
金額: 0.0667842412
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.47989
bought_total_shares_m: 0.58654415
tendered_old_cohort_shares_m: 0.58174983
old_holder_fraction_before: 0.9918261623
old_holder_fraction_after: 0.9918261623
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.913757700205
想定日: 2028-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2028-10-05
record_date: 2028-10-06
payment_date: 2028-11-03
board_declaration_date_assumed: 2028-08-04
usd_per_share: 0.1480884
gbp_per_share: 0.11091099
entitled_old_cohort_shares_m: 822.5789851
issuer_economic_shares_m: 829.3580229
old_holder_entitlement_oku: 0.9123305243
issuer_dividend_liability_oku: 0.9198492226
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-09-14
needs_issuer_confirmation_before_date: はい

内容を開く

year: 1.993155373032
想定日: 2028-11-03
金額: 0.9123305243
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.9198492226
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: interim

内容を開く

year: 2.108145106092
想定日: 2028-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9911485524

内容を開く

year: 2.121834360027
想定日: 2028-12-20
金額: 0.0667386146
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0673346235
assumed_execution_price_gbp: 11.46269
bought_total_shares_m: 0.58742426
tendered_old_cohort_shares_m: 0.5822247
old_holder_fraction_before: 0.9911485524
old_holder_fraction_after: 0.9911485524
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.335386721424
想定日: 2029-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2029-03-29
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 2.357289527721
想定日: 2029-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9901331538

内容を開く

year: 2.368240930869
想定日: 2029-03-20
金額: 0.0678621168
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.445705
bought_total_shares_m: 0.59881304
tendered_old_cohort_shares_m: 0.59290465
old_holder_fraction_before: 0.9901331538
old_holder_fraction_after: 0.9901331538
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.392881587953
想定日: 2029-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: final
date_confirmed: いいえ
ex_date: 2029-03-29
record_date: 2029-03-30
payment_date: 2029-05-23
board_declaration_date_assumed: 2029-02-26
usd_per_share: 0.2125797
gbp_per_share: 0.15921186
entitled_old_cohort_shares_m: 821.4038557
issuer_economic_shares_m: 829.5892856
old_holder_entitlement_oku: 1.3077723161
issuer_dividend_liability_oku: 1.3208044908
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-03-08
needs_issuer_confirmation_before_date: はい

内容を開く

year: 2.543463381246
想定日: 2029-05-23
金額: 1.3077723161
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3208044908
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: final

内容を開く

year: 2.60643394935
想定日: 2029-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9890815853

内容を開く

year: 2.620123203285
想定日: 2029-06-20
金額: 0.067790044
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.428368
bought_total_shares_m: 0.59972144
tendered_old_cohort_shares_m: 0.59317343
old_holder_fraction_before: 0.9890815853
old_holder_fraction_after: 0.9890815853
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.778918548939
想定日: 2029-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.275707
issuer_cash_proceeds_oku: 0.0287719791
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9887479801

内容を開く

year: 2.852840520192
想定日: 2029-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2029-10-04
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 2.855578370979
想定日: 2029-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.987736033

内容を開く

year: 2.872005475702
想定日: 2029-09-20
金額: 0.067697822
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.411058
bought_total_shares_m: 0.60063121
tendered_old_cohort_shares_m: 0.59326509
old_holder_fraction_before: 0.987736033
old_holder_fraction_after: 0.987736033
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.910335386721
想定日: 2029-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2029-10-04
record_date: 2029-10-05
payment_date: 2029-11-05
board_declaration_date_assumed: 2029-08-03
usd_per_share: 0.1442672
gbp_per_share: 0.10804914
entitled_old_cohort_shares_m: 820.2174172
issuer_economic_shares_m: 830.401433
old_holder_entitlement_oku: 0.8862378605
issuer_dividend_liability_oku: 0.8972416019
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-09-13
needs_issuer_confirmation_before_date: はい

内容を開く

year: 2.99794661191
想定日: 2029-11-05
金額: 0.8862378605
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8972416019
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: interim

内容を開く

year: 3.104722792608
想定日: 2029-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9870620648

内容を開く

year: 3.121149897331
想定日: 2029-12-20
金額: 0.0676516293
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0685383744
assumed_execution_price_gbp: 11.393961
bought_total_shares_m: 0.60153246
tendered_old_cohort_shares_m: 0.59374987
old_holder_fraction_before: 0.9870620648
old_holder_fraction_after: 0.9870620648
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.33196440794
想定日: 2030-03-07
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2030-03-28
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 3.353867214237
想定日: 2030-03-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9860521048

内容を開く

year: 3.367556468172
想定日: 2030-03-20
金額: 0.0688023463
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.377078
bought_total_shares_m: 0.61329957
tendered_old_cohort_shares_m: 0.60474534
old_holder_fraction_before: 0.9860521048
old_holder_fraction_after: 0.9860521048
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.38945927447
想定日: 2030-03-28
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: final
date_confirmed: いいえ
ex_date: 2030-03-28
record_date: 2030-03-29
payment_date: 2030-05-22
board_declaration_date_assumed: 2030-02-26
usd_per_share: 0.2151309
gbp_per_share: 0.16112261
entitled_old_cohort_shares_m: 819.018922
issuer_economic_shares_m: 830.6041009
old_holder_entitlement_oku: 1.3196246617
issuer_dividend_liability_oku: 1.3382910043
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-03-07
needs_issuer_confirmation_before_date: はい

内容を開く

year: 3.540041067762
想定日: 2030-05-22
金額: 1.3196246617
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3382910043
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: final

内容を開く

year: 3.603011635866
想定日: 2030-06-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9850061487

内容を開く

year: 3.619438740589
想定日: 2030-06-20
金額: 0.0687293641
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.359845
bought_total_shares_m: 0.61422995
tendered_old_cohort_shares_m: 0.60502027
old_holder_fraction_before: 0.9850061487
old_holder_fraction_after: 0.9850061487
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.775496235455
想定日: 2030-08-16
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.214263
issuer_cash_proceeds_oku: 0.0285999362
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.984674318

内容を開く

year: 3.849418206708
想定日: 2030-09-12
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2030-10-03
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 3.860369609856
想定日: 2030-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9836677517

内容を開く

year: 3.871321013005
想定日: 2030-09-20
金額: 0.0686359767
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.342638
bought_total_shares_m: 0.61516173
tendered_old_cohort_shares_m: 0.60511476
old_holder_fraction_before: 0.9836677517
old_holder_fraction_after: 0.9836677517
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.906913073238
想定日: 2030-10-03
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2030-10-03
record_date: 2030-10-04
payment_date: 2030-11-05
board_declaration_date_assumed: 2030-08-02
usd_per_share: 0.1437592
gbp_per_share: 0.1076687
entitled_old_cohort_shares_m: 817.808787
issuer_economic_shares_m: 831.3872093
old_holder_entitlement_oku: 0.8805240867
issuer_dividend_liability_oku: 0.8951437974
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-09-12
needs_issuer_confirmation_before_date: はい

内容を開く

year: 3.997262149213
想定日: 2030-11-05
金額: 0.8805240867
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8951437974
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: interim

内容を開く

year: 4.109514031485
想定日: 2030-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9829973547

内容を開く

year: 4.120465434634
想定日: 2030-12-20
金額: 0.0685891993
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0697755686
assumed_execution_price_gbp: 11.325644
bought_total_shares_m: 0.61608478
tendered_old_cohort_shares_m: 0.60560971
old_holder_fraction_before: 0.9829973547
old_holder_fraction_after: 0.9829973547
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.328542094456
想定日: 2031-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2031-03-27
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 4.350444900753
想定日: 2031-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9819927276

内容を開く

year: 4.366872005476
想定日: 2031-03-20
金額: 0.0697611912
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.308862
bought_total_shares_m: 0.62818378
tendered_old_cohort_shares_m: 0.61687191
old_holder_fraction_before: 0.9819927276
old_holder_fraction_after: 0.9819927276
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.386036960986
想定日: 2031-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: final
date_confirmed: いいえ
ex_date: 2031-03-27
record_date: 2031-03-28
payment_date: 2031-05-28
board_declaration_date_assumed: 2031-02-26
usd_per_share: 0.2144498
gbp_per_share: 0.16061246
entitled_old_cohort_shares_m: 816.5863054
issuer_economic_shares_m: 831.5604407
old_holder_entitlement_oku: 1.3115393474
issuer_dividend_liability_oku: 1.3355896745
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-03-06
needs_issuer_confirmation_before_date: はい

内容を開く

year: 4.555783709788
想定日: 2031-05-28
金額: 1.3115393474
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3355896745
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: final

内容を開く

year: 4.607802874743
想定日: 2031-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9809522742

内容を開く

year: 4.618754277892
想定日: 2031-06-20
金額: 0.0696872769
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.291732
bought_total_shares_m: 0.62913674
tendered_old_cohort_shares_m: 0.61715311
old_holder_fraction_before: 0.9809522742
old_holder_fraction_after: 0.9809522742
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.772073921971
想定日: 2031-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.153186
issuer_cash_proceeds_oku: 0.0284289221
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9806221831

内容を開く

year: 4.845995893224
想定日: 2031-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2031-10-02
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 4.859685147159
想定日: 2031-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.979620892

内容を開く

year: 4.867898699521
想定日: 2031-09-19
金額: 0.0695926949
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.274814
bought_total_shares_m: 0.63008075
tendered_old_cohort_shares_m: 0.61724027
old_holder_fraction_before: 0.979620892
old_holder_fraction_after: 0.979620892
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.903490759754
想定日: 2031-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2031-10-02
record_date: 2031-10-03
payment_date: 2031-11-05
board_declaration_date_assumed: 2031-08-04
usd_per_share: 0.1432836
gbp_per_share: 0.10731246
entitled_old_cohort_shares_m: 815.351912
issuer_economic_shares_m: 832.3137232
old_holder_entitlement_oku: 0.8749742237
issuer_dividend_liability_oku: 0.8931763612
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-09-11
needs_issuer_confirmation_before_date: はい

内容を開く

year: 4.996577686516
想定日: 2031-11-05
金額: 0.8749742237
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8931763612
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: interim

内容を開く

year: 5.108829568789
想定日: 2031-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9789539957

内容を開く

year: 5.11704312115
想定日: 2031-12-19
金額: 0.0695453183
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0710404356
assumed_execution_price_gbp: 11.257922
bought_total_shares_m: 0.63102618
tendered_old_cohort_shares_m: 0.6177456
old_holder_fraction_before: 0.9789539957
old_holder_fraction_after: 0.9789539957
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.325119780972
想定日: 2032-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2032-03-25
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 5.357973990418
想定日: 2032-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9779545957

内容を開く

year: 5.366187542779
想定日: 2032-03-19
金額: 0.0707579959
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.241055
bought_total_shares_m: 0.64364999
tendered_old_cohort_shares_m: 0.62946046
old_holder_fraction_before: 0.9779545957
old_holder_fraction_after: 0.9779545957
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.382614647502
想定日: 2032-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: final
date_confirmed: いいえ
ex_date: 2032-03-25
record_date: 2032-03-26
payment_date: 2032-05-26
board_declaration_date_assumed: 2032-02-26
usd_per_share: 0.2138049
gbp_per_share: 0.16012949
entitled_old_cohort_shares_m: 814.1047059
issuer_economic_shares_m: 832.456547
old_holder_entitlement_oku: 1.3036217043
issuer_dividend_liability_oku: 1.3330084137
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-03-04
needs_issuer_confirmation_before_date: はい

内容を開く

year: 5.552361396304
想定日: 2032-05-26
金額: 1.3036217043
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3330084137
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: final

内容を開く

year: 5.609856262834
想定日: 2032-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.976919535

内容を開く

year: 5.615331964408
想定日: 2032-06-18
金額: 0.0706831061
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.224213
bought_total_shares_m: 0.64461578
tendered_old_cohort_shares_m: 0.62973775
old_holder_fraction_before: 0.976919535
old_holder_fraction_after: 0.976919535
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.779603011636
想定日: 2032-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.09181
issuer_cash_proceeds_oku: 0.0282570682
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9765911484

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2032-10-07
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9755950266

内容を開く

year: 5.872689938398
想定日: 2032-09-20
金額: 0.0705872739
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.206842
bought_total_shares_m: 0.64561493
tendered_old_cohort_shares_m: 0.62985872
old_holder_fraction_before: 0.9755950266
old_holder_fraction_after: 0.9755950266
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.91923340178
想定日: 2032-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2032-10-07
record_date: 2032-10-08
payment_date: 2032-11-05
board_declaration_date_assumed: 2032-08-04
usd_per_share: 0.1428354
gbp_per_share: 0.10697678
entitled_old_cohort_shares_m: 812.8451094
issuer_economic_shares_m: 833.1788163
old_holder_entitlement_oku: 0.8695555324
issuer_dividend_liability_oku: 0.8913078775
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-09-16
needs_issuer_confirmation_before_date: はい

内容を開く

year: 5.998631074606
想定日: 2032-11-05
金額: 0.8695555324
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8913078775
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: interim

内容を開く

year: 6.110882956879
想定日: 2032-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9749315601

内容を開く

year: 6.121834360027
想定日: 2032-12-20
金額: 0.0705392701
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0723530481
assumed_execution_price_gbp: 11.190052
bought_total_shares_m: 0.64658367
tendered_old_cohort_shares_m: 0.63037483
old_holder_fraction_before: 0.9749315601
old_holder_fraction_after: 0.9749315601
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.340862422998
想定日: 2033-03-10
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2033-03-31
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 6.357289527721
想定日: 2033-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9739372804

内容を開く

year: 6.362765229295
想定日: 2033-03-18
金額: 0.0717931668
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.173839
bought_total_shares_m: 0.65970492
tendered_old_cohort_shares_m: 0.64251122
old_holder_fraction_before: 0.9739372804
old_holder_fraction_after: 0.9739372804
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.398357289528
想定日: 2033-03-31
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: final
date_confirmed: いいえ
ex_date: 2033-03-31
record_date: 2033-04-01
payment_date: 2033-05-25
board_declaration_date_assumed: 2033-02-25
usd_per_share: 0.2132415
gbp_per_share: 0.15970754
entitled_old_cohort_shares_m: 811.5722234
issuer_economic_shares_m: 833.2900277
old_holder_entitlement_oku: 1.2961420304
issuer_dividend_liability_oku: 1.3308270014
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-03-10
needs_issuer_confirmation_before_date: はい

内容を開く

year: 6.54893908282
想定日: 2033-05-25
金額: 1.2961420304
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3308270014
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: final

内容を開く

year: 6.609171800137
想定日: 2033-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9729075016

内容を開く

year: 6.620123203285
想定日: 2033-06-20
金額: 0.0717172573
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.156546
bought_total_shares_m: 0.66072746
tendered_old_cohort_shares_m: 0.6428267
old_holder_fraction_before: 0.9729075016
old_holder_fraction_after: 0.9729075016
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.778918548939
想定日: 2033-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 10.031301
issuer_cash_proceeds_oku: 0.0280876415
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9725807842

内容を開く

year: 6.858316221766
想定日: 2033-09-15
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2033-10-06
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

100

内容を開く

year: 6.861054072553
想定日: 2033-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9715897244

101

内容を開く

year: 6.872005475702
想定日: 2033-09-20
金額: 0.0716201182
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.139647
bought_total_shares_m: 0.66172978
tendered_old_cohort_shares_m: 0.64292986
old_holder_fraction_before: 0.9715897244
old_holder_fraction_after: 0.9715897244
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

102

内容を開く

year: 6.915811088296
想定日: 2033-10-06
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2033-10-06
record_date: 2033-10-07
payment_date: 2033-11-04
board_declaration_date_assumed: 2033-08-04
usd_per_share: 0.1424308
gbp_per_share: 0.10667373
entitled_old_cohort_shares_m: 810.2864668
issuer_economic_shares_m: 833.9800705
old_holder_entitlement_oku: 0.8643627837
issuer_dividend_liability_oku: 0.889637634
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-09-15
needs_issuer_confirmation_before_date: はい

103

内容を開く

year: 6.995208761123
想定日: 2033-11-04
金額: 0.8643627837
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.889637634
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: interim

104

内容を開く

year: 7.110198494182
想定日: 2033-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9709296162

105

内容を開く

year: 7.121149897331
想定日: 2033-12-20
金額: 0.0715714588
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0737143636
assumed_execution_price_gbp: 11.122957
bought_total_shares_m: 0.6627227
tendered_old_cohort_shares_m: 0.6434571
old_holder_fraction_before: 0.9709296162
old_holder_fraction_after: 0.9709296162
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

106

内容を開く

year: 7.337440109514
想定日: 2034-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2034-03-30
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

107

内容を開く

year: 7.356605065024
想定日: 2034-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9699403492

108

内容を開く

year: 7.367556468172
想定日: 2034-03-20
金額: 0.0728667587
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.106475
bought_total_shares_m: 0.67640711
tendered_old_cohort_shares_m: 0.65607455
old_holder_fraction_before: 0.9699403492
old_holder_fraction_after: 0.9699403492
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

109

内容を開く

year: 7.394934976044
想定日: 2034-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: final
date_confirmed: いいえ
ex_date: 2034-03-30
record_date: 2034-03-31
payment_date: 2034-05-24
board_declaration_date_assumed: 2034-02-24
usd_per_share: 0.2127452
gbp_per_share: 0.1593358
entitled_old_cohort_shares_m: 808.9869352
issuer_economic_shares_m: 834.0584407
old_holder_entitlement_oku: 1.2890058447
issuer_dividend_liability_oku: 1.3289537298
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-03-09
needs_issuer_confirmation_before_date: はい

110

内容を開く

year: 7.545516769336
想定日: 2034-05-24
金額: 1.2890058447
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3289537298
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: final

111

内容を開く

year: 7.60848733744
想定日: 2034-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9689157403

112

内容を開く

year: 7.619438740589
想定日: 2034-06-20
金額: 0.072789785
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.089652
bought_total_shares_m: 0.67743322
tendered_old_cohort_shares_m: 0.65637571
old_holder_fraction_before: 0.9689157403
old_holder_fraction_after: 0.9689157403
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

113

内容を開く

year: 7.778234086242
想定日: 2034-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 9.971154
issuer_cash_proceeds_oku: 0.0279192306
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9685906565

114

内容を開く

year: 7.854893908282
想定日: 2034-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2034-10-05
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

115

内容を開く

year: 7.857631759069
想定日: 2034-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9676045507

116

内容を開く

year: 7.871321013005
想定日: 2034-09-20
金額: 0.0726912819
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.072855
bought_total_shares_m: 0.67846088
tendered_old_cohort_shares_m: 0.65648184
old_holder_fraction_before: 0.9676045507
old_holder_fraction_after: 0.9676045507
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

117

内容を開く

year: 7.912388774812
想定日: 2034-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2034-10-05
record_date: 2034-10-06
payment_date: 2034-11-03
board_declaration_date_assumed: 2034-08-04
usd_per_share: 0.1420704
gbp_per_share: 0.10640381
entitled_old_cohort_shares_m: 807.6740776
issuer_economic_shares_m: 834.7150466
old_holder_entitlement_oku: 0.8593960173
issuer_dividend_liability_oku: 0.8881686394
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-09-14
needs_issuer_confirmation_before_date: はい

118

内容を開く

year: 7.991786447639
想定日: 2034-11-03
金額: 0.8593960173
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8881686394
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: interim

119

内容を開く

year: 8.106776180698
想定日: 2034-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9669477286

120

内容を開く

year: 8.120465434634
想定日: 2034-12-20
金額: 0.0726419381
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0751249896
assumed_execution_price_gbp: 11.056265
bought_total_shares_m: 0.67947891
tendered_old_cohort_shares_m: 0.65702059
old_holder_fraction_before: 0.9669477286
old_holder_fraction_after: 0.9669477286
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

121

内容を開く

year: 8.33401779603
想定日: 2035-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2035-03-29
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

122

内容を開く

year: 8.355920602327
想定日: 2035-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9659633656

123

内容を開く

year: 8.366872005476
想定日: 2035-03-20
金額: 0.0739789056
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 11.039882
bought_total_shares_m: 0.69371776
tendered_old_cohort_shares_m: 0.67010594
old_holder_fraction_before: 0.9659633656
old_holder_fraction_after: 0.9659633656
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

124

内容を開く

year: 8.39151266256
想定日: 2035-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: final
date_confirmed: いいえ
ex_date: 2035-03-29
record_date: 2035-03-30
payment_date: 2035-05-23
board_declaration_date_assumed: 2035-02-26
usd_per_share: 0.2123162
gbp_per_share: 0.15901453
entitled_old_cohort_shares_m: 806.3469511
issuer_economic_shares_m: 834.7593499
old_holder_entitlement_oku: 1.2822087899
issuer_dividend_liability_oku: 1.3273886315
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-03-08
needs_issuer_confirmation_before_date: はい

125

内容を開く

year: 8.542094455852
想定日: 2035-05-23
金額: 1.2822087899
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3273886315
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: final

126

内容を開く

year: 8.605065023956
想定日: 2035-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9649438138

127

内容を開く

year: 8.618754277892
想定日: 2035-06-20
金額: 0.0739008226
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 11.02316
bought_total_shares_m: 0.69477013
tendered_old_cohort_shares_m: 0.67041414
old_holder_fraction_before: 0.9649438138
old_holder_fraction_after: 0.9649438138
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

128

内容を開く

year: 8.777549623546
想定日: 2035-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 9.911368
issuer_cash_proceeds_oku: 0.0277518296
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9646203276

129

内容を開く

year: 8.851471594798
想定日: 2035-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2035-10-04
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

130

内容を開く

year: 8.854209445585
想定日: 2035-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9636390668

131

内容を開く

year: 8.870636550308
想定日: 2035-09-20
金額: 0.0738008978
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 11.006463
bought_total_shares_m: 0.69582409
tendered_old_cohort_shares_m: 0.67052328
old_holder_fraction_before: 0.9636390668
old_holder_fraction_after: 0.9636390668
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

132

内容を開く

year: 8.908966461328
想定日: 2035-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2035-10-04
record_date: 2035-10-05
payment_date: 2035-11-05
board_declaration_date_assumed: 2035-08-03
usd_per_share: 0.1417546
gbp_per_share: 0.10616734
entitled_old_cohort_shares_m: 805.0060137
issuer_economic_shares_m: 835.3812557
old_holder_entitlement_oku: 0.8546534401
issuer_dividend_liability_oku: 0.8869020253
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-09-13
needs_issuer_confirmation_before_date: はい

133

内容を開く

year: 8.996577686516
想定日: 2035-11-05
金額: 0.8546534401
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8869020253
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: interim

134

内容を開く

year: 9.103353867214
想定日: 2035-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.567
source_treasury_shares_m: 0.567
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9629854578

135

内容を開く

year: 9.119780971937
想定日: 2035-12-20
金額: 0.0737508407
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0765856225
assumed_execution_price_gbp: 10.989973
bought_total_shares_m: 0.69686817
tendered_old_cohort_shares_m: 0.67107391
old_holder_fraction_before: 0.9629854578
old_holder_fraction_after: 0.9629854578
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

136

内容を開く

year: 9.330595482546
想定日: 2036-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2036-03-27
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

137

内容を開く

year: 9.352498288843
想定日: 2036-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9620058892

138

内容を開く

year: 9.368925393566
想定日: 2036-03-20
金額: 0.0682822598
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0709790455
assumed_execution_price_gbp: 10.973507
bought_total_shares_m: 0.64682188
tendered_old_cohort_shares_m: 0.62224646
old_holder_fraction_before: 0.9620058892
old_holder_fraction_after: 0.9620058892
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

139

内容を開く

year: 9.388090349076
想定日: 2036-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: final
date_confirmed: いいえ
ex_date: 2036-03-27
record_date: 2036-03-28
payment_date: 2036-05-28
board_declaration_date_assumed: 2036-02-26
usd_per_share: 0.2119554
gbp_per_share: 0.15874434
entitled_old_cohort_shares_m: 803.7126933
issuer_economic_shares_m: 835.4550656
old_holder_entitlement_oku: 1.2758483902
issuer_dividend_liability_oku: 1.3262376089
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-03-06
needs_issuer_confirmation_before_date: はい

140

内容を開く

year: 9.557837097878
想定日: 2036-05-28
金額: 1.2758483902
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.3262376089
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: final

141

内容を開く

year: 9.609856262834
想定日: 2036-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.882
source_treasury_shares_m: 0.882
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.960991359

142

内容を開く

year: 9.620807665982
想定日: 2036-06-20
金額: 0.0682102494
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0709790455
assumed_execution_price_gbp: 10.956886
bought_total_shares_m: 0.64780311
tendered_old_cohort_shares_m: 0.62253319
old_holder_fraction_before: 0.960991359
old_holder_fraction_after: 0.960991359
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

143

内容を開く

year: 9.774127310062
想定日: 2036-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.28
discounted_issuer_subscription_gbp: 9.852102
issuer_cash_proceeds_oku: 0.0275858867
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9606694841

144

内容を開く

year: 9.848049281314
想定日: 2036-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2036-10-02
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2036
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

145

内容を開く

year: 9.86173853525
想定日: 2036-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8505
source_treasury_shares_m: 0.8505
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9596931097

146

内容を開く

year: 9.869952087611
想定日: 2036-09-19
金額: 0.0681181009
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.0709790455
assumed_execution_price_gbp: 10.940469
bought_total_shares_m: 0.64877513
tendered_old_cohort_shares_m: 0.62262503
old_holder_fraction_before: 0.9596931097
old_holder_fraction_after: 0.9596931097
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

147

内容を開く

year: 9.905544147844
想定日: 2036-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2036
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2036-10-02
record_date: 2036-10-03
payment_date: 2036-11-05
board_declaration_date_assumed: 2036-08-04
usd_per_share: 0.141484
gbp_per_share: 0.10596467
entitled_old_cohort_shares_m: 802.4675351
issuer_economic_shares_m: 836.1709874
old_holder_entitlement_oku: 0.8503320708
issuer_dividend_liability_oku: 0.8860458226
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-09-11
needs_issuer_confirmation_before_date: はい

148

内容を開く

year: 9.998631074606
想定日: 2036-11-05
金額: 0.8503320708
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 0.8860458226
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2036
dividend_kind: interim

valuation

内容を開く

initial_old_cohort_market_cap_oku: 97.20288656
pv_old_holder_cashflows_oku_at_coc_k: 17.31697301
pv_old_cohort_terminal_oku_at_coc_k: 17.06696688
total_present_value_oku_at_coc_k: 34.38393989
NPV_oku: -62.81894667
value_to_market_ratio: 0.35373373
IRR_timed_old_holder: -0.0418433201
comparison_v1_IRR_timed_old_holder: -0.0424760546
comparison_no_future_paid_subscription_proceeds_IRR_timed: -0.0420564229
comparison_full_market_paid_subscription_IRR_timed: -0.0418195989
comparison_market_repurchase_neutral_IRR_timed: -0.0419570186

audits

内容を開く

number_of_full_forecast_fiscal_years_2027_to_2036: 10
number_of_partial_period_ledger_rows: 2
end_excluded_future_period_days_in_2036: 55
total_unique_cashflow_events: 148
cashflow_events_with_zero_amount: 91
max_row_identity_error: 0
sum_timed_cashflow_oku: 26.015324632
sum_yearly_legacy_cashflow_oku: 26.015324632
initial_old_cohort_equals_current_economic_float: はい
all_event_dates_after_basis_and_not_after_endpoint: はい
event_year_computed_by_exact_days_div_365_25: はい
terminal_value_not_deducting_book_debt_twice: はい
year_2036_after_11_06_flows_not_included: はい
stock_compensation_cashflow_zero: はい
pre_ex_date_rechecks_included_count: 20
post_horizon_constant_absolute_share_delivery_mode_verified: はい
post_horizon_paid_issue_cash_included_once_and_separate_from_FCFE: はい
future_paid_issue_reinvestment_or_retention_assumed: いいえ
original_2026_2036_ledger_SHA256_unchanged: a2e5b5ea6f11ae27f99b0e9ef7fb45ccfb193bd7e58dd3d6ecefffce2ba154f2

売上高

52.94296745

営業利益

6.35315609

純利益

4.44009597

equity_oku

60.57924382

期間内の親会社利益合計（億）

41.98126344

multiple

kind

dcf

why

2037年以降の発行株数、有償引受と旧株主持分を毎年更新した継続価値。

detail

内容を開く

version

v2_2026_11_08

理由

1: Paid new issue capital proceeds missing from v1 terminal
2: Fixed annual shares incorrectly treated with perpetually fixed issuance ratio
3: Future ex-dates need separate pre-ex reconfirmation events

source_file

smith_nephew_aiv2_eu_20261106_full.json

all_years_2026_to_2036_ledgers_preserved_verbatim

はい

company_issuer_future_paid_cash_not_operating_FCFE

はい

issuer_cash_assumed_passed_through_to_preissue_holders_not_retained

はい

mathematical_cash_treatment

Paid cash enters one time; no separate addition to company terminal equity and no double subtraction of buyback expenses.

future_review_events_are_not_automated_reminders

はい

scenario_corrections

内容を開く

id: very_bear
label: 最悪
確率: 10.00%
free_SBC_m: 3.4
paid_issued_m: 0.4
total_issued_m: 3.8
old_2036_terminal_oku: 10.678822546
corrected_2036_terminal_oku: 10.770428062326
old_2036_IRR: -0.1531105824
corrected_2036_IRR: -0.1526010931
old_PV_oku: 16.64944402
corrected_PV_oku: 16.68640356
start_2036_economic_shares_m: 867.0366575
2037_post_economic_shares_m: 870.8366575
2037_issuer_paid_subscriptions_oku: 0.0046566245895818
2037_paid_issue_per_share_GBP: 1.1641561473954
2037_fair_price_after_issue_GBP: 1.2935068304394
2037_fair_price_market_buyback_policy_GBP: 1.2975825267948
2037_gross_repurchase_market_oku: 0.049308136018204
2037_paid_issue_cash_market_neutral_policy_oku: 0.0046712970964614
2037_net_cash_required_market_neutral_policy_oku: 0.044636838921743
2037_future_SBC_expense_oku: 0.45626728043192
no_future_paid_issuance_terminal_old_oku: 10.772984454596
ignored_paid_proceeds_2036_terminal_oku: 10.737024536969
full_fair_market_paid_proceeds_2036_terminal_oku: 10.774151977858
market_neutral_repurchase_2036_terminal_oku: 10.758565446598
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: c1a3b546cd8847dce8be9cfad727549c050a3f2e81a70832280f68783a48a4f3

内容を開く

id: bear
label: 弱気
確率: 20.00%
free_SBC_m: 3.15
paid_issued_m: 0.28
total_issued_m: 3.43
old_2036_terminal_oku: 41.949231702
corrected_2036_terminal_oku: 42.301083592521
old_2036_IRR: -0.0424760546
corrected_2036_IRR: -0.0418433201
old_PV_oku: 34.2419803
corrected_PV_oku: 34.38393989
start_2036_economic_shares_m: 836.1709874
2037_post_economic_shares_m: 839.6009874
2037_issuer_paid_subscriptions_oku: 0.013337295340245
2037_paid_issue_per_share_GBP: 4.7633197643733
2037_fair_price_after_issue_GBP: 5.2925775159703
2037_fair_price_market_buyback_policy_GBP: 5.3055846700607
2037_gross_repurchase_market_oku: 0.18198155418308
2037_paid_issue_cash_market_neutral_policy_oku: 0.013370073368553
2037_net_cash_required_market_neutral_policy_oku: 0.16861148081453
2037_future_SBC_expense_oku: 0.56106876163074
no_future_paid_issuance_terminal_old_oku: 42.30951074455
ignored_paid_proceeds_2036_terminal_oku: 42.182331118377
full_fair_market_paid_proceeds_2036_terminal_oku: 42.314318079806
market_neutral_repurchase_2036_terminal_oku: 42.237692980634
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: a2e5b5ea6f11ae27f99b0e9ef7fb45ccfb193bd7e58dd3d6ecefffce2ba154f2

内容を開く

id: base
label: 中立
確率: 40.00%
free_SBC_m: 2.9
paid_issued_m: 0.2
total_issued_m: 3.1
old_2036_terminal_oku: 114.63489927
corrected_2036_terminal_oku: 115.75462821196
old_2036_IRR: 0.0635234669
corrected_2036_IRR: 0.0643258394
old_PV_oku: 76.78471106
corrected_PV_oku: 77.23648145
start_2036_economic_shares_m: 730.2724252
2037_post_economic_shares_m: 733.3724252
2037_issuer_paid_subscriptions_oku: 0.03008847851086
2037_paid_issue_per_share_GBP: 15.04423925543
2037_fair_price_after_issue_GBP: 16.715821394922
2037_fair_price_market_buyback_policy_GBP: 16.739661132638
2037_gross_repurchase_market_oku: 0.51892949511179
2037_paid_issue_cash_market_neutral_policy_oku: 0.030131390038749
2037_net_cash_required_market_neutral_policy_oku: 0.48879810507304
2037_future_SBC_expense_oku: 0.70783231206378
no_future_paid_issuance_terminal_old_oku: 115.77471799239
ignored_paid_proceeds_2036_terminal_oku: 115.41430820689
full_fair_market_paid_proceeds_2036_terminal_oku: 115.79255978604
market_neutral_repurchase_2036_terminal_oku: 115.45189520245
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: 86bf5243f42d553f0bdf9d6126c77ba8638d36579d68bbc75616192591e11fe5

内容を開く

id: bull
label: 強気
確率: 22.00%
free_SBC_m: 2.9
paid_issued_m: 0.2
total_issued_m: 3.1
old_2036_terminal_oku: 203.684307187
corrected_2036_terminal_oku: 206.18132779122
old_2036_IRR: 0.1254535399
corrected_2036_IRR: 0.1265285363
old_PV_oku: 122.1404103
corrected_PV_oku: 123.14786837
start_2036_economic_shares_m: 687.4005414
2037_post_economic_shares_m: 690.5005414
2037_issuer_paid_subscriptions_oku: 0.057310035570423
2037_paid_issue_per_share_GBP: 28.655017785211
2037_fair_price_after_issue_GBP: 31.838908650235
2037_fair_price_market_buyback_policy_GBP: 31.844463999628
2037_gross_repurchase_market_oku: 0.98717838398848
2037_paid_issue_cash_market_neutral_policy_oku: 0.057320035199331
2037_net_cash_required_market_neutral_policy_oku: 0.92985834878915
2037_future_SBC_expense_oku: 0.86055882766899
no_future_paid_issuance_terminal_old_oku: 206.21758591791
ignored_paid_proceeds_2036_terminal_oku: 205.42105562617
full_fair_market_paid_proceeds_2036_terminal_oku: 206.26613094086
market_neutral_repurchase_2036_terminal_oku: 205.34347903854
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: f1f361d13021796ed8f9b406e365682ab4eaf0d6db69b4cfc986b8a2f1dce40a

内容を開く

id: very_bull
label: 最良
確率: 8.00%
free_SBC_m: 3.05
paid_issued_m: 0.24
total_issued_m: 3.29
old_2036_terminal_oku: 300.349987929
corrected_2036_terminal_oku: 305.34655505458
old_2036_IRR: 0.1685798416
corrected_2036_IRR: 0.1701055776
old_PV_oku: 168.88656248
corrected_PV_oku: 170.90249774
start_2036_economic_shares_m: 668.745312
2037_post_economic_shares_m: 672.035312
2037_issuer_paid_subscriptions_oku: 0.10556409673347
2037_paid_issue_per_share_GBP: 43.985040305614
2037_fair_price_after_issue_GBP: 48.872267006237
2037_fair_price_market_buyback_policy_GBP: 48.784554666435
2037_gross_repurchase_market_oku: 1.6050118485257
2037_paid_issue_cash_market_neutral_policy_oku: 0.1053746380795
2037_net_cash_required_market_neutral_policy_oku: 1.4996372104462
2037_future_SBC_expense_oku: 1.0172246276761
no_future_paid_issuance_terminal_old_oku: 305.40141089449
ignored_paid_proceeds_2036_terminal_oku: 303.74247715319
full_fair_market_paid_proceeds_2036_terminal_oku: 305.52576372641
market_neutral_repurchase_2036_terminal_oku: 303.40973167543
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: a67ab6a8b4b7e5b01bccdf926c4036ea419ebf17cb0749a98dd17593a8ba4420

v1_expected_IRR

0.0687102009

v2_expected_IRR

0.0697092425

v1_expected_PV_oku

79.60904015

v2_expected_PV_oku

80.204751772

old_10y_cash_receipts_sum_expected_unchanged

はい

scenario_annual_rows

first_20year_future_sensitivity_ledger_rows

100

future_pre_ex_date_review_zero_cash_events_added

100

最悪（確率 10.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: -0.02
Sports_Medicine_ENT: 0
Advanced_Wound_Management: -0.012

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: -0.013
Sports_Medicine_ENT: -0.005
Advanced_Wound_Management: -0.01

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.08

terminal_cost_of_equity

0.125

terminal_perpetual_total_FCFE_growth

future_discretionary_buybacks_fraction_of_FCFE_surplus

2026_announced_500m_buyback_remaining_completion_fraction_assumed

0.5

annual_2027_plus_ESPP_new_shares_m_assumed

0.4

annual_2027_plus_vested_awards_m_assumed

3.4

buyback_execution_GBP_per_share_growth_from_11_61_assumed

-0.03

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

単位の説明

money: 億GBP
one_oku_gbp: 100,000,000 GBP
reported_actuals: USD million
株数: million shares (m) except where stated
rates: decimal
events: amount=億GBP、date_assumed=YYYY-MM-DD、year=daycount/365.25

分析基準とデータ

価格・単価

11.61

株価基準日

2026-11-06

株数

837234165

株価の出所

https://shareprices.com/lse/sn./

株数の出所

https://www.smith-nephew.com/en/investors

detail

内容を開く

価格・単価

内容を開く

日付: 2026-11-06
exchange: London Stock Exchange
gbp_pence: 1161
gbp_per_share: 11.61
source_key: ft_price_20261106
状態: 現地主上場市場の二次情報で確認済み終値

株数

内容を開く

reference_date: 2026-10-31
date_published: 2026-11-02
発行済株式数: 877750024
自己株式数: 40315859
voting_rights_shares: 837434165
employee_trust_held_shares_2025_12_31_approx: 400000
employee_trust_shares_at_basis_proxy: 200000
employee_trust_at_basis_strictly_verified: いいえ
economic_shares_m_at_basis_proxy: 837.234165
market_cap_oku_GBP_using_voting_rights: 97.22610656
market_cap_oku_GBP_using_economic_denominator_proxy: 97.20288656
ordinary_issued_changes_Nov1_to_Nov6_verified: いいえ
denominator_basis: 発行済−自己株−2026年11月6日時点未確認の従業員信託0.2百万株代理。自己株と信託を重複控除しない。
source_key: lse_total_voting_rights_20261031
sensitivity_no_trust_mcap_oku: 97.22610656
sensitivity_trust_0_4_mcap_oku: 97.17966656

内容を開く

GBPUSD: 1.3352
日付: 2026-11-06
historical_market_spot_source: gbpusd_20261106
forecast_conversion_rule: 全予測2026-2037年でGBPUSD=1.3352固定。現実には変動し、感応度で見直す。

financial_actual_2025_IFRS_usdm

内容を開く

sales: 6164
costs_including_sbc: 5370
operating_profit: 794
profit_before_tax: 779
parent_attributable_profit_after_sbc: 625
parent_equity: 5289
cash: 557
gross_debt_incl_lease: 3327
simple_net_debt: 2770
company_reported_net_debt: 2759
cash_capex: 433
SBC_expense: 43
dividends_paid: 330
purchase_own_shares_paid: 502
FY2025_trading_profit_nonIFRS: 1211
US_sales: 3306
Other_Established_sales: 1855
Emerging_sales: 1003
source_key: company_fy2025_20f

financial_actual_H1_2026_IFRS_usdm

内容を開く

期間末: 2026-06-27
sales: 3097
COGS: 901
SGA_including_SBC: 1598
RD: 150
operating_profit: 448
net_interest_income: 10
interest_expense: 65
other_finance_cost: 18
associate_income: 5
profit_before_tax: 380
income_tax: 77
parent_attributable_profit_after_sbc: 303
noncontrolling_interest: 0
parent_equity: 5180
cash: 754
gross_borrowings_including_lease: 3785
company_reported_net_debt: 3019
simple_net_debt: 3031
company_net_debt_vs_simple_gap_explained_by_definition_usdm: -12
cash_capex: 190
SBC_expense_equity_settled: 34
dividends_paid: 205
cash_paid_for_own_shares_H1: 116
H1_equity_reduction_for_buyback_including_obligations: 250
H1_buyback_purchased_shares: 9076588
H1_buyback_purchased_cost_usdm: 137
H1_buyback_forward_contract_commitment_usdm: 113
H1_contingent_acquisition_consideration_liability: 286
source_key: company_h1_2026_6k

Q3_2026_actual_revenue_usdm

内容を開く

quarter_end: 2026-09-26
consolidated: 1551
sports_medicine_ENT: 507
advanced_wound: 454
orthopaedics: 590
US: 812
Other_Established: 456
Emerging: 283
source_key: company_q3_2026

2026_Q4_full_projection_from_guidance_usdm

内容を開く

consolidated

1763

by_segment

Orthopaedics: 687
Sports_Medicine_ENT: 582
Advanced_Wound_Management: 494

reported_2026_full_sales

6411

company_guidance_trading_profit_usdm_around

1250

company_guidance_free_cash_flow_usdm_around

750

company_guidance_underlying_revenue_growth

0.03

comment

2026Q4=6411−3097−1551; 6411は2025年6164に会社示唆約4.0%報告成長を適用した予測、確定実績ではない

at_asof_2026_11_06_financial_proxy_usdm

内容を開く

H1_2026_reported_parent_equity: 5180
post_H1_to_Nov06_parent_profit_forecast: 190
post_H1_to_Nov06_SBC_non_cash_equity_credit_forecast: 26
interim_dividend_declared_and_paid_post_H1_estimate: 131
extra_H2_buyback_equity_debit_before_Nov06_assumed: 0
post_H1_OCI_assumed: 0
calculated_proxy_parent_equity: 5265
cash_at_H1: 754
post_H1_pre_basis_fcf_proxy: 320
post_H1_pre_basis_prior_buyback_obligation_cash_settlement_proxy: 134
interim_dividend_payment_proxy: 131
estimated_cash_at_Nov06: 809
estimated_gross_borrowings_at_Nov06: 3785
unreconciled_exact_post_H1_event_data: 未確認
uncertainty: 2026-06-27から2026-11-06の実際の損益・現金・SBC交付・取得決済は未公表。2.50億USDの買戻しはH1資本に既に計上済みで、当該決済を再び資本控除しない。

prior_ex_div_payment_excluded_from_future_holder_flows

内容を開く

fiscal_year: 2026
kind: interim
usd_per_share: 0.156
confirmed_ex_date: 2026-10-01
confirmed_record_date: 2026-10-02
confirmed_payment_date: 2026-11-06
date_status: confirmed_by_issuer
cashflow_in_y10: いいえ
理由: 基準日11月6日終値から買う/同日終値で評価する旧株主群に新しい権利は付かず、基準日前に権利が分離済み。

追加データ・検証記録

分析ごとに収録された追加の前提、年度別データ、検証上の注意を確認できます。

追加データを開く →

分析に使用した資料

← AI銘柄分析一覧へ戻る　ヒートマップを見る →